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ABSTRACT 
 
 
dvances in reconstructive surgery are providing treatment options in the face of major 
trauma and cancer.  Body Sensor Networks (BSN) have the potential to offer smart 
solutions to a range of clinical challenges.  The aim of this thesis was to review the current 
state of the art devices, then develop and apply bespoke technologies developed by the 
Hamlyn Centre BSN engineering team supported by the EPSRC ESPRIT programme to 
deliver post-operative monitoring options for patients undergoing reconstructive surgery.   
 
A wireless optical sensor was developed to provide a continuous monitoring solution for free 
tissue transplants (free flaps).  By recording backscattered light from 2 different source 
wavelengths, we were able to estimate the oxygenation of the superficial microvasculature.  
In a custom-made upper limb pressure cuff model, forearm deoxygenation measured by our 
sensor and gold standard equipment showed strong correlations, with incremental reductions 
in response to increased cuff inflation durations.  Such a device might allow early detection of 
flap failure, optimising the likelihood of flap salvage. 
 
An ear-worn activity recognition sensor was utilised to provide a platform capable of 
facilitating objective assessment of functional mobility.  This work evolved from an initial 
feasibility study in a knee replacement cohort, to a larger clinical trial designed to establish a 
novel mobility score in patients recovering from open tibial fractures (OTF).   The Hamlyn 
Mobility Score (HMS) assesses mobility over 3 activities of daily living: walking, stair 
climbing, and standing from a chair.  Sensor-derived parameters including variation in both 
temporal and force aspects of gait were validated to measure differences in performance in 
line with fracture severity, which also matched questionnaire-based assessments.  Monitoring 
the OTF cohort over 12 months with the HMS allowed functional recovery to be profiled in 
great detail.  Further, a novel finding of continued improvements in walking quality after a 
plateau in walking quantity was demonstrated objectively.  
 
The methods described in this thesis provide an opportunity to revamp the recovery paradigm 
through continuous, objective patient monitoring along with self-directed, personalised 
rehabilitation strategies, which has the potential to improve both the quality and cost-
effectiveness of reconstructive surgery services.  
A 
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CHAPTER 1 
INTRODUCTION 
 
urgery is the management of choice in a multitude of medical conditions and scenarios.  
There tends to be multiple surgical options, and alternate conservative medical 
approaches.  Knowing which options to take, and when to take them can be difficult, with the 
decision being based on the results of clinical tests, the surgeon’s personal experience, and the 
patient’s wishes.  Following an operation, the road to recovery varies depending on patient 
physiology and co-morbidities, the surgical case, and the follow-up strategy.  Some patients 
will recover more quickly than others, and post-operative function may fall above or below 
that of the pre-operative state.  Peri-operative assessment therefore has multiple purposes, 
including: 
 
• Profiling patient indicators for surgery 
• Detecting post-operative complications 
• Informing and directing patient rehabilitation strategies  
• Evaluation of post-operative patient outcomes  
 
1.1.  Clinical Challenges 
 
Many challenges and limitations exist within the current patient assessment methods:  
 
• The pre-operative assessment for many conditions and procedures is often based on 
subjective measures (e.g. questionnaires) rather than objective clinical evidence 
• Physical assessment is often carried out on one occasion in the clinic, which may not be a 
reliable or accurate representation of the patient’s physiological or biomechanical status 
• Post-operative monitoring in the ward environment is prone to human error, non-
continuous, and lacking technological support 
• Assessment following hospital discharge is sporadic, with arbitrarily timed out-patient 
appointments 
• Lack of functional status updates to healthcare team and patients prevent timely 
adaptation of rehabilitation strategies and delay the detection of complications  
S 
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1.2.  Proposed Solutions 
 
A range of approaches have attempted to meet said challenges, including the implementation 
of clinical practice guidelines and scoring systems based on biochemical, physical and 
radiological tests.  Mobile phone applications and home care packages are starting to lessen 
the sharpness of the transition experienced at the time of hospital discharge, by retaining a 
communication link between the patient and healthcare staff.   Body Sensor Networks (BSN) 
are very much at the heart of this shift from subjective to objective patient assessment, 
snapshot to continuous measurements, and assessment in natural unrestricting environments 
such as the community setting.   
 
This thesis focuses on the design, development and implementation of bespoke technologies 
to support post-operative monitoring of patients undergoing reconstructive surgery.  In the 
acute period (in-patient care), wireless optical sensors are developed to provide continuous 
monitoring solutions for free tissue transplants (free flaps), allowing early detection of flap 
failure and improving chances of flap salvage.  In the longer term, an ear-worn activity 
recognition sensor (e-AR, Sensixa Ltd. and Imperial College London) is utilised to provide a 
platform capable of facilitating objective assessment of functional mobility in multiple 
environments with minimum healthcare support.  This is being developed with the aim of 
providing both healthcare staff and patients with feedback on rehabilitation progress, to allow 
early detection of complications, dynamic adaptation of rehabilitation strategies, and 
evaluation of surgical management to inform future operative management decisions. 
 !
1.3.  Thesis Overview 
 
The concept of BSN was developed by Professor Guang-Zhong Yang at Imperial College 
London, whereby pervasive devices may facilitate the provision of high quality, personalised 
healthcare through continuous monitoring of biophysical human parameters in natural, 
unrestricting environments.1 
 
Hypothesis – BSN facilitates smart post-operative monitoring solutions for patients 
undergoing reconstructive surgery.   
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• Chapter 2.  BSN has a role in health and social care 
 
This chapter introduces the concept of BSN in healthcare, including key technical 
considerations, study design, cost-effectiveness, and clinical translation.  A selection of case 
reports are reviewed to demonstrate how wearable technologies may provide solutions to 
current challenges across the health and social care spectrum.  The implementation of BSN as 
a vehicle for achieving the proposed paradigm shift towards community-based care where 
possible, as well as the future landscape of the research environment is proposed. 
 
 
• Chapter 3.  BSN in gait analysis: a review of the state of the art 
 
In this chapter, the normal gait cycle is described, along with the importance of the ability to 
walk to complete activities of daily living and its association with health status.  Sensor 
platforms are compared with regards to sensor input, number, and analysis technique, and a 
further review of those systems used for the assessment of gait in the setting of lower limb 
surgery is provided.  The ear-worn activity recognition sensor developed at Imperial College 
London is unusual in its location, and as such the effects of walking on head movements is 
reviewed, with practical conclusions and recommendations made regarding sensor design and 
implementation. 
 
 
• Chapter 4.  Objective mobility assessment in the home is feasible using wearable sensor 
technology 
 
The community-based care paradigm is explored through a prospective longitudinal cohort 
study in patients undergoing Total Knee Arthoplasty (TKA).  The feasibility of using a 
wearable sensor in the home environment is assessed through derivation of a mobility score 
using feature-based motion data analysis methods.  Expected post-operative recovery curves 
are produced using sensor data, with encouraging correlations to corresponding gold-standard 
mobility metrics.  The ability to perform blind classification of patients into chronological 
phases is demonstrated, including its application to identify patients deviating from the 
expected recovery trajectory.  
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• Chapter 5.  A wearable motion sensing system may provide a valid and reliable objective 
assessment method for patients undergoing lower limb reconstruction.  
 
Building on the outcomes of the previous clinical study, a further study is conducted, 
designed to facilitate the development of a more easily interpretable sensor-based mobility 
score – the Hamlyn Mobility Score.  The activity protocol is abbreviated and abstract mobility 
scores are replaced with meaningful kinematic parameters.  A thorough psychometric 
evaluation demonstrates comprehensive reliability and validity of the score for the assessment 
of functional mobility following reconstructive surgery. 
 
 
• Chapter 6.  The Hamlyn Mobility Score is able to quantify and characterise a patient’s 
return to functional mobility following post-traumatic lower limb reconstruction.  
 
The Hamlyn Mobility Score is implemented to provide an objective longitudinal report on 
return to functional mobility following post-traumatic lower limb reconstruction.  Differences 
in rate and extent of recovery are quantified according to fracture severity.  Novel findings 
associated with the lag in improvement of walking quality compared to capacity are 
described, as well as detection and characterisation of late post-operative complications.  
 
 
• Chapter 7.  A miniaturised, low-power NIRS device is capable of detecting pulsatile blood 
flow and quantifying changes in tissue oxygenation. 
 
The final technical chapter investigates the more acute aspect of post-operative monitoring 
after reconstructive surgery with the assessment of free tissue autograft viability.  A 
miniaturised wearable device based on optical technology is investigated using a novel free 
flap failure model.  The ability to quantify tissue oxygenation changes and detect the presence 
of pulsatile blood flow is encouraging, provoking discussion regarding clinical 
implementation and the potential for disruption to current post-operative monitoring 
strategies. 
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1.4.  Original Contributions of the Thesis 
 
1. Piloted a community-based activity protocol and validated a feature-based mobility 
assessment method following knee replacement surgery 
2. Developed and validated an objective, sensor-based mobility assessment method in 
patients following lower limb reconstruction 
3. Objectively profiled the 1-year recovery pathway of lower limb reconstruction patients  
4. Developed and evaluated a free flap failure model using upper limb cuff inflations 
5. Validated a miniature device for free flap monitoring, which provides both tissue 
oxygenation predictions and detection of pulsatile blood flow 
 
The contents of this thesis have resulted in the following book chapters, publications and 
conference proceedings: 
 
• Book Chapter:  Kwasnicki R M, Yang G Z. (2014) Clinical applications of body sensor 
networks.  In Nikita K (Ed.). Handbook of the Biomedical Telemetry. Wiley-IEEE 
 
• Book Chapter:  Yang G Z, Aziz O, Kwasnicki R M, Merrifield R, Darzi A, Lo B. (2014) 
Introduction.  In Yang G Z (Ed.) Body Sensor Networks (2nd ed.). Springer. 
 
• Publication:  Jarchi D, Wong C, Kwasnicki R M, Heller B, Tew G, Yang GZ. (2014) Gait 
parameter estimation from a miniaturised ear-worn sensor using singular spectrum 
analysis and longest common subsequence. IEEE Transactions in Biomedical Engineering. 
61; 1261:1273 
 
• Publication:  Bouarfa L, Atallah L, Kwasnicki R M, Pettitt C, Frost G, Yang G Z. (2013)  
Predicting free-living energy expenditure using a miniaturized ear-worn sensor: an 
evaluation against doubly labelled water.  IEEE Transactions in Biomedical Engineering. 
61; 566:575 
 
• Publication:  Kwasnicki R M, Hettiaratchy S, Jarchi D, Nightingale C, Wordsworth M, 
Simmons J, Yang G Z, Darzi A. (2014)  Assessing functional mobility after lower limb 
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reconstruction: a psychometric evaluation of a sensor-based mobility score.  Annals of 
Surgery. In press. 
 
• Presentation and conference proceedings:  Wong W, Zhang Z, Kwasnicki R, Liu L, Yang, 
GZ. (2012) Motion reconstruction from sparse accelerometer data using PLSR.  9th 
International Conference on Wearable and Implantable Body Sensor Networks (London, 
UK). 178-183 
 
• Presentation and conference proceedings:  Chen C-M, Kwasnicki R M, Lo B, Yang, GZ. 
(2014) Wearable Tissue Oxygenation Monitoring Sensor and a Forearm Vascular 
Phantom Design for Data Validation.  11th International Conference on Wearable and 
Implantable Body Sensor Networks (Zurich, Switzerland). 
 
• Presentation and published abstract:  Kwasnicki R M, Ali R, Jordan S J, Atallah L, Jones 
G, Darzi A, Yang G Z. (2013) An Affordable, Objective Peri-operative Assessment Tool 
for Knee Arthroplasty. Associations of Surgeons in Training (ASiT) International Surgical 
Conference (Manchester, UK)  International Journal of Surgery. 11(8); 569-746 
 
• Presentation and published abstract:  Kwasnicki R M, Hettiaratchy S, Simmons J, 
Nightingale C, Yang GZ, Darzi A. (2013) Personalised motion sensor directed 
rehabilitation after lower limb reconstruction – a new standard of care. Annual meeting of 
the American Society of Plastic Surgeons. (California, USA). Plastic and Reconstructive 
Surgery. 132 (4 Suppl 1):1-178 
 
• Presentation and published abstract:  Kwasnicki R M, Hettiaratchy S, Okogbaa J, Yang 
GZ, Darzi A. (2014) Re-Exploration of the Post-Operative Route to Functional Mobility 
After Lower Limb Reconstruction. Annual meeting of the American Society of Plastic 
Surgeons. (Chicago, USA). Plastic and Reconstructive Surgery Suppl. 
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CHAPTER 2 
CLINICAL APPLICATIONS OF BODY SENSOR 
NETWORKS* 
 
 
Abstract 
 
This chapter acts as a general introduction to the use of body sensor networks (BSN) in health 
and social care.  Initially, the key concepts of biotelemetry in healthcare are outlined: remote 
data collection, data transmission, expert review and feedback (so-called ‘closing the loop’).  
Technological advances central to facilitating scalable and cost-effective biotelemetry are 
reviewed, along with suggestions as to how these can be used to meet the changes in 
healthcare demands.  
 
The main body of the chapter considers the current uses of BSN during various stages of the 
healthcare pathway, as well as further applications in community-based inventions and 
sensing in extreme conditions such as military operations and expeditions.  Further, 
comments focused on current implementation challenges that we face including fault 
tolerance, security, safety concerns and how device implementation can be streamlined by 
considering clinician and patient preferences.  
 
 
 
  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
* Chapter based on Book Chapter: Kwasnicki R M, Yang G Z. (2014) Clinical applications of body sensor 
networks.  In Nikita K (Ed.). Handbook of the Biomedical Telemetry. Wiley-IEEE 
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2.1.  Introduction 
 
Using the body as the medium, a source of inspiration and energy, Body Sensor Networks 
(BSN) may facilitate the provision of high quality, personalised healthcare through 
continuous monitoring of human physiological parameters in natural, unrestricting 
environments.1 A BSN is not a specific system, but is in fact an architecture in which one or 
more sensors connected to the body, either wearable or implantable, may seamlessly 
communicate with each other to provide coordinated monitoring and intervention.  The 
simplest embodiment of each sensor consists of a micro-processing unit, battery pack, and 
wireless transmitter.  Future development is focused on the use of bio-inspired design to avoid 
this stereotypical architecture, and instead to rely on the body as the transmission medium and 
power source (through power harvesting), as well as to explore cellular level signalling and 
smart particles (a wireless network of mini-sensors) combined with novel sensing and 
imaging techniques.  The current generation of BSN components may use the same or 
different input measurements including temperature, motion, and surface conductance.  
Effective ‘on-node’ processing and storage is key to the wider deployment of the technology, 
although it is common to use a Local Processing Unit (LPU) for data aggregation and then 
transmit to the central database for potential intervention.  At this point, data may undergo 
further processing and fusion before being wirelessly transmitted to a central server.   
 
Advances in technology and high-quality research programmes continue to reshape the 
standards of healthcare.  In parallel, patient expectations have increased, and the general 
public expect to receive the latest treatment options available.  With a growing population and 
rising healthcare demands, it is vital that health-technologies and healthcare reform develops 
with sustainability in mind.  Pervasive sensing with BSN offers high-quality care that is 
potentially cost and resource-effective.  Part of the aim is to safely relocate appropriate 
healthcare services to the community setting, allowing patients to take a more active role in 
their own management.  Additionally, continuous patient monitoring strategies are likely to 
improve conventional clinic-based recordings of patient physiology, where time and resources 
are often wasted trying to capture transient pathological episodes. 
 
Platforms for BSN include wearable devices (such as a ring-like finger worn sensor for 
measuring heart rate and blood pressure), textile incorporated sensors (such as intelligent 
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vests with integrated ECG electrodes), and implantable or ingestible devices (including 
subcutaneous glucose sensors, or engineered pills that transmit core body temperature).  
Within the BSN architecture, these modalities may be combined to produce a hybrid platform 
capable of multimodal human physiological monitoring, for example, data from an ingested 
pill for core temperature monitoring may be combined with that of a wearable motion sensor 
to produce an early warning system for heat exhaustion in athletic performance.  Similarly, 
BSN may be combined with ambient sensors from wireless sensor networks (WSN) to 
facilitate context aware sensing, such as relating body temperature to that of the local 
environment.   
 
Communication plays a vital role in allowing the evolution of a BSN to that of a functional 
biotelemetric platform.  Data transmission must be reliable and secure, and importantly must 
have a low energy cost to preserve battery life.  On-node processing may reduce the volume 
demand for data transmission.  The destination of the data depends on the function of the 
platform.  A BSN designed to monitor the vital signs of a patient with heart disease would be 
suited to real-time communication with the local emergency department.  Patients at high risk 
of fatal cardiac events, such as a myocardial infarction (‘heart attack’), are often treatable, so 
long as the interval between the emergency call and the intervention is brief (often described 
as the ‘golden hour’).  A coronary occluding thrombus (clot) can be dissolved rapidly with 
medication, but the longer the heart muscle is starved of oxygen and nutrients the more 
widespread and irreversible the damage becomes.  Early detection of event-preceding vital 
signs may facilitate a more timely intervention and more lives saved.   
 
Alternatively, data collected from a BSN assessing post-operative gait in knee arthroplasty 
patients may be more suitably sent to a central server for kinematic modeling.  It is less likely 
in this case that there be a need for emergency intervention, yet supervised rehabilitation, 
including goal setting and strengthening regimens are essential for optimal recovery.  A 
personalised follow-up strategy is best achieved with supporting functional data gained from 
regular, objective mobility assessments. 
 
Another important drive of BSN is that of a ‘closed loop’ system such the ‘artificial pancreas’ 
device.  Patients with diabetes lack the important homeostatic mechanism required to control 
their blood sugar effectively.  Normo-physiologically, blood sugar levels are detected at 
multiple sites, initiating a response of insulin or glucagon secretion to reduce or increase 
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sugar levels correspondingly.  In diabetes, the failing pancreas is replaced by a BSN which 
firstly allows glucose levels in the interstitial fluid (between cells) to be monitored by a 
subcutaneous sensor, and secondly for those levels to be used to titrate the dose of exogenous 
insulin or glucagon infused into the patient.  Frequent, accurate adjustments of blood sugar 
not only reduces user demand (e.g. the need for self testing and injecting) but also may 
improve outcome as a result of finer regulation of the blood sugar profile.  A self-sustainable 
platform, such as the artificial pancreas, is the desirable outcome for many biotelemetry 
systems. 
 
 
 
Figure 2.1.  Examples of BSN in the healthcare pathway.  In all user scenarios, the BSN must have a 
positive benefit/demand ratio. A healthy user requires appropriately pervasive monitoring, preferably 
through a device already carried.  Implementation of a BSN with higher user demand is more 
acceptable in high-risk subjects as their potential benefit is likely to be greater. (Figure by Dr Robert 
Merrifield) 
 
 
2.1.1.  Hypothesis 
 
BSN has a role in health and social care. 
  
! 33 
2.2.  Healthcare paradigm shift for pervasive sensing  
 
Advances in medical care and human hygiene are causing continuous evolution of the 
population and a corresponding change in healthcare demands.  The population is not only 
growing, but is ageing, with the number of people over 65 predicted to double in the next 10 
years.2 In addition to the rise in age-related diseases including cancer, heart failure, arthritis 
and dementia, we are also experiencing an obesity epidemic. 
 
Consequently, 29% of the UK population are living with a long-term medical condition, of 
which Type 2 Diabetes Mellitus forms a significant proportion.  Today, 80% of the healthcare 
budget is spent on chronic disease.3  
 
In the UK, when the National Health Service (NHS) was created in 1946, it was designed to 
manage acute illness.  In the early 20th century, infectious diseases were more prevalent, and 
conditions often associated with long-term health support such as cancer and severe trauma 
had vastly higher mortality rates.  Patients were mostly managed through short-term 
concentrated inpatient care where they would either be cured and discharged, or would pass 
away in hospital.  Modern hospitals now have relatively small departments dedicated to 
managing this type of patient, and instead have facilities for a wide variety of specialist 
services including health screening, elective surgery, psychiatric care, interventional 
radiology, haemofiltration for those waiting for renal transplants and so on.  Ironically, it is 
increasingly unusual for one to see a sick (critically unwell) patient in hospital, due to 
improved access to care, early detection and presentation of disease, and advances in 
monitoring and supporting patient physiology. 
 
The quality of patient care is improving in line with research advances in pharmacology, 
technology and surgery.  Structured research programmes allow valuable data collection and 
organisation, which initiates and supports the progression of many specialties towards 
evidence-based patient management.  When deciding how to manage a patient, the most 
effective and reliable plans will be those based on high quality patient information.  
Information can be collected in a variety of forms, ranging from simple tasks such as taking a 
patient’s history and clinical examination, to more advanced methods including 3-
dimensional imaging, or obtaining a tissue biopsy for histological assessment.  Often, 
intermediate assessments are performed in the clinic setting such as blood pressure readings, 
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or capturing an electrocardiogram to map the electrical activity of the heart.  This data, 
including that from clinical examination, gives the doctor a snapshot impression of the 
patient’s physiological state.  However, human physiology is dynamic, and pathology has a 
tendency to be sporadic and as such is often missed.  This particular situation can arise on 
many levels within the healthcare setting, with important recognised sequelae.  The awareness 
of this low diagnostic sensitivity phenomenon is such that when a ‘snapshot’ test result 
returns negative, the healthcare professional may interpret this as 1. True negative, there is no 
pathology, the patient is healthy and can go home, or 2. False negative, we cannot confirm 
pathology, but neither can we allow the patient to go home because we are not sure.  Situation 
1 may result in a missed diagnosis which would compromise patient safely, whereas situation 
2 is likely to cause a number of inappropriate hospital admissions and unnecessary further 
investigations.  This is one situation where a continuous, and potentially remote, data 
collection method might provide a solution. 
 
There are many resource-demanding scenarios associated with the management of chronic 
disease, and of the elderly population.  In each scenario, whether in community care, 
diagnostics, rehabilitation or any other, the key components are first the efficient collection of 
valuable patient information, and second the accurate processing of the data in order to 
determine further management strategies.  To reiterate the scope of these long-term healthcare 
demands, three typical case examples include the typical follow-up and rehabilitation of a 
patient with arthritis who has undergone a hip replacement, or monitoring and advising an 
overweight child who is at risk of developing diabetes, or titrating (optimising) the dose of 
medication given to a patient with Parkinson’s disease to ease their symptoms.  A number of 
these scenarios may be more effectively managed through the use of BSN, either in the 
clinical setting or at the patient’s home.   
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2.3.  Usage Scenarios 
 
This section provides a non-exhaustive review of BSN applications to meet the current 
healthcare challenges, and is organised according to the clinical setting (Table 2.1).   
 
 
2.3.1. In the community 
 
One day in a standard hospital bed, without an operation or specialist tests, can cost up to 
£400.  Although cost alone provides a strong motive to reduce the length of patient stay in 
hospital, there are added risks including hospital acquired infections (HAI) and the potential 
consequences of immobility such as muscle wasting and blood clotting conditions. 
 
This is particularly important when considering the elderly population, who are more at risk 
of HAI and losing their independence following prolonged bed rest.  Monitoring the elderly, 
and other high-risk populations such as the immune deficient and the disabled, especially 
during winter, may allow healthcare professionals to be alerted should their attention be 
required (the elderly often fail to seek medical attention), but also reduce unnecessary hospital 
appointments through remote consultations.   
 
BSN in the community should improve overall healthcare standards, as well as changing the 
location of treatment.  For example, the treatment of patients with Diabetes Mellitus (DM) 
requiring exogenous insulin has made considerable advances through BSN technology.  DM 
is a chronic metabolic disorder in which the patient either fails to produce enough insulin, or 
becomes resistant to it effects.  This results in a dangerous inability to control blood glucose 
autonomously, and as such the patient must manage the balance actively with multiple daily 
finger prick glucose tests and appropriate insulin injections.  Not only does this method of 
management reduce quality of life, in the majority of cases the blood glucose control is vastly 
inferior to that of healthy subjects.   
 
Table 2.1 – Clinical applications of BSN 
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Clinical Applications of BSN 
C
O
M
M
U
N
IT
Y
 
 
Promoting healthy lifestyle choices and improving chronic disease management 
D
IA
G
N
O
ST
IC
S 
 
Replacing ‘snap-shot’ clinical data with continuous pervasive monitoring to reflect true 
physiology in unrestricted, natural environments 
• Remote patient surveillance for cost-effective, appropriate medico social 
support, including detection of acute deterioration 
- Bespoke BSNs with wireless communication capabilities facilitate a 
medically supervised home care package 
• Raising awareness and modifying lifestyle behaviour through user-friendly 
interventions at primary care level  
- Real-time lifestyle assessment and feedback through activity pattern 
detection and motivational reaction   
 
 
 
 
Next: Safely shifting the responsibility and setting of appropriate healthcare 
scenarios to the patient in their home  
 
 
• Encourage ambulatory patient assessment in order to optimise diagnostic 
sensitivity in more realistic environments 
- Streamlined cardiac arrhythmia detection through autonomic data organisation 
and user-controlled electronic symptom tagging 
• Investigating dynamic patient symptomatology in response to fatigue, natural 
diurnal variation and medico-surgical interventions, to refine diagnostic accuracy 
and titrate pharmacological therapy 
- Supplementing subjective, qualitative data with objective measures such as 
motion/location estimation alongside patient activity diaries  
- Remote ad hoc consultations using a web interface with integrated home 
worn sensor inputs  
 
Next: Reducing resource demand through autonomic sensing protocols and closed-loop 
systems combining monitoring with therapeutics 
Table 2.1 – Clinical applications of BSN 
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Clinical Applications of BSN 
PE
R
I-
O
PE
R
A
TI
V
E 
 
High-quality patient data, collected remotely and stored electronically, which can 
be continued following discharge in a home environment 
 
EX
TR
EM
E 
EN
V
IR
O
N
M
EN
TS
 
 
Pervasive monitoring of vital signs in hazardous, unpredictable environments 
• Utilising wireless BSNs to collect detailed bioinformatics, including during 
the ward-to-home transition period, with secure integration with electronic 
medical records 
- Combined sensor inputs allow inference of several vital signs, with 
mobile phone or ward based data relay stations to allow raw/processed 
signals to be sent to a central server 
• Pervasive motion sensors provide objective kinematic data, allowing 
pervasive monitoring of functional rehabilitation 
- Post-operative analysis of patient biomechanics with BSNs allows early 
detection of surgical complications characterised by movement 
abnormalities 
Next: Pervasive sensing to indicate need for surgery, prediction of outcome, and 
personalisation of post-operative follow-up  
 
• Remote surveillance of vital signs in combat/hazardous environments  
- Simulated environments and events such as high humidity, extreme 
temperatures and haemorrhage allow training of BSN systems to recognise 
and report notable incidents 
• Smart sensor integration with personal apparel (such as smart textiles), including 
rescue medication delivery apparatus 
- Pervasive biochemical sample interrogation, skin surface conductance and 
salivary hormone profiling; minimally invasive tissue and blood evaluation 
with micro-needles for oxygen, CO2, lactate, electrolytes 
 
 
Next: Combining implantable and wearable sensors for continuous performance 
monitoring, with retrospective data analysis for training evaluation and psychophysical 
event preparation. 
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The consequence of poor glycaemic control is an increased risk of micro and macro-vascular 
disease including ischaemic heart disease, stroke, renal failure, blindness and ischaemic limbs 
often requiring amputation.  A miniature, continuous subcutaneous insulin infusion (CSII) 
device, known as the ‘patch pump’, is revolutionising the management of diabetes.  Through 
simple algorithms using minimal information entered by patient, the device calculates the 
necessary insulin dose, including compensatory increases during meal-time, and provides a 
natural delivery throughout the day through an indwelling catheter (which only needs 
replacing twice a week).  When combined with a continuous glucose-monitoring device, even 
less manual data input is needed.  In addition, some devices are able to delivery both insulin 
and glucagon, allowing control of both high and low blood sugar levels.  CSII, also known as 
the ‘artificial pancreas’, claims the responsibility for glycaemic control, and also has been 
shown to significantly improve the glycosylated haemoglobin levels (HbA1c) which causes a 
marked reduction in the risk of diabetic complications and therefore increased cost-
effectiveness.4 
 
Central to the natural history of many diseases there are often lifestyle choices including diet, 
exercise, alcohol use and smoking.  Desiderius Erasmus was the first to say that ‘prevention is 
better than a cure’ and today we actively target those who are making unhealthy lifestyle 
choices with media campaigns and new technology.  One cost-effective, scalable approach to 
this promoting healthy living is through utilisation of smart phones, which already contain 
useful inbuilt hardware and communication capabilities.  The key to tackling obesity is 
finding an effective method of rebalancing the food intake – energy output ratio.  As such, 
multiple smart phone applications are combining food intake diaries with activity monitors in 
order to make the user aware of why they might be gaining unwanted weight.5 The creative 
approach of the UbiFit wellness system 6 projects activity levels onto a the condition of a 
virtual garden, providing the user with regular, graphical feedback.  Other products such as 
Nike+ and Map My Run allow the user to share workout data with friends on social 
networking sites. 
 
Regarding the efficacy of these system, no randomised controlled trials (RCT) were found 
(May 2012), however, some low level evidence shows that during a case – control study the 
intervention arm, using a mobile phone activity and diet application, incurred significant 
weight loss whereas the control arm did not.7 The next step in this research is to implement a 
robust smart phone application in a large scale RCT to assess the value of this technology in 
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weight management.  A simple tool with the ability to influence behavioural economics, 
particularly incentives, norming, and ego 8 may play an important role in dealing with the 
obesity epidemic.  The phone application ‘ActiveMiles’, under development at the Hamlyn 
Centre, Imperial College London, is one example of such technology (Fig. 2.2).  Paying 
particular attention the beneficial exploitation of human psychology, ActiveMiles allows the 
primary user to compare their activity to others within a chosen cohort (e.g. Classmates, 
weight management group), as well as directly competing against a chosen friend or rival – 
the so-called ‘Nemesis’.  The potential for competition, extending the access of personal 
activity levels, and raising awareness regarding the variation in performance of 
contemporaries, is likely to act as an activity-promoting behavioural intervention. 
 
 
Figure 2.2.  Example screenshots of ActiveMiles (Imperial College London, UK) showing activity 
levels including that of their associated group and chosen nemesis (left), as well as geographical 
activity review (right). (Figure by Dr Robert Merrifield) 
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2.3.2.  Diagnostics 
 
When evidence based medical practice (EBM) is used wisely, without discounting the unique 
features of the case at hand, it has the potential to improve patient outcomes by utilising the 
results of one or more research studies. Diagnostics, and EBM in general, requires high 
quality patient information, i.e. reliable, reproducible, accurate, representative, specific, and 
contextualised.  BSN are beginning to play a more central role in improving the quality of 
patient information through continuous, pervasive monitoring.  There are several examples of 
this in everyday healthcare. 
 
Considering the management of cardiac arrhythmias (CA), often events are sporadic, and as 
such are often difficult to capture in a snapshot diagnostic investigation.  Misdiagnosis of CA 
may result in life threatening consequences such as stroke and cardiac arrest.  Although there 
are a variation of CAs, each with different aetiology and symptomatology, current medical 
practice often involves clinical examination and electrocardiography (ECG).  ECG provides a 
short cardiac trace that allows the rhythm to be analysed for diagnostic purposes.  This is 
often inadequate for diagnosis, and as such several technological devices and techniques have 
been devised and implemented.9 
 
In a scenario where the initial ECG is negative, patients are either admitted to a ward for 
continuous inpatient cardiac assessment over 24-48 hours or alternatively sent home for 24-
hour ambulatory cardiac monitoring using a Holter monitor.  A Holter monitor records 
electrical signals from the heart via a set of wired electrodes attached to the chest.  The 
electrodes are connected to a base station unit worn on the patient’s belt or hung around the 
neck.  The device improves the management process through the facilitation of continuous 
monitoring in the patient’s natural environment.  However, the device is quite bulky, and 
therefore likely to affect the patient’s behaviour.  Additionally, the entire sequence of raw 
data collected by the device (limited by memory and battery constraints) must be reviewed by 
a physician at the end of the collection period, which is time consuming and does not allow 
warning of the healthcare team at the time of a cardiac event. 
 
A further improvement to the management of CAs is the external loop recorder (ELR), which 
avoids the memory and battery life limitations of the Holter monitor by data collection being 
user-initiated upon experiencing symptoms.10 ELRs also offer software that automatically 
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detects arrhythmias such as Atrial Fibrillation (AF).  ELR over 4 to 7 days detects 
arrhythmias in 6-8% of patients that had a negative 24-hour Holter test, hence showing 
greater diagnostic sensitivity.11 Further, in patients who are at high risk of unsafe CAs, an 
Implantable Loop Recorder (ILR) may be used.  This subcutaneous device also features 
software capable of detecting arrhythmias, which conveniently prompts data saving 
immediately before, during and for a short duration after the event.  This significantly reduces 
the amount of data passed on to the physician for review, and reduces energy consumption 
allowing the implant to function for up to 2 years post-implantation.12 
 
 
 
Figure 2.3.  Advances in cardiac monitoring show a trend of increased resource demand alongside 
improvements in sensitivity.  Developing a highly sensitive diagnostic tool with low resource demand 
is one target for BSN. (Figure by Dr Robert Merrifield) 
 
 
Mobile Cardiac Outpatient Telemetry (MCOT) combines Holter monitor and ILR techniques 
to produce a wearable device capable of continuous data collection, but with daily data 
transmission to a central library for processing and review.  The data is electronically tagged 
by the patient at the onset of symptoms, complemented by feature detection software to 
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maximise the cost effectiveness of the service and the diagnostic sensitivity.13 Future 
development of MCOT to close the feedback loop, as with the artificial pancreas, may be to 
link therapeutic action in response to data collected such as rescue medication delivery or 
cardiac defibrillation in ventricular fibrillation. 
 
Many clinical conditions are dynamic in a sense that the associated symptom severity and 
character can vary depending on factors such as a medication’s duration of action, systemic 
illness, and environmental changes.  Also, many conditions deteriorate over time, which 
requires reassessment, and occasionally re-diagnosis.  Parkinson’s disease (PD) for example 
is a neurological disorder characterised by tremor, bradykinesia (slow movements), rigidity 
and impairment of postural balance.14 Current diagnostic strategies mainly involve clinical 
examination, and exclusion of other differential diagnoses that may be seen on 3D imaging, 
neurological tests and blood tests.  BSN in the form of motion sensing has been trialed in 
characterising the movement patterns of patients with PD, for potential use in diagnosis but 
also to assist in titration of medication regimes and monitoring disease progression. 
 
In a simple but effective study, Cavanaugh et al. collected accelerometry data from a small 
cohort of PD patients for 1 week at baseline and at 1 year follow-up, in order to explore long-
term changes in daily ambulatory activity and how these measures compare to conventional 
clinical measures of gait and disease severity.15 Clinical testing consists of questionnaires 
regarding limitations of activities of daily living, and physician-led movement analysis during 
a variety of short activities.  Although the tests provide a score on the Unified Parkinson’s 
Disease Rating Scale (UPDRS), they are limited, as they remain subjective, snapshot 
assessments.  Accelerometer data collected over days or weeks can be analysed using a 
variety of methods, such as machine learning techniques for activity classification and pattern 
recognition, specific detailed analysis of signal patterns for biomechanical profiling including 
gait parametrics, activity indexing whereby the magnitude of the motion data is taken and 
subdivided into variable activity intensities, and many more.  In Cavanaugh’s study, 
accelerometer data showed objective reductions in the amount and intensity of daily 
ambulatory activity but not in its frequency or duration.  
 
Moving from observational studies to clinical translation in the form of telemetry platforms in 
diagnosis and disease monitoring, Bonato et al. developed MercuryLive, which is a system 
that connects wearable sensors to a laptop-based data collection engine and a web-based 
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graphical user interface with video conferencing capabilities.14 MercuryLive is programmed 
to conduct automatic data analyses, which could provide the user (and their care team) with 
estimates of clinical scores reflecting disease severity at appropriate intervals, avoiding a 
formal visit to the hospital.  Based on preliminary test results, the authors speculate that 
frequent longitudinal observations will allow clinicians to adjust patients’ medication regimen 
more effectively. 
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2.3.3.  Peri-operative 
 
The scope for peri-operative BSN applications is vast, as by definition this time period 
describes before, during and after an operation.  Every operation has a risk of complications, 
which may arise from the anaesthetic, the surgery itself, or just as a result of being in a 
hospital.  As many operations are elective, as opposed to emergencies, it is essential that the 
risk of peri-operative morbidity and mortality is minimised.  Although this section will focus 
on BSNs for inpatient care and post-operative recovery, uses of biotelemetry in the pre-
operative setting must not be overlooked.  Pre-operative continuous pervasive monitoring 
may be useful in developing an evidence-based approach to determining the need for, and the 
timing of a particular operation.  Similarly, assessment of pre-operative fitness allows 
prediction of post-operative morbidity,16 which may allow services to plan resource allocation 
and personalise patient follow-up strategies. 
 
Patients in hospital are monitored according to their individual needs.  Monitoring is 
conducted through many strategies including continuous data collection from worn devices 
(e.g. Pulse oximetry), observations from nurses and other healthcare staff (eg. respiratory rate 
and temperature) and through specific investigations such as blood tests, urinalysis, and 
imaging.  Results are most often inserted into the patient’s paper-based notes, though many 
more complex test results will be available on a computer database.  Each patient on the 
intensive care unit has their own nurse and hourly observations are recorded, whereas a 
patient on a standard hospital ward most likely will have observations recorded every 4 hours.  
Patient monitoring is resource demanding, subject to human error and non-continuous.   
 
The LOBIN platform (Locating and Biomonitoring by means of Wireless Networks in 
Hospitals) combines e-textiles and wearable technologies to provide remote location data and 
healthcare monitoring.17 This novel IT platform is an excellent example of a BSN, capable of 
monitoring physiological parameters such as ECG, heart rate, angle of inclination, activity 
index and body temperature, as well as allowing location tracking of patients within the 
hospital.  Additionally, software designed to identify abnormal ECG traces can trigger an 
alarm.  This wealth of data is collected using a smart e-textile shirt, and is transmitted through 
a low-cost wireless sensor network infrastructure based at the hospital.  This boasts the 
advantage of automatic electronic documentation of patient information, which could then be 
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transferred to relevant displays and settings such as a tablet PC on a ward round, or to an on-
call surgeon’s home PC when considering an ‘out of hours’ intervention.  
 
The system hardware consists of 2 subsystems, the physiological sensors and a wearable data 
acquisition device (WDAD).  The physiological parameters are calculated using data from 3 
sensor inputs: e-Textile electrodes, tri-axial accelerometer and thermometer.  The WDAD 
contains a data acquisition and processing board (DAPB) and a wireless transmission board 
(WTB).  Preliminary tests to assess the feasibility of using the device in a clinical setting were 
conducted, allowing validation of the sensor measurements and providing feedback from the 
patients and healthcare staff.  Appropriate post-feedback modifications of the software and 
smart shirt dimensions will soon result in larger scale application of this technology. 
 
Following an operation, or time in hospital, it is important to undergo a period of functional 
rehabilitation.  A focused effort serves to ensure that the patient may resume standard 
activities of daily living and accordingly, regain optimum quality of life.  In many cases, 
patients are discharged from hospital with a set of rehabilitation exercises to perform at home, 
for example following a knee replacement.  A structured and timely recovery, to a high 
functional level, is likely to reduce the amount of time taken off work, and prevent future 
complications and healthcare resource requirements.  Accurate, reliable home-based 
assessment of function may facilitate improved recovery, and allow those patients who are 
struggling to be identified for additional support. 
 
The Gait Evaluation Differential Entropy Method (GEDEM) has been used to analyse gait 
data obtained from a tri-axial accelerometer in patients following anterior cruciate ligament 
(knee) reconstruction.18 There are many gait metrics, with multiple methods of acquisition.  
Simple parameters such as gait speed and cadence (steps per minute) are often supplemented 
with those derived from key gait events namely heel contact and toe off.  The phase between 
toe off and heel contact is known as the swing time, and the time between heel contact and the 
next toe off is known as the stance time.  Lower limb acceleration rates and ground reaction 
forces are also recordable with multi-sensor systems and force plate platforms.  Trunk gait 
accelerometry is able to show minor changes in normal walking caused by pathological 
biomechanics and learnt injury behaviour.  In this study, patients were fitted with an 
accelerometer and asked to walk along a straight 40m walkway.  GEDEM analysis revealed 
highly significant reductions in mean spectral differential entropy post-operatively in the 
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medio-lateral and antero-posterior axes of the signal, implying decreased gait variability after 
surgical repair.  At 6-8 months after surgery, there was still a significant difference in 
mediolateral spectral differential entropy compared to the control group, suggesting some 
rotational instability remained. 
 
Objective gait analysis is a luxury that is often unavailable as part of standard surgical follow-
up, mostly due to centres lacking expensive gait laboratories and trained technicians.  Current 
clinical evaluation of knee stability is limited to questionnaires and simple examination 
techniques, which often do not correlate well with functional outcome.  Use of BSN in an 
efficient, low-cost gait analysis setting would facilitate high value data collection which could 
be used to improve clinical practice, through personalisation of post-operative care and 
meaningful evaluation of surgical techniques. 
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2.3.4.  Extreme Environments 
 
When a healthy body is put under unusual stress, there may be obvious, or not so obvious 
effects.  Human physiology tends to adapt to meet external challenges, but often due to the 
extreme environment or circumstance we are not aware of exactly how the body is changing.  
Paradoxically, it is a time where human monitoring is vital, yet very rarely carried out.  
Capturing and investigating said physiological coping mechanisms may give more insight 
into how the body is responding, what the threshold of human adaptation is, and at what stage 
the extreme conditions are causing irreversible damage and there becomes a necessity for 
medical support.  Furthermore, answering these questions is undoubtedly important to permit 
optimal design specifications for specialised BSN in a variety of settings. 
 
Extreme environments that the human body may encounter include elite sport, expeditions, 
and military pursuits.  In all of these settings, peak physical and mental condition must be 
maintained throughout to support top-level performance.  A subject’s control of body 
temperature, water and electrolyte balance, energy levels and avoidance of unnecessary 
external insults will determine their relative success.  It is not unusual for dehydration of up to 
8% body mass to occur during physical activity 19 yet just a 5% loss is enough to cause a 
significant increase in heart rate, core temperature and perceived exertion ratings, with 
concomitant decrease in blood volume, stroke volume, cardiac output and skin blood flow.20 
Impaired cardiovascular and thermoregulatory function is likely to have a negative effect on 
physical and mental performance.  However, verifying said parameters outside of a controlled 
environment is technically challenging.  
 
Climbing Mount Everest is universally considered extreme, and it is one scenario in which a 
telemetric BSN platform was applied to monitor the health status of 3 mountaineers.21 A 
combination of wearable and ingested sensors was used to provide heart rate, 3-lead ECG, 
accelerometry, global positioning system (GPS), surface body temperature and core body 
temperature.  Time and geo-stamped data collected by the user’s local receiver was 
aggregated every minute and transmitted to a laptop computer at Everest Base Camp (EBC).  
Data from EBC was sent via satellite (Imarsat) using transmission control protocol/internet 
protocol to Yale University School of Medicine, United States, rerouted from Malaysia.  Vital 
signs and global positioning was monitored for 24-hours, in which 2 of the 3 sensors 
functioned 100% of the time, with the other functioning at around 75%.  Although the sensing 
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only covered 24 hours, it is commendable that even through periods of intense and arduous 
activity at 17,800 ft, none of the subjects were ever without a full set of data for more than 25 
minutes. 
 
Another extreme setting in which improved physiological monitoring would be of great 
benefit is in field-based military personnel.  Firstly, the physical strain of non-contact 
operations in many battle climates (eg. Middle East) is of a similar magnitude to that of many 
elite sporting activities.  Secondly, to add the risk of injuries related to a war-zone one might 
argue that the soldiers should be monitored as if they were about to undergo an invasive 
procedure.  As pervasive vital signs monitoring has already been discussed in this chapter, we 
have chosen an example of how manipulation of bioinformatics can be used to predict the 
extent of haemorrhage, which is the leading cause of death on the battlefield.   The need for 
an accurate predictor of haemorrhage comes from the phenomenon observed whereby during 
the early compensatory phases of haemorrhage, no clinical alterations occur in mental status, 
pulse character, blood pressure, oxygen saturation, respiratory rate, or blood pH.  This results 
in patients who appear stable, to suddenly and irreversible ‘crash’ (decompensate) due to 
massive blood loss.  
 
In order to investigate the effects of mass haemorrhage in human subjects, a safe and realistic 
model was designed.22 This involves applying negative pressure to the lower body, which 
simulates controlled hypovolaemic hypotension by the redistribution of blood away from the 
head and heart.   Lower body negative pressure (LBNP) was shown to accurately mimic 
haemodynamic, autonomic, respiratory and metabolic compensatory responses when 
compared to the early stages of haemorrhage in anaesthetised animal models, and 
computational models.23 Using this model, Convertino et al. 24 applied feature extraction and 
machine learning methods to recognise and predict hypovolaemic cardiovascular collapse 
from complex, multi-input data sequences.  Continuous data was collected from a pulse 
oximeter, transthoracic impedance plethysmography, a near-infrared tissue perfusion monitor, 
transcranial Doppler flow probe and a finger infrared blood pressure monitor.  This provided 
respiratory rate, heart rate, arterial blood pressure, stroke volume and cardiac output.  In 28 
subjects, LBNP was gradually increased to simulate a gradual reduction in central blood 
volume.  The algorithm was 96.5% accurate in predicting the level of LBNP.  When the data 
set was expanded using computer-generated model subjects, the refined algorithm was 
capable of tracking central blood volume reduction in real time at 95% accuracy.  If military 
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personnel were able to wear similar sensors, this method may be used to immediately, 
remotely, and continuously assess the physiological status of the subject, enabling efficient 
resource allocation and critical casualty prioritisation in multi-trauma scenarios.   
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2.4.  Opportunities and Future Challenges 
 
In this emerging field, there are many opportunities for sensor development and application, 
all with their own specific challenges and questions to explore.  Although the relationship 
between technical and clinical development is entwined, the matters discussed, or rather the 
questions raised, are more so from a clinical perspective.  Readers from a variety of 
backgrounds should, at a minimum, have an awareness of the holistic approach to BSN and 
biotelemetry, as we all share the common goal of improving user outcome.  In healthcare, this 
may be extended to improving patient outcome, increasing quality of life, and improving the 
socio-economic efficacy of healthcare provision. 
 
 
2.4.1.  User Preferences 
 
Biotelemetry projects, as with all product developments, are often approached from 2 
different angles; top down, in which a clinical problem is identified and a system is developed 
to solve the problem, or bottom up, when an existing technology is applied to various clinical 
problems in an attempt to solve them.  Of course, a mixed approach may be employed.  It 
must be remembered, as stated at the beginning of the chapter, that BSN are not specific 
systems for solving a clinical problems (or otherwise), they are the architectural backbone that 
may be manipulated and applied to various scenarios.  Whichever approach is being taken, 
recording and considering user preferences is fundamental in ensuring successful uptake of 
the technology, optimal data collection, efficient and meaningful data processing, and 
consequently improvements in patient outcomes and cost benefit.  In a bottom-up scenario, if 
the sensing apparatus cannot be modified, the study or usage protocol and the manner in 
which it is introduced to the user should be appropriately designed.   
 
The user is not only the subject wearing the device, but also the healthcare professional 
prescribing it, and any supporting staff who may be involved in data analysis and further 
management.  The user preferences of patients and their doctors do not always match.  This 
was highlighted by a recent systematic review by Bergmann et al.,25 which reported that 
patients preferred small and compact sensors that are easy to operate, don’t affect normal 
daily activities, and reduce the required travel to clinics and hospitals, whereas clinicians want 
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sensors that have a real-time function, are capable of adapting dynamically to different 
situations, and that are centered around assisting patient training, education and self-
management.  Additionally, it should be noted that in most cultures, patients have a great deal 
of respect for their doctor leading to 2 important points: firstly, if the doctor believes in the 
device, it is likely that they will be able to convince the patient to wear it, and secondly, the 
patient does not want to replace their doctor with a sensor and so it may be prudent to 
describe biotelemetry as a continuous information portal from the patient to the doctor.  
Finally, if the sensor is well received by all users, it is likely to have a positive effect on 
patient outcome thus improving commercial viability.  
 
Disappearance is a concept of increasing popularity in the BSN community, referring to the 
level of pervasiveness of a sensing system.  Miniaturisation is not the only method of 
reducing the awareness of sensor usage; furthermore, size restrictions often impact negatively 
on the functionality of the device.  People wear a variety of garments and accessories for 
fashion and functional purposes.  It is not farfetched to foresee one or more sensors 
disappearing within the daily wearable apparel.  In fact, this is already occurring, for example, 
many sports watches function as heart rate monitors, and training shoes may be fitted with 
off-the-shelf GPS devices and accelerometers for exercise monitoring.  There must be a 
balance however between disappearance and functionality.  Most users consider the burden-
benefit ratio, whether or not this is verbalised.  For instance, should a patient suffer from 
sporadic cardiac arrhythmia, they are likely to prefer a slightly larger, more apparent device 
that was highly effective at alerting themselves and appropriate healthcare professionals when 
a dangerous rhythm is detected, rather than a less effective miniaturised sensor disguised as a 
bracelet.  Conversely, if a device monitors food intake, or everyday health parameters, the 
health benefits are perceptually smaller and this must be offset with a more discrete sensor 
design.  Possibly the increasing feasibility of implantable or ingestible sensors will 
indisputably swing the balance of modern BSN implementation in a favourable direction. 
 
Although few studies have assessed the ability for BSN to improve patient outcome, the 
theory is closely linked to behavioural economics.  In other words, how can BSN change the 
way a subject behaves, or feels, in order to improve their outcome?  Consider the concept of 
competition, for example, if a group of school children were taught the benefits of exercise, 
then were fitted with activity monitors it is expected that the children would exercise more in 
an attempt to score the highest and ‘win’ the competition.  Or similarly with motivation, if 
!! 52 
someone is given a set of exercises to perform every day as part of a rehabilitation 
programme, they are more likely to complete this if they have the extrinsic motivation of 
being supervised by their physiotherapist or doctor, or even the immediate feedback from a 
motion sensor.  Therefore the sensor’s ability to direct behaviour must be evaluated. 
 
 
2.4.2.  Clinical Translation 
 
Implementation of healthcare technologies is largely dependent on cost.  More specifically, a 
cost-utility analysis must be performed in order to provide a monetary value on the impact of 
the technology or intervention on a patient.  This is often calculated using quality-adjusted life 
years (QALY’s), which are decided by multiplying the resultant quality of life change by the 
number of years where that quality of life will be experienced.  Though unofficial, in the UK, 
if the technology does not gain 1 QALY for less than around £30,000, it is unlikely that the 
National Health Service (NHS) will implement it.  For example, if the ‘artificial pancreas’ 
(continuous subcutaneous insulin infusion pump) improved quality of life by 20% (0.2) and 
increased life expectancy by 5 years (0.2 x 5.0 = 1.0 QALY), it would be implemented should 
it cost £30,000 or less in total.  However, should the implementation of a device provide an 
essential step in refining another aspect of healthcare, or reduce the number of clinic 
appointments in a patient group, it may also be adopted.   
 
To maximise the chances of meeting QALY targets, one must consider the scalability and 
versatility of the device.  Many mobile phone healthcare applications are now being used 
which is highly scalable and low-cost due to downloadable software, and versatile as different 
software can be downloaded for different applications, and further this software can gain data 
from any combination of inbuilt, or additional, phone sensors.  BSN nodes may be considered 
as more specialised devices, but a simple user interface may allow convenient, wireless 
programming to facilitate a variety of functions.  For example, a patient may wear a small 
number of BSN nodes during the day for general activity and vital signs monitoring, but 
during their rehabilitation exercises re-programming of the nodes to start high-frequency data 
collection for more detailed biomechanical analysis. 
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2.4.3.  Practical Considerations 
 
There are still many ‘unknowns’ in biotelemetry.  Big questions exist including: who will 
benefit the most from these technologies, when do they need to be implemented, what needs 
to be measured, how much information is needed, and what will be the optimum balance 
between sensor and clinician input?  Answering these questions may be specific to each 
study, or technology, or clinical problem, but as more high quality trials are carried out we 
expect a pattern to emerge which is likely to provide some direction to the development of the 
field in general.  Regarding sensor inputs, several groups are investigating the importance of 
sensor placement to provide useful user metrics, as well as exploring the possibilities of 
reducing the sensor number and using mathematical models to reconstruct missing data.26-28  
 
On a similar line of questioning, what happens to the data when it is collected is up for 
debate.  On the post-operative ward for example, if a patient is wearing a BSN allowing 
continuous collection of vital signs, how often should that data be sent to the patient files?  
Current patient management is based on 4-hourly observations, so what benefit would result 
from reducing that time interval to 1 hourly, or every minute?  Potentially, vast amounts of 
physiological data post-operatively could be analysed to give an early predictor of recovery or 
complications, but it is also possible that a situation could arise where there is too much data, 
causing handling difficulties with little or unknown benefit.  Continuing with the hospital 
theme, the data has many potential recipients.  Firstly, it is important for an appropriate 
amount of data to be stored in the patient’s medical records.  Next, it might be useful for the 
medical team, including the nurses, to have a continuous flow of vital signs data from each 
patient to monitor their condition.  This could be accessed on a tablet computer on the ward 
round, perhaps.  Also, the status of the patient might be of interest to the family, in a more 
general sense, perhaps with a graphical representation or description of their physical 
condition. 
 
Collecting and transmitting large volumes of data also creates a security challenge.  On the 
matter of patient confidentiality, the UK the Data Protection Act 1998 describes clearly how 
data must be handled in order to preserve one’s privacy and human rights.  Part of this 
legislation includes data being used for the specific purposes for which it was collected.  As 
such, detailed data from sensing devices such as global positioning, motion, and vital signs 
must be treated sensitively.  In addition, patients must consent to wearing these devices, 
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within which they should be informed of the intended use of the data collected.  ‘On-node’ 
data processing to derive physiological measures before transmitting might make it more 
ethico-legally acceptable, as there are clear outcomes with pre-determined uses. 
 
Healthcare technology innovation and adoption can be unpredictable.  A careful balance must 
be found between providing supplementary patient information to healthcare staff, and 
overloading them.29 As mentioned previously, devices such as the Holter monitor are able to 
provide clinicians with continuous, ambulatory data but analysing this data is time 
consuming.  Implementing autonomic data processing techniques is an essential step towards 
producing a BSN that is feasible for use outside of the research environment.  As a matter of 
safety, this is best limited to highlighting areas of data needing expert review.  Alternatively, 
early pattern recognition suggesting an immediate health risk may prompt further 
investigations such as a phone call to the patient, and possibly asking the patient to complete a 
short test such as home blood pressure monitoring or pulse oximetry for example. 
 
 
2.4.4.  Personalisation 
 
Although EBM is largely practiced in the UK, it is of utmost importance to treat every case 
on its own individual merits.  An algorithm for treating a particular medical condition, 
however complex, must be used only as an adjunct to clinical judgment and also the patient’s 
own wishes.  Utilising the qualities of a BSN in healthcare can allow more personalised care 
provision.  The more data captured from a patient, from a variety of sensor inputs, the more 
the clinician knows about that patient.  This includes their physiological character, their 
response to pathology, and their tolerance or reaction to pharmacological or physical 
interventions.  The continuous, pervasive data collection throughout diagnosis and treatment 
provides a more reliable indication of their health status, which in some circumstances can 
allow closing the loop through personalised medication dose titration, feedback including 
encouragement and motivation, and prompting patients to seek further medical care when 
necessary, rather than at arbitrarily timed follow up appointments.  
 
Clinical application of BSN should follow fore mentioned practical concepts.  Sensor inputs 
must be chosen carefully, considering the role of the BSN.  Gaining data from the 
environment to provide context awareness may be necessary to allow meaningful analysis of 
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human data.  Quality of service with regards to sensor communications should be a high 
priority.  The complexity of the human body in its natural environment creates 
communication challenges, which often lead to unwanted data packet loss, and reduced data 
quality.  Sensor embodiment design, including material choices, must also be taken into 
account to optimise communications.  In addition, a flexible radio protocol that allows secure 
communication between multiple devices such as mobile phones, other sensors, and hospital 
computer systems should be pursued.  The sensor battery life should be maximised through 
intelligent conservation methods, i.e. when data need not be collected or sent (or when data 
sampling rate can be reduced) the device enters a low-power mode.  A BSN must be designed 
with usability in mind, including the needs of both the patient and the clinician.  Sensors 
where possible should be dynamic, and scalable.  The ability to reprogramme a sensor node 
for a different function rather than need to buy or wear another will improve usability and 
cost-effectiveness.  Studies must be completed to prove the cost-effectiveness of the BSN, 
taking into account the limitations of an already stretched health care system. 
Table 2.2 – Technical and clinical challenges (Based on Yang, G-Z.  Body Sensor Networks. 2006) 
   
TECHNICAL CLINICAL 
Nodes Limited number* and size of nodes, miniaturised or hidden on 
user (bracelet etc); biocompatibility (and biodisposability in 
implantable sensors) essential to reduce patient adverse reactions 
Problem Clinical problem must be identified and defined; theorise how 
BSN can explain or solve the problem. 
Software Flexible, customisable and light-weight software infrastructure 
required to cater for heterogeneous sensors, diverse data formats, 
application specific meta-data requirements and varied end-user 
visualisation platforms; options for on-node data processing, 
designed to increase battery life without compromising data output 
quality; remote re-programming. 
Population Device choice based on user characteristics, eg. Elderly person 
may be unable to change small battery; patient location considered 
(hospital, care home etc); decide best method for delivering 
feedback, receiving used sensors; appropriately matched healthy 
comparison group may be required. 
Fault tolerance System should be robust against local failure, including hardware 
failure and software crashes; data normalisation; audit trails to 
ensure efficient system recovery. 
Device Sensor input, data sampling rate and battery life must satisfy trial 
requirements; if the sensor data is going to be analysed alongside 
other clinical data, time-stamp calibration may be required. 
Dynamics Changing environment requires need for context awareness, 
possibly integrating ambient wireless sensor networks; motion 
artifact creates a challenge and should be actively addressed 
Study design Observational studies may provide quantitative insight into a 
clinical problem, but to show value of BSNs in improving patient 
outcome or the cost effectiveness of a service, a Randomised 
Controlled Trial will often be required.  
Power Miniaturised sensor creates battery limitations, energy scavenging 
potential from body heat and motion; reduced accessibility to 
implantable sensors 
Activity 
protocol 
Is there an activity protocol for the patient to follow, or is natural 
behaviour being recorded?  Does the data require labeling?  
Manual labeling requires easily recognisable signal events.  
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Data handling Options for on-node data storage, otherwise low-power 
communications needed; data transfer between multiple nodes 
must be optimised to reduce packet loss and sensor drift; real-time 
data interrogation; flexible connectivity allowing LPU change-
over in different locations. 
Time scale What duration of data collection will provide an accurate 
representation of patient physiology?  For activities of daily living, 
two weekdays and one weekend day is a sufficient duration.  Does 
the sensor operate effectively over the chosen time schedule 
without replacement?  Is longitudinal data collection needed? 
Incremental 
processing 
Process and update statistics from sensor data online to increase 
abstraction and compression, enhancing the scalability of the 
system 
Ethics When working with healthy or sick subjects, performing simple or 
high-risk activities usually requires ethical approval from local and 
national committees.  Begin this process well in advance of study. 
Security High-level security required to maintain data integrity and 
authentication; ensuring patient information privacy by giving 
users the ability to control the information collected from them. 
Data analysis Data often must undergo multiple layers of processing before 
formal analysis; what outcome measures are required and can the 
analysis be streamlined; expert assistance may be needed. 
Medical device Tested to ensure safe for medical application; consider interaction 
with other medical equipment such as bandages, splints, catheters, 
blood pressure cuffs, and wireless interference of life support 
machines and other electronics. 
Data Output Output must be suited to the user in terms of the detail and extent 
of information shown, the format (eg scatter plot, table, bar chart) 
and the available further options such as seeking help, contacting a 
patient, or conducting further data analysis. 
Electronic 
Medical 
Records (EMR) 
Consider integration of BSN data with national EMR system, 
facilitating data access to appropriate medical personnel through 
conventional means. 
User Interface 
and preferences 
Bespoke packages for specific applications, a suitable user 
interface and phone/online technical support improves 
acceptability of BSNs to patients and clinicians.  
 
* For external body sensors only, for implantable sensors the size of the sensor network may become extremely large
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2.4.5.  Future 
 
Although the potential for BSN to positively influence healthcare provision has been shown, 
the frequent reliance on surrogate signs rather than direct sensing creates an aspect of 
uncertainty.  For example, it has been suggested that monitoring patient activity levels post-
operatively may allow early detection of complications such as infection or deep vein 
thrombosis (DVT).30 This theory relies on the correlation between reduced activity, or a 
change in gait, with the presence of said complications.  A more robust approach would be to 
implant a device during the operation to directly assess the surgical site post-operatively for 
features such as inflammatory markers.   
 
Although several healthcare settings are candidates for implantable sensors, post-operative 
application is a prime target as the skin has already been breached and a potential implant site 
accessed.  Minimally invasive surgical techniques are reducing the amount of iatrogenic 
trauma sustained in the operating theatre, resulting in a drastic increase in rate of 
convalescence.  Although patients are often discharged much earlier, it must be recognised 
that post-operative care should be augmented, not withdrawn.  Smaller incisions reduce the 
need for inpatient care with frequent dressing changes and physiological support, but a 
similar internal operation is likely to have been conducted and complications may still occur.  
If the patients are recovering at home, it is even more important that complications are 
detected promptly to alert the healthcare team and arrange readmission.  Clinician-directed 
technical developments in BSNs are essential to allow the realisation of effective, transient 
biochemical sensing. 
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Figure 2.4.  Future BSN apparatus – smart sensor placement, and integration with surgical 
intervention to facilitate reliable, unrestricted, personalised health surveillance and dynamic 
interventions. (Figure by Dr Robert Merrifield) 
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2.5.  Conclusions 
 
Health technologies such as BSN have the potential to improve patient outcomes, the 
efficiency of the service, and our understanding of medical conditions.  In addition, they may 
have a positive effect on society as a whole by promoting healthy living as a disease 
prevention strategy, including psychosocial support.   
 
There are clear changes in healthcare demands initiated by advances in technology, and an 
ageing population with an increasing prevalence of chronic disease.  Healthcare services 
worldwide are unsustainable, and as such, a focused approach to healthcare reform through 
restructuring and resource-effective implementation of technology is required. 
 
The application of BSN in healthcare has been demonstrated in numerous clinical scenarios.  
It is now a matter of providing the evidence needed to permit widespread implementation of 
BSN as an answer to changing healthcare demands.  BSN and biotelemetry facilitate the 
relocation of several health services to the community environment.  In this setting, the 
patient is able to take responsibility for their disease management, knowing that medical 
assistance is readily available should the need arise.  Biotelemetry in healthcare is also about 
bridging the gap between the clinical setting and the home.  Post-operative patients should be 
able to feel safe in that they are appropriately monitored upon prompt hospital discharge.  
Likewise, patients with progressive disorders, such as PD, should be followed up by periodic 
symptom assessment in order to maintain a most favourable quality of life. 
 
Through appropriate resource allocation, personalisation of care and advanced bioinformatics 
for health research, BSNs are well poised to meet current and future healthcare challenges. 
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CHAPTER 3 
BODY SENSOR NETWORKS FOR GAIT ANALYSIS: A 
REVIEW OF THE STATE OF THE ART 
 
 
Abstract 
 
BSN for gait analysis come in a variety of forms, including the number, position, and input 
type.  Comparisons with camera-assisted motion capture systems have allowed multiple 
wearable systems to be validated for gait analysis in non-specialist environments.  This 
improves the feasibility of gait analysis in clinical studies, research, and everyday practice 
when gait laboratories are not available. 
 
In this chapter, the normal gait cycle is described, along with the importance of the ability to 
walk to complete activities of daily living and its association with health status.  Sensor 
platforms are compared with regards to sensor input, number, and analysis technique, and a 
further review of those systems used for the assessment of gait in the setting of lower limb 
surgery is provided.  The sensor featured in further chapters, the ear-worn activity recognition 
(e-AR) sensor developed at Imperial College London, is unusual in its placement, and as such 
the effects of walking on head movements is reviewed, with practical conclusions and 
recommendations made regarding sensor design and implementation. 
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3.1. Introduction 
 
The first scientific investigation into animal locomotion occurred in the 19th Century when 
Leland Stanford (the founder of Stanford University) employed Eadweard Muybridge to 
settle the equine question regarding the presence of ground contact during trotting.31 
Muybridge was able to capture detailed visual information about the gait cycle using a rapid 
sequence of photographs.  Today, a not dissimilar approach is applied for the study of human 
and animal locomotion, whereby multiple cameras are used to produce 3-dimensional subject 
information, enhanced by reflective markers placed on relevant bony landmarks in order to 
provide quantifiable kinematics at extremely high resolution.32 Some gait laboratories 
combine optical data with data from force-plates to provide a more holistic assessment.  
Although such systems have great value in circumstances such as the research setting or 
specialist health and sports centres, implementation on a larger scale and capturing movement 
during natural activities is severely limited.  A gait laboratory is expensive and requires 
dedicated space, preferably with high ceilings for optimum camera placement.  Assessment 
of gait alone for 1 subject can take 2 hours, not including the analytical process.  This is in 
part due to the time taken to place the reflective markers and calibrate the system.  
Furthermore, data collection can only occur within the physical constraints of the laboratory, 
limiting the nature and extent of activities possible.  Many healthcare applications require 
more continuous assessment of gait or mobility over longer periods of time and in 
unrestricted environments, to allow the evaluation of physical independence and more 
advanced factors such as the effect of fatigue or medication on activity behaviour.  Such 
challenges are being met by wearable body sensor networks (BSN). 
 
BSN for gait analysis come in a variety of forms, including the number, position, and input 
type.  Data collected from such systems can be processed in a number of ways depending on 
the parameters required, which range from gait speed estimation,33 to detailed kinematics,34 
to foot/ground interactions and kinetics.35 In all circumstances, appropriate gold standard 
systems are used, at least initially, to validate the measurements the BSN is claiming to make.  
Once validity and reliability is established, the system may my implemented in the desired 
arena.  
 
 
 !
! 65 
3.1.1.  Hypothesis 
 
BSN is a valid method for the assessment of human gait, including in the setting of 
pathology.   
 
 
Scientific literature related to the validation of BSN for gait analysis, aswell as those systems 
implemented in the healthcare environment will be reviewed, with particular attention to 
applications in the peri-operative setting.  This will provide context to the technical chapters 
addressing the clinical challenges arising before and after lower limb reconstruction.  BSN 
and devices focused on the assessment of neuromuscular function will be omitted as they are 
outside the remit of this review and the topic of the thesis.   
 
 
3.1.2.  Bipedal locomotion  
 
Walking plays a variety of roles in daily life, ranging from more essential tasks such as 
getting to the lavatory or collecting and preparing food, to more advanced activities including 
socialising, working, and exercise.36 Competent walking requires balance, coordination, 
strength and stamina, and although the inability to walk remains compatible with life, it is 
associated with increased morbidity and mortality.37, 38 Furthermore, the assessment of gait 
provides insight into health status, and can be of more significant use in conditions 
characterised by mobility disorders, such as Parkinson’s disease39 or musculoskeletal injuries 
and/or surgery.40 
 
Walking in most cases is a cyclic activity, with well-defined phases.41 Such phases can be 
used to profile and quantify abnormal gait patterns.  One of the simplest methods for 
classifying gait is based on the presence or absence of foot/ground contact.  Stance and swing 
phases relate to when the foot is in contact, or not in contact with the ground, respectively.  
Assessing or quantifying these parameters requires the identification of 2 key events, the heel 
contact (or heel strike) and toe-off.  The time between heel contact to toe-off on one foot is 
therefore the stance phase, and between toe-off and the subsequence heel contact is the swing 
phase.  In addition, the period when both feet are in contact with the ground is referred to as 
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the dual-stance duration.  This parameter is often increased in obesity, where single leg 
support requires more effort.42 There are however limitations with this system, particularly 
when heel contact and toe-off events may or may not occur, as often seen in the setting of 
grossly pathological gait.  As such, a more inclusive phase terminology has been 
established.43 (Fig. 3.1.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  Phases of the gait cycle.  Alternative nomenclature that may be unsuitable in some 
abnormal gait patterns is in italics.  
 
 
3.1.3.  Sensor inputs  
 
There are many different aspects of gait that can be measured, and often more than one way 
of measuring the same aspect.  The most commonly targeted parameter is lower limb 
kinematics, i.e. the physical position of the limbs over time, and other associated factors such 
as joint angles and segment displacement vectors.  A gait monitoring BSN platform situated 
on the lower limb lends itself to the assessment of these features.  However, acquiring such 
parameters may require several sensors, such as the initial DynaPort gait analysis platform.44 
Other approaches bypass the multi-sensor requirement by, for example, interrogating the 
knee flexion angle directly using a flexible goniometer,45 or utilising surrogate signs of 
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particular gait phases such as the cyclic medio-lateral sway of the body or the ground reaction 
force propagating through the axial skeleton to a sensor on the trunk, neck or head.46 
 
Many of the more recent sensors platforms are based on combinations of complementary 
inputs, and are known as Inertial Measurement Units (IMU).  The individual components are 
outlined below. 
 
Accelerometry 
 
Accelerometers, which vary in number of geometric axes from 1-3, measure 3-dimensional 
(in the case of a 3-axis accelerometer) accelerations of the placement site.  The signal is 
altered by the constant vertical acceleration of gravity, which may be removed, or interpreted 
across the 3 perpendicular sensor axes to estimate orientation.47 As previously mentioned, 
attaching one or more accelerometers to the lower limb segments facilitates the derivation of 
kinematics and thus assessment of gait patterns.48 Accelerometers placed outside of the lower 
limb are also able to detect abrupt gait events such as the heel contact.  Detection of a sharp 
ground reaction force in conjunction with the medio-lateral sway of the subject provides 
enough information to accurately identify left and right heel contacts.46 Simple walking 
symmetry calculated from these gait events may be a sufficient level of information in some 
healthcare scenarios, for example the longitudinal patient assessment after surgery.49 
 
Gyroscopy 
 
Gyroscopes, which vary similarly to accelerometers in the number of axes, measure angular 
velocity of the placement site.  Considering the peripheral skeletal arrangement of long bones 
and joints, the assessment of corresponding changes in angular displacement of long bone 
segments in theory is appropriate.  A popular clinical application of this type of sensor is 
monitoring sway at the pelvis during walking.50 The SwayStar (GmbH, Switzerland) is a 
trunk-worn sensor that concurrently measurements sway and provides multisensory feedback, 
including auditory and vibrational.  In a series of patients with a balance disorder (bilateral 
vestibular loss), this feedback reduced abnormal sway during walking.51 
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Goniometry 
 
Flexible goniometry provides a more direct measurement of joint angles compared to those 
estimated by accelerometry and gyroscopy.  The sensor spans the joint under investigation, 
with a flexible module that mimics the joint angle.  Data capture can be performed using a 
traditional strain-gauge system, or more recently fibre-optics have been validated to provide 
similar measurements.52 There is potential for such apparatus to be incorporated into clothing 
or smart joint braces and sports equipment as electronic-textiles (e-textiles).53 Although the 
information collected from goniometers is more limited than that from IMU’s, the data is not 
vulnerable to magnetic field artifacts from ferromagnetic objects commonly found in the 
clinical or laboratory setting (e.g. wheelchairs, walking frames, bed frames).54 
 
 
3.1.4.  Sensor number and position 
 
BSN boast advantages to gait laboratories partly because of their superior usability and thus 
versatility for clinical and sporting applications.  As such, one of the research streams has 
been optimising sensor placement and reducing the network size whilst maintaining 
application-appropriate accuracy.  Data collected from a wearable sensor is derived from a 
number of sources, including body movement, gravity, external movements (e.g. standing on 
a moving train), and the vibrations or movements associated with a loosely attached sensor 
and/or the mobility in human tissue.55 
 
One potential cause of error in the use of BSN for gait analysis is sensor placement 
inconsistency.  This error is likely to be amplified upon using multiple sensors.  The 
DynaPort MiniMod (McRoberts, The Netherlands) is a single 3-axis accelerometer worn on 
the trunk.  The trunk is considered to be a suitable position for movement analysis as it lies 
close to the human centre of mass.56 Rispens et al. investigated the effect of relatively minor 
changes in sensor positions on gait parameter estimations.57 The results showed that 
placement at the cervical or lumbar segment of the lumbar spine had very little effect on gait 
parameter estimation, yet further (lateral) movement to the anterior superior iliac spine 
(ASIS), close to front of the hip joint (on one side), showed a less strong agreement.  
Although this is reassuring with regards to minor sensor placement inconsistencies, it does 
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show that data captured from different body locations is unique (e.g. lumbar spine v.s. ASIS) 
and should be analysed as such. 
 
Lutzner investigated the effect of sensor placement on step count (both walking and stair 
climbing), using 5 3-axis accelerometers on the lower limb (medial and lateral thigh, 
proximal lateral shank, and distal medial and lateral shank).  Both the position of the sensor 
and the walking speed significant influenced the accuracy of the step count.  The sensors 
located on the thigh or the proximal shank were the most accurate.58 Kavanagh et al. 
demonstrated the similarity of accelerations from the shank, trunk, neck and head during 
straight line walking, at least with regards to periodicity.59  
 
More holistic investigation into the effect of sensor location on gait analysis accuracy has not 
been explored.57 There is, however, a small body of evidence regarding the effect of sensor 
location on estimation of energy expenditure, where walking is considered amongst other 
activities.  
 
Bouten et al. explored the relationship between physical activity and body segment motion by 
collecting data from multiple sensors simultaneously.60 Three-axis accelerometers were 
placed on the shank, thigh, trunk, upper arm and forearm, whilst subjects walked at different 
speeds on a treadmill.  Comparisons were made between sensor outputs and actual energy 
expenditure determined by indirect calorimetry (gold-standard).  It was concluded that 
although the effects of sensor location are significant, its influence on the correlation with 
energy expenditure is negligible.  So long as location-specific analyses are conducted, there 
are many eligible options for sensor placement.  This theory is supported by more recent 
studies with similar methodology.61, 62 
 
Wong and Tautges have both demonstrated the ability to reconstruct 3D body motion using 
sparse accelerometer networks, i.e. fewer sensors than body segments.63, 64 With regards to 
gait, Arminian et al. initially proposed and validated a BSN for gait analysis using 4 
gyroscopes placed on the lower limb.65 Assuming a rhythmic and coordinated relationship 
between thigh and leg movement, a model was developed which allowed estimates of gait 
parameters to be made with similar accuracy using 3 or even 2 gyroscopes.66 There exists a 
variety of BSN platforms ranging in sensor number.  A single sensor may be able to provide 
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simple gait parameters, but is unlikely to be able to record detailed lower limb kinematics.  
The choice of platform must therefore take into account the application and specific user 
requirements. 
 
3.1.5.  Kinematics vs. Kinetics 
 
While both kinematics and kinetics consider the movement of objects, kinetics further deals 
with the forces causing the movement.  Many gait laboratories fitted with camera assisted 
motion capture systems combine this approach with a force plate technology, providing a 
more holistic assessment by facilitating concurrent investigation of ground reaction forces 
(GRF) throughout specific gait phases.67 
 
Data collected from various sensor modalities can be used to detect and measure the duration 
of gait phases whilst assessing further features including limb segment acceleration and joint 
angles.  J.R. Morris first described this concept in Oxford in 1973 using accelerometry.68 
Mathie and Godfrey have both provided thorough reviews on the use of sensors, particularly 
accelerometers, for the assessment of human gait kinematics.69, 70 Although multi-sensor 
systems are capable of achieving highly accurate estimations of full lower limb kinematics, 
both authors acknowledge the practical value of single wearable sensors and the wide range 
of measurable gait parameters available such as step counts and stride duration. 
 
Kinetic calculations require both lower limb kinematics and information regarding the GRF.71 
There are multiple non-wearable options for capturing GFR, which mostly include the use of 
force plates in either the gait laboratory setting72 or built into a treadmill.73 Wearable 
alternatives require sensors to be added to the footwear, which can come in the form of an 
instrumented shoe with sensors mounted to an aluminium sole plate,74 or the more versatile 
yet less accurate options of pressure sensing insoles.75 Pressure insoles are suited to capturing 
vertical forces between the ground/shoe and the foot yet may neglect the transverse 
(frictional) components of the GRF.   
 
In the setting of lower limb kinematics, combined with GRF (including centre of pressure), it 
is possible to estimate joint moments and powers in the lower limb.76 This methodology is 
likely to carry healthcare applications.77  
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Table 3.1.  Body Sensor Networks for gait analysis (extended from Shull et al.)78 
Author Sensor input Number Parameters Cohort and 
protocol 
Reference  
Inertial Measurement Unit 
Takeda 
200934 
IMU (100Hz) 
50 x 50 x 15mm, 
136g 
4 – thighs and 
shanks 
Lower limb 
kinematics 
 
Healthy young 
males (n=3) 
 
Walking 10m 
Camera motion 
capture system 
(DIPP-Motion 
Pro, Ditect Co., 
Ltd.) 
Watanabe 
201179 
IMU (100Hz) 7 – thigh, 
shanks, feet, 
lumbar region 
Joint angles and 
stride length  
Lower limb 
kinematics 
Healthy young 
males (n=3)  
 
Walking 5m at 
different speeds 
Camera motion 
capture system 
(OPTOTRAK, 
Northern Digital 
Inc.) 
Strohrmann 
201280 
IMU (ETH 
Orientation 
Sensor) (100Hz) 
50 x 50mm flat, 
weight 27g 
12 – wrist, upper 
arm, upper back, 
trunk, thigh, 
shank and feet 
Full body 
kinematics  
21 Healthy 
Subjects  
 
Treadmill and 
free-running 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
Kun 
201181 
IMU (100Hz) 4 – 2 sensors on 
thigh and shank 
of a single leg 
Lower limb 
kinematics 
5 Healthy male 
and female  
 
Walking at 3 
different speeds 
Camera motion 
capture system 
(NAC Hi-Deam 
II, NAC Image 
Technology, 
Japan) 
Rouhani 
201282 
IMU (200Hz) 
Physilog 
(BioAGM, La-
Tour-de-Peilz, 
Switzerland) 
20 x 20 x 10mm 
4 – shank, 
hindfoot, 
forefoot and toes 
Ankle and foot 
kinematics 
10 healthy 
subjects and 12 
patients with 
ankle 
osteoarthritis  
 
Walking 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
Nanhoe-
Mahabier 
201283 
IMU (SwayStar, 
GmbH, 
Switzerland) 
2 (within single 
housing) - trunk 
Kinematics – 
roll and pitch 
sway angles and 
20 patients with 
Parkinson’s 
Disease 
- 
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150 x 110 x 
90mm, 750g, 40 
minute battery 
velocity  
Gait-related 
tasks 
Guo 
 201284 
IMU (100Hz) 
60 x 27 x 2mm 
3 – thigh, shank, 
foot (all right 
side) 
Lower limb 
kinematics 
7 healthy 
subjects, 7 
patients with 
hemiplegia 
 
Walking 5m 
Xsens 
Development 
Kit (Xsens, 
Enschede, The 
Netherlands) 
Spain 
201285 
IMU (50Hz) 
(Xsens, 
Enschede, The 
Netherlands) 58 
x 58 x 22m, 58g  
 
6 – shank, 
wrists, upper 
trunk and 
lumbar trunk 
Lower limb and 
trunk kinematics 
Healthy subjects 
(n=28) and 
patients with 
multiple 
sclerosis (n=31) 
 
Walking (25ft) 
and timed up 
and go test 
- 
 
Jolles 
201240 
IMU (200Hz) 
Physilog 
(BioAGM, La-
Tour-de-Peilz, 
Switzerland) 
20 x 20 x 10mm 
5 – sacrum, 
thigh and shank 
Lower limb 
kinematics 
Patients 
undergoing total 
knee 
arthroplasty 
(n=56) 
 
Walking 30m 
- 
Accelerometry 
Djuric-
Jovicic 
201148 
3-axis 
accelerometer 
(100Hz) 70 x 25 
x 15mm, 27g 
(Texas 
Instruments, 
USA) 
4 – thigh and 
shank 
Lower limb 
kinematics 
Healthy subjects 
(n=27) 
 
Walking 
Flexible 
goniometers 
(Biometrics, 
Gwent, UK) 
Adkin 
200539 
Accelerometer 
(SwayStar, 
GmbH, 
2 (within single 
housing) - trunk 
Trunk 
kinematics 
Healthy subjects 
(n=76) and 
patients with 
- 
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Switzerland) 
150 x 110 x 
90mm, 750g, 40 
minute battery 
Parkinson’s 
Disease (n=14) 
 
Walking 
Derrick 
200286 
Accelerometer/e
lectrogoniometer
s (1000Hz) 
8 – Acc. on 
head, leg, gon. 
on knee and 
rearfoot 
Lower limb 
kinematics 
Healthy subjects 
(n=10) 
 
Running 
- 
Liu  
200987 
3-axis 
accelerometers 
3 – trunk and 
thigh 
Lower limb 
kinematics 
Healthy subjects 
(n=8) 
 
Walking 
Camera motion 
capture system 
(NAC Hi-Deam 
II, NAC Image 
Technology, 
Japan) 
Van den 
Bogert 
199688 
3-axis 
accelerometers 
(500 Hz) 
(EGAXT-10, 
ENTRAN, 
Fairfield, NJ, 
USA)  
4 – upper body Hip kinetics Healthy subject 
(n=1) 
 
Walking and 
single leg stance 
Camera motion 
capture system 
(Motion 
Analysis Corp., 
Santa Rosa, CA, 
USA) 
Willemsen 
199189 
1-axis 
accelerometers 
(500Hz) 
10 – pelvis, 
thigh and shank 
(4 sensors per 
bracket) 
Lower limb 
kinematics 
Healthy subject 
(n=1) 
 
Walking 
Camera motion 
capture system 
(Elite Motion 
Systems LLC, 
USA) 
Cardon 
200490 
3-axis 
Accelerometer 
(10Hz) 
(CSA Inc., 
Shalimar, FL, 
USA) 51 x 38 x 
15mm (43g) 
1 – Right hip 
(waistband) 
Physical activity Healthy subjects 
(children) 
(n=47) 
 
School 
behaviour 
Portable 
ergonomic 
observation 
(PEO) using 
video cameras 
Willemsem 
199091 
1-axis 
Accelerometers 
(Kyowa AS-
8 – thigh and 
calf (2 sensors 
per segment per 
Lower limb 
kinematics 
Healthy subject 
(n=1) 
 
Flexible 
goniometer 
(Penny + Giles 
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5GA) limb) Walking and 
ADL 
G180) 
Wu  
199392 
 
Accelerometer - Lower limb 
kinematics and 
kinetics 
Healthy subject 
(n=1) 
 
Walking 
- 
Gyroscope 
Verhoeff 
200993 
Gyroscope 
(SwayStar, 
GmbH, 
Switzerland) 
150 x 110 x 
90mm, 750g, 40 
minute battery 
2 (within single 
housing) - trunk 
Trunk sway 
(kinematics) 
Healthy 
subjects, young 
and elderly 
(n=29) 
 
Walking 
- 
Janssen 
200994 
Gyroscope 
(SwayStar, 
GmbH, 
Switzerland) 
150 x 110 x 
90mm, 750g, 40 
minute battery 
2 (within single 
housing) - trunk 
Trunk sway 
(kinematics) 
Healthy subjects 
(n=40) 
 
Walking 
- 
Davis 
201050 
Gyroscope 
(SwayStar, 
GmbH, 
Switzerland) 
150 x 110 x 
90mm, 750g, 40 
minute battery 
2 (within single 
housing) - trunk 
Trunk sway 
(kinematics) 
Healthy 
subjects, young 
and elderly 
(n=64) 
 
Walking 
- 
Salarian 
201366 
3-axis 
gyroscopes 
(200Hz) 
2, 3, or 4 – lower 
limb 
Lower limb 
kinematics (gait 
parameters) 
Healthy subjects 
(n=18) and 3 
patient cohorts 
(Parkinson’s 
disease, n=10, 
and musculo-
skeletal, n=43) 
 
Camera motion 
capture system 
(Elite Motion 
Systems LLC, 
USA) 
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Walking 
Hegeman 
200551 
Gyroscopes Trunk Trunk sway 
(kinematics) 
Patients with 
bilateral 
vestibular loss 
(n=6) 
 
Walking 
- 
Allum 
200395 
Gyroscopes 
 
2 (within single 
housing) - trunk 
Trunk sway 
(kinematics) 
Patients with 
unilateral 
vestibular deficit 
(n=28) 
 
Walking 
- 
Tong 
199996 
1-axis 
gyroscopes  
20 x 7 x 10mm 
4 – thigh and 
shank 
Lower limb 
kinematics 
Healthy subject 
(n=1) and a 
patient with an 
incomplete 
spinal cord 
injury (n=1) 
 
Walking 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
Goniometry 
Mohamed 
201252 
2 goniometers 
Strain-gauge 
flexible gon. vs. 
fibreoptic gon. 
2 – 1 sensor on 
each knee 
Knee kinematics Healthy adults 
(n=6) 
 
ADL 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
van der 
Linden 
200845 
2 goniometers 
(50Hz) 
(M180, 
Biometrics Ltd, 
Gwent, UK) 
2 – one on each 
knee 
Footswitches 
also used to 
track gait phase 
Knee kinematics Healthy subjects 
(n=6) and 
patients 
undergoing total 
knee 
arthroplasty 
(n=9) 
 
ADL 
Single expert-
assessed knee 
motion 
Nutton 2 goniometers 2 – one on each Knee kinematics Patients - 
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200897 (50Hz) 
(M180, 
Biometrics Ltd, 
Gwent, UK) 
knee 
Footswitches 
also used to 
track gait phase 
undergoing total 
knee 
arthroplasty 
(n=56) 
 
ADL 
Myles 
200698 
2 goniometers 
(50Hz) 
(M180, 
Biometrics Ltd, 
Gwent, UK) 
2 – one on each 
knee 
Footswitches 
also used to 
track gait phase 
Knee kinematics Healthy subjects 
(n=20) and 
patients 
undergoing total 
knee 
arthroplasty and 
patella 
resurfacing 
 
ADL 
- 
Benedetti 
201299 
2 goniometer 
(Step32, 
DemItalia, Italy) 
2 – one on each 
ankle 
Footswitches 
and surface 
electromyograph
y also used. 
Lower limb 
kinematics 
Healthy subjects 
(n=10) and 
patients with 
neurological 
impairment 
(n=11) 
 
Walking 
- 
Indramoha
n 2009100 
2 goniometers 
(SUDALS, 
SG150, 
Biometrics, 
Gwent, UK) 
2 – one on each 
knee 
Footswitches 
also used to 
track gait phase 
Lower limb 
kinematics 
Healthy subjects 
(n=10) 
 
ADL 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
Bell 
2007101 
2 goniometers 
(50Hz) 
2 - trunk Lumbar 
kinematics 
Healthy subjects 
(n=5) 
 
ADL 
Video camera 
with Noldus 
Observer 
Software 
Huddleston 
2006102 
2 goniometers 
and 
accelerometers 
5 – sternum, 
thigh, foot and 
processing unit 
Lower limb 
kinematics 
Healthy subjects 
(n=5) 
 
Camera motion 
capture system 
(Selspot II, 
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IDEEA (32Hz) 
16 x 14 x 4mm 
(waist) ADL Selective 
Electronics, 
Partille, 
Sweden) and 
force plate 
(Kistler, 
Switzerland) 
Magnetic accelerometer rate gyroscope 
Picerno 
2008103 
MARG (120Hz) 
Xsens (Xsens 
Technologies, 
Enschede, The 
Netherlands) 
58 x 58 x 22m, 
58g 
4 – sacrum, 
thigh, shank and 
foot 
Lower limb 
kinematics 
Healthy subjects 
(n=1) 
 
Walking 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK)  
Goulermas 
2008104 
MARG 
Xsens (Xsens 
Technologies, 
Enschede, The 
Netherlands) 
58 x 58 x 22m, 
58g 
4 – Shank and 
foot 
Lower limb 
kinematics 
Healthy subjects 
(n=8)  
 
Walking – 3 
different speeds 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
O’Donovan 
2007105 
MARG (500Hz) 
Custom-made,  
60 x 40 x 24mm 
2 – shank and 
foot 
Ankle joint 
kinematics 
Healthy young 
males (n=2) 
 
Walking and 
other lower limb 
exercises 
Camera motion 
capture system 
(Eva Real-Time 
Software – 
EvaRT, Motion 
Analysis, USA) 
Roetenberg 
2007106 
MARG (120Hz) 
(Xsens) and 
magnetic sensors 
(120Hz) – 210 x 
110mm 
1 magnetic base-
station on trunk, 
6 sensors – 
upper arm, 
trunk, and thigh 
Full body 
kinematics 
Healthy subject 
(n=1)  
 
Walking and 
body poses 
Camera motion 
capture system 
(Vicon, Oxford 
Metrics, UK) 
NB. Literature review by Shull et al (Table 3).  IMU, goniometer and accelerometer retrieved 33, 24, 
and 11 papers respectively, though only the most recent 10 were reported (4 additional papers deemed 
unrelated were excluded). Predominant data analysis input modality is used. No reference 
measurement documented if previously validated.  Magnetic accelerometer rate gyroscope (MARG).  
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3.2.  Assessment of gait in the peri-operative setting using BSN 
 
A literature search was performed to identify studies in which wearable sensors were used to 
assess gait in patient cohorts who had undergone lower limb surgery (e.g. knee replacement). 
Eighteen papers were identified (Table 3.2).18, 40, 41, 45, 49, 65, 66, 97, 98, 107-115!!The DynaPort Knee Test (McRoberts, The Netherlands) and bilateral electro-goniometer 
systems (M180, Biometrics Ltd, Gwent, UK) were repeated in the search results.  Inertial 
measurement units were the most frequently used sensors (39%), followed by goniometers 
(33%). Half of the studies used 2 sensors, usually one on each leg, with the mean number of 
sensors used being 2.9.!
 
The most common cohort was those patients undergoing knee arthroplasty (56%), followed 
by hip arthroplasty (33%) and just 2 studies recruiting patients with anterior cruciate ligament 
injury.  This is likely to be due to the high prevalence of knee and hip arthroplasty.116 The 
average number of patients in a study cohort was 35, with a wide inter-study range of 86 
patients.  Gait assessments in half of the studies was carried out on a single occasion, and the 
mean number of assessments was 2.3 (maximum = 6).40  
 
More than half of the studies (56%) used classic gait outcome measurements, including gait 
cycle duration, swing, stance and double support times.  The other most common parameters 
were knee angles, typically measured by electro-goniometry.  
 
The literature is fairly limited with regards to study size and lack of longitudinal follow-up, 
and the increase in clinical studies of this nature appears to be linear, with a similar number 
of studies from 2004-2009 as that between 2010 and 2014 so far.  Whilst several papers 
address the validation of BSN in peri-operative gait assessment, the next phase of studies 
should look to apply BSN as a feasible and objective outcome measure for answering 
relevant clinical questions, such as in the more recent randomised controlled trial by Reininga 
et al. where the outcomes following 2 different surgical techniques were compared.110 
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Table 3.2.  Assessment of gait in the peri-operative setting using BSN 
Author Sensor Cohort Follow-up Parameters 
Aminian 
200465 
Physilog (BioAGM, 
CH)  
4 gyroscopes on 
thighs and shanks 
(200Hz) and 1 data 
unit on trunk (300g) 
Patients with 
coxarthrosis (n=11), 
and patients 
undergoing total hip 
arthroplasty (n=8) 
1 occasion  Cycle duration, 
swing, stance, double 
support, stride 
velocity, thigh, shank 
and knee range of 
rotation 
 
Schulze 
2012107 
SHIMMER 4 - 1 
IMU on each thigh 
and shank  
100Hz 
Patients with knee 
pathology (n=5) 
1 occasion Knee angle 
measurements 
Patterson 
2014108 
Xsens – 2 - 1 IMU’s 
on each shank 
(100Hz) 
Patients with ACL 
repair (n=14) 
1 occasion Cycle duration, 
swing, stance, double 
support 
Zhu  
2013109 
Knee-assistive 
instrument for 
walking rehabilitation 
(KAI-R) Motor 
driven 
Patients undergoing 
total knee arthoplasty 
(n=16) 
Pre and post-
operatively a 1 and 4 
weeks 
Cycle duration, stride 
length, knee and hip 
joint angles 
Reininga 
2013110 
Xsens – 2 IMU’s - 
trunk and upper 
thorax 
Patients undergoing 
total hip arthoplasty 
(n=75) 
Pre and 
postoperatively at 6, 
12 and 24 weeks 
Stride length, cycle 
duration, pelvic 
orientation 
Zijlstra 
200741 
2 triaxial IMU’s on 
trunk and upper 
thorax 
Patients after hip 
arthroplasty (n=4) 
1 occasion Cycle duration and 
pelvic orientation 
Bhargava 
2007111 
UltraFlex 
Instrumented shoes  
Patients undergoing 
total hip arthroplasty 
(n=20) 
1 occasion > 6 
months post-
operatively 
Cycle duration, 
swing, stance, double 
support, ground 
reaction force 
Myles  
2002112 
Electro-gonionmeters 
– 1 on each knee 
Patients undergoing 
total knee 
arthroplasty (n=42) 
Pre and post-
operatively at 4 and 
24 months 
Knee kinematics 
Nutton 
200897 
Electro-gonionmeters 
– 1 on each knee 
Patients undergoing 
total knee 
Pre and post-
operatively at 1 year 
Knee kinematics 
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arthroplasty (n=56) 
van der 
Linden 
200845 
Electro-gonionmeters 
– 1 on each knee 
Patients undergoing 
total knee 
arthroplasty (n=9) 
Variable Knee kinematics 
Jolles  
201240 
IMU’s – 5 – trunk 
thighs and shanks 
(200Hz) 
Patients undergoing 
total knee 
arthroplasty (n=56) 
 
Pre and post-
operatively at 6, 12, 
24 weeks, 1 and 5 
years. 
Cycle duration, 
swing, stance, stride 
length, lower limb 
kinematics 
Salarian 
201366 
3-axis gyroscopes – 
2-4 on lower limbs 
(200Hz) 
Patients undergoing 
total hip arthroplasty 
(n=43) 
1 occasion Cycling duration, 
swing, stance, dual 
support, lower limb 
kinematics 
Myles  
200698 
Electro-gonionmeters 
– 1 on each knee 
Patients undergoing 
total knee 
arthroplasty and 
patella resurfacing 
(n=50) 
Pre and post-
operatively at 4 and 
24 months 
Knee kinematics 
Kleijn 
 200749 
DynaPort – 5 IMU’s, 
thorax, thighs and 
shanks 
Patients undergoing 
unicompartmental 
knee arthroplasty 
(n=40) 
Pre and post-
operative at 3, 6, 12, 
24 months 
Knee kinematics, 
DynaPort knee scores 
Mokkink 
2005113 
DynaPort – 5 IMU’s, 
thorax, thighs and 
shanks 
Patients with knee 
osteoarthritis (n=92) 
1 occasion DynaPort knee scores 
Atallah 
2014114 
e-AR – triaxial 
accelerometer worn 
on the ear (130Hz) 
Patients undergoing 
hip or knee 
arthroplasty (n=50) 
1 occasion Cycle duration and 
step time asymmetry 
Tsivgoulis 
201118 
1 triaxial 
accelerometer (trunk) 
Patients with ACL 
deficiency (n=20) 
Pre and post-
operatively at 6 
months 
Gait evaluation 
differential entropy 
method (GEDEM) 
performance score117 
Aminian 
1999115 
Accelerometers on 
lower limb 
Patients undergoing 
total hip arthroplasty 
(n=12) 
Pre and post-
operatively at 3, 6 
and 9 months 
Cycle duration, 
swing, stance, double 
support 
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3.3. Background and validity of an ear-worn accelerometer for gait analysis 
 
The Pervasive Sensing team at the Hamlyn Centre has trialed numerous commercially 
available sensor platforms, and has also designed, developed and validated custom sensors.  
The findings and conclusions from the literature associated with BSN and gait analysis in the 
clinical setting influenced the construction of this thesis, from choice of sensor to study 
cohort.   
 
The main specifications were to: 
 
• Utilise the practical benefits of a single sensor with consistent placement for clinical 
studies 
• Look for the next step with the choice of study cohort, i.e. away from joint 
replacement, or at least a novel setting 
• Employ a longitudinal study design where possible to profile mobility changes over 
time 
• Answer a relevant clinical question following validation of the sensor platform 
 
 
3.3.1.  Ear-Worn Activity Recognition Sensor 
 
The e-AR sensor is a lightweight device designed jointly by the Hamlyn Centre for Robotic 
Surgery at Imperial College London and the Helen Hamlyn Centre for Design at the Royal 
College of Arts.  This approach provided a wide range of expertise, resulting in both a 
functional, and ergonomically designed device.  The sensor hardware is minimalistic, 
containing a triaxial accelerometer, micro-processing unit, communication module, and 
battery.  The concept was bio-inspired, based partly on the human vestibular apparatus for 
balance control.  The human system of perpendicular semi-circular canals provides sensitive 
3-dimensional information regarding head orientation and kinetics.  A triaxial accelerometer 
worn at a similar position may be able to capture a similar form of data, providing insight into 
physical activity behaviours.  Furthermore, the elastic property of the external ear maintains 
close contact between the sensor and the adjacent mastoid bone of the skull.  As the skull 
forms part of the axial skeleton, it was hypothesised that ground reaction forces might be 
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transmitted to the sensor via the bony skeleton.  This combination of head kinematics and 
ground contact reaction forces has the potential to provide a valuable device for the 
assessment of gait and mobility in general. 
 
 
3.3.2.  Head position and gait 
 
During walking, the postural system must contend with many compromising intrinsic and 
extrinsic factors.118 The trunk, including the recruitment of paraspinal muscles, acts as one of 
the key stabilisers, minimising gait-related oscillations from impacting head motion.119, 120 
Hirasaki et al. directly investigated head motion during walking using a camera-assisted 
motion analysis platform focused on subjects walking on a treadmill.121 Although the 
mechanisms were not fully understood, physiologists knew of multiple reflex responses 
which maintained stable gaze and head motion during walking and other movements.  The 
main cortico-motor pathways described are the vestibulo-ocular and vestibulo-collic reflexes 
(VOR and VCR).  VOR and VCR refer to compensatory movement of the eyes or neck to 
maintaining fixed gaze, respectively.  At preferred or quicker walking velocities, it was noted 
that the head pitch and vertical displacement change cyclically.  During walking, body and 
head displacement in the sagittal plane is compensated for by reciprocal changes in head 
pitch.  As walking velocity increased, increases in step frequency had a corresponding effect 
on head movements.  Furthermore, vertical head translation strongly correlated with the heel 
strike phase of gait.  
 
 
Figure 3.2. Head movements: vertical translation (VT), lateral translation (LT), sagittal translation 
(ST) 
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Kavanagh et al. used wearable sensors to compare accelerations of the head and trunk in all 
planes during walking.122 Although the oscillatory dynamics were similar, those measured at 
the head were smoother than those at the trunk.  This suggests that the accelerations of the 
head are significantly attenuated and more tightly controlled compared to accelerations of the 
trunk, and that the upper body has a role to play in this control.  Further work from this group 
built on the methodology by adding sensors to the neck and shank for comparison.59 The use 
of 4 sensors allowed 3 incremental comparisons (i.e. from shank to trunk, trunk to neck, and 
neck to head) and therefore a higher level of granularity in the results.  At preferred walking 
speed, the biggest difference in accelerations measured was between the trunk and neck, 
suggesting the trunk was the main body of movement attenuation.  Differences between 
accelerations at the head and neck only occurred at increased walking velocities.  This paper 
also provides further evidence associating head and shank movements.  Similar work by 
Cromwell and Wellmon show the pattern of decreased amplitude and improved smoothness 
of gait signals from the lower limb up to the trunk and the head.123 This phenomenon has 
been described as a biological low-pass filter for gait related kinematic data collected at the 
head.124 
 
Further investigation into such head controlling mechanisms include work assessing subjects 
during walking on irregular surfaces, which shows that although gait patterns become more 
variable, changes in head movements are minimal, suggesting comprehensive control of head 
stability.125 Additionally, Brodie et al. demonstrated age-related reductions in the ability to 
control head position during walking.126 
 
These findings provide a good background to the application of sensors that interrogate head 
movements during walking after lower limb surgery.  Firstly, vertical head translation is 
strongly correlated with the heel contact phase of gait, allowing the derivation of simple 
temporal gait parameters.  Also, the signal recorded at the head is likely to be less noisy than 
that from the trunk due to intrinsic postural control mechanisms, although the reduction in 
total signal magnitude has the potential to disguise important parameters.  The cyclical 
change in head pitch described will alter the orientation of an ear-worn sensor, and so the 
antero-posterior and supero-inferior axes must be cross-examined to prevent jeopardising the 
validity of sensor measurements.  
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3.3.3.  Validation and application of the e-AR sensor 
 
The first description of the e-AR sensor was in 2007, where its potential use for real-time 
pervasive monitoring for post-operative care was proposed.127 The sensor was piloted in a 
small clinical study to monitor the activity levels and vital signs of general surgical patients 
post-operatively in the home environment. 128 Although the oxygen saturation measuring clip 
failed to provide reliable results, the activity monitoring aspects were able to quantify the 
changes in physical activity during the acute recovery period (first 5 days following 
discharge).  Following this study, the e-AR sensor was redesigned as a new lightweight 
model omitting the vital signs monitoring module.  The new sensor was implemented in 
combination with ambient sensors in an activity classification feasibility study using a 
simulated home environment.129 
 
The e-AR was first used for gait analysis in 2009 as part of a laboratory study where 
pathological gait was simulated using knee and trunk restraints.130 Abnormal gait was 
correctly classified with 85% accuracy using a Discrete Wavelet transform method.  Formal 
gait analysis validation was achieving by collecting gait data from healthy subjects using the 
e-AR sensor and a force-plate instrumented treadmill simultaneously.131 Estimates of gait 
cycle duration from the e-AR sensor data were accurate to within 0.02 seconds.  Furthermore, 
there was a statistically significant correlation between the e-AR sensor data and the GRF as 
measured by the treadmill, particularly when combining the antero-posterior and supero-
inferior axes.  This allows estimation of both kinematic and kinetic parameters, or in clinical 
terms, both temporal and force aspects of the gait.  An improved version of this algorithm 
was used in patients undergoing hip and knee arthroplasty, showing high levels of validity 
compared to the instrumented treadmill.114 
 
Further validation of more detailed kinematics was achieved by Jarchi et al.46 A synchronised 
high-speed camera was used to identify gait events in the sensor signal, before validating a 
low-level machine-learning algorithm for unsupervised gait assessment (details shown in a 
further chapter).  Detection of both heel contact and toe-off gait events were demonstrated, 
allowing derivation of swing, stance and stride durations with mean absolute errors of less 
than 0.03 seconds.   
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In addition, the e-AR sensor has been validated in the estimation of energy expenditure in 
healthy subjects.  Two forms of indirect calorimetry were used (gas exchange and doubly 
labeled water) in comparison to estimates from e-AR sensor data.132, 133 
 
 
3.4.  Conclusion 
 
There is a growing body of evidence demonstrating the use of BSN in the assessment of gait.  
The advantage of portability and lack of restriction makes BSN suitable for clinical 
applications, including the assessment of patient gait in natural environments over extended 
periods of time.  Although multiple sensor placement locations are outlined in the literature, 
there is no clear superior site.  The stablising function of the trunk and neck for head control 
and maintaining a steady gaze reduces the noise of the signal from sensors work on the head, 
which is encouraging considering the placement of the e-AR sensor.  Furthermore, the ability 
of the e-AR sensor to capture both basic kinematic parameters as well as information 
regarding the GRF provides further advantage over other systems, making the gait 
assessment more holistic. 
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CHAPTER 4 
AN AFFORDABLE, OBJECTIVE PERI-OPERATIVE 
ASSESSMENT TOOL FOR KNEE ARTHROPLASTY† 
 
Abstract !
Background:  Indications for Total Knee Arthroplasty (TKA) are partly based on subjective 
patient data.  The post-operative period lacks personalised, dynamic rehabilitation strategies 
and regular follow-up, potentially resulting in sub-optimal patient outcomes.  This study 
investigates the feasibility of using a low-cost, ear-worn accelerometer (e-AR, Sensixa Ltd 
and Imperial College London) to conduct objective, home-based mobility assessments in the 
peri-operative setting. 
 
Methods:  Fourteen patients on the waiting list for TKA, and 15 healthy subjects, were 
recruited.  Pre-operatively, and at 1, 3, 6, 12 and 24 weeks post-operatively, patients 
underwent standard clinical assessment including functional mobility testing (timed up and 
go test) and knee examination (including bilateral knee range of motion), as well as an 
‘activities of daily living’ (ADL) protocol whilst wearing the e-AR sensor.  During the ADL, 
objective motion data was collected using an ear-worn sensor.  Features extracted from 
sensor data were used to quantify patient performance as compared to healthy controls, and to 
predict the patient’s recovery phase. 
 
Results:  Patient function estimated by the sensor and measured by clinical tests consistently 
declined following the operation, before gradually returning to a level similar or greater than 
that during pre-operative testing.  Sensor-based performance closely correlated with clinical 
measures in several activities, allowing functional recovery of individual subjects to be 
profiled and compared, including the detection of a complication.  Features from the sensor 
data were used to classify subjects into normal, pre-operative and 24-week post-operative !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
† Chapter based on publication:  Kwasnicki R M, Ali R, Jordan S J, Atallah L, Jones G, Darzi A, Yang G Z. 
(2013) An Affordable, Objective Peri-operative Assessment Tool for Knee Arthroplasty. Associations of 
Surgeons in Training (ASiT) International Surgical Conference (Manchester, UK)  International Journal of 
Surgery. 11(8); 569-746 
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groups with 89% (median) accuracy.  Classification accuracy was reduced to 69% when 
including all post-operative time intervals.  
 
Discussion:  The study demonstrates a resource-sparing, objective method of assessing 
mobility in the community setting.  This could be used to supplement surgical decision-
making, facilitate community-based follow-up and early detection of complications.  
Furthermore, active post-operative surveillance with patient feedback might result in 
improved patient outcomes. 
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4.1.  Introduction 
 
Modern day clinical decisions are highly dependent on a reliable evidence base (evidence 
based medicine).  The evidence consists of organised information both about the patient, and 
the natural history observed in previous patients with similar complaints.  One source of 
information is the patient history, in which the doctor invites the patient to divulge their 
health concerns.  Although this is largely a listening exercise for the physician, their ability to 
subtly structure the account and reveal undisclosed, but important details will often determine 
the value of the process.  Information gathered in this manner must be handled with care: it is 
not fact; it is the patient’s subjective experience of events.  For example, when reporting pain 
one may use different terminology to describe magnitude, possibly comparing the pain to 
previous experience.  Not only does this make it difficult for the doctor to interpret, but also it 
prevents fair comparison between patients.   
 
Patient reports can be used in the first instance for diagnosis, but can also be used to monitor 
the patient’s response to management.  In both scenarios, the information is subjective and 
should only be used to supplement a more objective assessment of the patient’s clinical state.  
In the elective setting (i.e. non-emergency) the assessment process is often cost-driven, 
meaning if there is a chance that a simple test can provide a definitive diagnosis with 
acceptable accuracy, it is likely to be used first.  However, more sophisticated assessment 
techniques may be more accurate, and able to tease out subtle details in a patient’s condition.   
 
This chapter considers one scenario, total knee arthroplasty (TKA), in which clinical 
decisions are highly dependent on subjective data, both in deciding whether or not to operate, 
and in the follow-up phase.  Biomechanical analysis in clinical practice is limited to few 
patients due to factors such as cost, availability of facilities, and technical expertise.  
However, its potential use in picking out the patients who will benefit most from surgical 
management and monitoring progress seems logical considering the quality of information 
collected.  Wearable sensors are now at a stage where many features, once only detectable by 
optical motion tracking systems, are achievable in a free-living environment.  This may be an 
affordable route to improving patient outcomes.  We set out to investigate this further through 
a longitudinal feasibility study. 
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4.1.1.  Pathophysiology of the Knee 
 
The knee is a pivotal hinge joint that lies between the femur in the thigh and the tibia in the 
leg.  There is also the patella (‘knee cap’), which lies at the anterior aspect of the knee joint.  
Lining the articulating surface of the joint is semicircular shaped meniscal cartilage.  The 
joint is controlled by several muscles above and below the knee, and stabilised by 4 main 
ligaments.  Two of these ligaments are extra-capsular and lie on the medial and lateral aspects 
of the joint (collateral) and 2 are intracapsular, positioned in a crossed formation within the 
intercondylar notch (cruciate). 
 
 
 
Figure 4.1 The Knee joint.  Quadriceps tendon (QT), Patella (Pat.), Lateral collateral ligament (LCL), 
Posterior cruciate ligament (PCL), Meniscus (Men.), Medial collateral ligament (MCL), Anterior 
cruciate ligament (ACL), Patella tendon (PT) 
 
 
Osteoarthritis 
 
Osteoarthritis (OA) is a degenerative joint disease involving the articulate cartilage and 
subchondral bone.  As the knee is a weight-bearing joint, it is one of the hallmark sites in 
which the articular cartilage is prone to wear over time.  Although this process is rarely 
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symptomatic until old age, several factors may accelerate joint degeneration.  This includes 
hereditary traits, knee trauma, obesity, and other arthritic conditions (e.g. Rheumatoid, 
infectious).  As mentioned in the introduction, the perception of symptoms also varies 
between patients.  Some patients may have advanced osteoarthritis (OA) but minimal 
symptoms whereas others notice symptoms and experience morbidity at a very early stage.  
 
Radiological imaging alongside clinical examination is used to diagnose OA.  The 4 cardinal 
signs of OA on the radiograph are joint space narrowing, subchrondral cyst formation, 
subchondral sclerosis, and osteophyte formation.  
 
 
4.1.2.  Management of Knee Osteoarthritis 
 
There are multiple levels of management options for knee OA.134 The choice depends on both 
the severity and nature of the pathology, but also strongly on patient characteristics.  
Validated disease-specific or quality of life questionnaire (e.g. Knee Osteoarthritis Outcome 
Score (KOOS), Oxford Knee Score, Short Form health survey (SF-36) may be used during 
assessment.  Knee-specific questionnaires often aim to elucidate a global disease score based 
on mobility limitation, pain, and disturbance of daily life.  This is explored using likert-type 
multiple choice questions, with a combination of negative and positively worded statements 
to avoiding leading the patient’s response.  Final scores such as that of the Oxford Knee 
Score are graded according to severity, which often has implications for suggested 
management strategies, e.g. surgical vs. non-surgical treatment.   Although the aetiology is 
likely to be multifactorial, it is essential to eliminate any reversible, predominant risk factors 
if possible (such as obesity or infection).  Conservative treatment may begin with escalation 
of analgesia, physiotherapy, and exercise counselling, but with time, disease progression and 
reassessment, it may be necessary to intervene surgically. 
 
Often, surgical intervention will start with an arthroscopy, where the joint surface is 
visualised directly through an operative endoscope.  This allows diagnosis and immediate 
treatment of meniscal pathologies using debridement or reparatory techniques.  Arthroscopy 
may also confirm indications for joint replacement surgery (TKA), that being end-stage OA. 
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Knee Arthroplasty 
 
The prevalence of TKA is increasing.  In the UK, between 1991 and 2006, the estimated age-
standardised rates for primary TKA (per 100,000 person-years) increased from 42.5 to 138.7 
for women, and from 28.7 to 99.4 for men.116  More than 77,500 TKAs were carried out in 
UK in 2009.135 Considering that the two main risk factors for OA are age and obesity,136 in 
the context of an ageing population and obesity epidemic, the rise in TKA is unsurprising. 
 
TKA involves replacing both proximal and distal articulating surfaces of the knee joint.  
Following appropriate general or regional anaesthesia and aseptic skin preparation, the knee 
is usually accessed through an anterior longitudinal incision.  Bone cuts in the mechanical 
axes of both the distal femur and proximal tibia are made, paying attention to the 
maintenance of the natural joint line upon placement of the prostheses.  Patello-femoral 
articulation is assessed intra-operatively to ensure appropriate tracking.  Post-operative 
complications can be avoided by a subtle patella ligament release technique if necessary. 
 
After the operation the patient is cared for on the hospital ward for 5-7 days, where they will 
interact with a physiotherapist and occupational therapist to determine an appropriate date for 
discharge, once sufficient independence is achieved.  
 
 
Post-operative follow-up 
 
Following TKA, follow-up is intermittent and functional rehabilitation is largely dependent 
on the patient carrying out suggested activities at home.  Where possible, patients return to 
the hospital to see the physiotherapist for a limited number of sessions where assessment is 
based on clinical examination (e.g. range of motion), and possibly a repeated questionnaire. 
Patients are generally encouraged to take sensible amounts of exercise and recondition 
surrounding muscles, particularly the Quadriceps Femoris group. 
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4.1.3.  Outline of the clinical problem 
 
Rate of progress and long-term outcomes are poorly documented, with surgical revision 
being the gold standard outcome measurement.  This fairly gross outcome measure can be 
misleading considering that a recent patient survey revealed up to 20% of patients continue to 
complain of knee pain or disability post-operatively,137 without undergoing revision.  Whilst 
major post-operative complications are likely to be reported by the patient, those struggling 
with rehabilitation exercises due to manageable causes may not be identified until their next 
appointment, if at all.  Even patients with a good surgical outcome may endure slower 
convalescence than necessary as a result of deficient supervision, understanding, and 
motivation. 
 
Currently there is no consensus as to the level of symptoms warranting surgical 
intervention.138 Several patient factors are taken into account, including age, weight, severity 
of symptoms including pain and mobility (self reported), and response to non-surgical 
interventions.  A radiological or arthroscopic evaluation of knee anatomy is also considered.  
Although decision algorithms have been used with great effect in many medical and surgical 
specialties (including cancer care), they are not universally used in TKA.139 More evidence 
regarding the pre-operative predictors of outcome after TKA is needed to guide knee OA 
management decisions,140 specifically who needs TKA, and when should it be offered. 
 
Poorly defined operative indication guidelines, suboptimal rehabilitation, and intermittent 
follow up is likely to result in poor functional recovery, and reduced quality of life with 
resultant long-term health sequelae, and the social burden of preventable sick leave.   
 
Peri-operative movement analysis in a gait laboratory may offer a solution, but arguably the 
high prevalence of TKA and uncertain associated cost-benefits would make it an unfeasible 
resource demand.  An alternative solution is a low cost motion-sensing device for 
community-based assessment of functional mobility.  Miniaturised body sensors have been 
tested and validated to identify and characterise human movement aberrations.30, 141 however 
to the best of our knowledge, a home-based longitudinal study in TKA has not been 
conducted.  
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4.1.4.  Wearable motion sensors in peri-operative assessment 
 
There are a range of wearable motion-sensing systems available, which may differ in number 
of sensors, sensor type, sensor placement, sensor environment (e.g. laboratory, free-living) 
and data analysis techniques.  The choice of sensor system should be matched to the 
application requirements.  It is unrealistic to expect a patient to wear several sensors for long 
periods of time, or equally that the information gained from a multi-sensor system over 
multiple days will be reliable. 
 
Sensor options: 
 
• Activity monitor – many versions exist, including those integrated in mobile phones.  The 
benefits of using this type of sensor include low-cost, ability to potentially download an 
application to a device already owned by the patient, and simplicity.  Mobile phones are 
readily equipped with communication options such as Bluetooth and Wi-Fi, making data 
transfer feasible.  However, often phone-sensors and other activity monitors collect data 
at low frequencies (<20Hz) and are more suited to calculating gross activity levels over 
longer periods.  Further, although activity levels may change throughout recovery, it fails 
to meet the requirements of short assessments, and would require the subjects to use the 
device over several days or weeks.  A further limitation is the position of the device.  
Mobile phones are carried in multiple locations, such as trouser pockets, handbags, clips 
on the waistband, jacket pockets etc.  This lack of inter- and intra-subject consistency is 
likely to provide misleading results, or at least create the need for more advanced analysis 
methods.  
• Multi-sensor system – systems exist whereby data received from multiple body worn 
sensors can be used to reconstruct total body movement.142, 143 Although this data would 
provide a thorough assessment of functional mobility, multi-sensor systems are often 
more expensive and difficult to use without technical support.  Brief data collection 
would be enough to provide an assessment, yet the time needed to charge and apply the 
sensors might be inconvenient in a number of scenarios.  Further, the level of detail from 
these systems is probably too elaborate for this application. 
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• Joint-covering flexible sensors – recent technical advances have made joint angle 
prediction and gait analysis possible with smart materials.144 This might be valuable in 
assessment of injuries or reconstruction across joints, such as knee replacement or ankle 
reconstruction, but is unlikely to offer extra useful information in other cohorts. 
• Single motion sensors – these are possibly the simplest sensors to use.  Most have a 
consistent placement site, often waistband, arm or wrist, and are able to collect data at 
high frequencies.  The ear-worn activity recognition sensor (e-AR, Sensixa Ltd. and 
Imperial College London) has been subject to many hardware iterations and software 
construction based on data collected in a variety of environments, including patient 
studies.  The position of the sensor on the ear is unique, and offers ultimate consistency, 
without need for straps or clips, remaining static and closely adherent to the body.  Unlike 
sensors worn on the waistband, which can move and create noise in the data, the e-AR 
sensor lies very still, and is adherent to the mastoid bone, providing an excellent 
conducting pathway from the ground to the sensor through the skeletal system.  The 
advantages of the location result in the ability to obtain clear 3-dimensional movement 
signals during various activities, without restriction.  The signals also provide significant 
information regarding the interaction between the subject and the ground and other solid 
structures, such as heel contacts and sitting.  The e-AR sensor also has data transmission 
capabilities, both wired and wireless, to complete the link from data capture to analysis 
and data output. 
 
 
 
Gait analysis is a popular choice for assessment of functional mobility.  Walking requires the 
coordinated activity of several muscle groups, joints and senses.  Furthermore, control of 
walking is mostly a subconscious process, and as such the gait cycle tends to be regular and 
reproducible. 
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Figure 4.2.  Gait events (from left to right): Right heel contact (RHC), left toe off (LTO), left heel 
contact (LHC), right toe off (RTO).   
 
Some well-documented gait analysis systems include: 
 
• Intelligent Device for Energy Expenditure and Physical Activity (IDEEA)145 – this 
system consists of 5 bi-axial accelerometers (1 sternum, 2 thigh, 2 plantar surface of 
foot) and has been validated to determine spatiotemporal gait parameters such as 
swing and stance durations, cycle duration, and some joint angles 
• Technology Research for Independent Living (TRIL) Gait Analysis Platform 
(GAP)146 – this system combines wearable sensors (accelerometer and gyroscope) 
with cameras and a pressure sensing walkway to help determine the risk of falling 
• DynaPort Knee Test44 – this portable system consists of 6 uni-axial accelerometers in 
5 different locations.  Two are based in a large waist worn unit (1 vertical and 1 
sagittal), 1 on each thigh and 1 on each leg.  A short activity protocol has been 
developed including walking, but also using stairs, carrying objects and ‘sit-to-stand’ 
actions.  
 
The last of the 3 examples incorporates several activities of daily living (ADL).  Exploring 
movement patterns during other activities may elucidate functional limitations that aren’t 
seen during walking alone.  For example, a patient may be able to support their body weight 
on a single leg during walking, but lack flexibility in the knee and hip, and power at extremes 
of range of motion to allow standing from a low chair, or bending over to pick up a dropped 
item.   
 
4.1.5.  Hypothesis 
Objective mobility assessment in the home is feasible using wearable sensor technology.  
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4.2.  Methods 
 
4.2.1.  Outline 
An e-AR sensor was used to assess 14 patients undergoing TKA peri-operatively.  In the 
home setting, patients underwent standard clinical assessment including functional mobility 
testing (timed up and go test) and knee examination (including bilateral knee range of 
motion), as well as an ‘activities of daily living’ (ADL) protocol whilst wearing the e-AR 
sensor.  A range of abstract features from the patient sensor data were analysed in relation to 
that of healthy controls.  The extent to which patient performance differed to the controls was 
calculated from the data features.  The sensor ‘score’ was compared to gold standard clinical 
follow-up methods longitudinally, to evaluate its use as a surrogate marker of patient mobility 
and stage of recovery.  
 
 
4.2.2.  Conducting clinical trial 
 
Ethical approval 
 
Before starting data collection, ethical approval was sought and granted from the St Mary’s 
Local Research Ethics Committee (December 2007 – Ref 07/H0712/139).  This occurred 
before the conception of the National Research Ethics System (NRES) of application.  
 
Recruitment and eligibility 
 
Patients scheduled for TKA at St Mary’s Hospital or Charing Cross Hospital between 
January 2009 and January 2011 were identified and assessed in line with study eligibility 
criteria.  Fourteen patients and 15 healthy controls were recruited. 
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Table 4.1.  Eligibility criteria for recruitment 
Inclusion Exclusion 
TKA for end-stage knee osteoarthritis Previous lower limb surgery 
 Known mobility disorder 
 Symptomatic osteoarthritis of contralateral 
knee  
 
 
Data collection  
 
Dr L. Atallah was responsible for data collection until 2011 when I took over responsibilities. 
 
During a pre-operative outpatient clinic appointment, a member of the direct healthcare team 
introduced the patient to the study protocol, and gained verbal consent for the researcher to 
organise a follow-up appointment to discuss the finer details.  Patients received a participant 
information sheet, and if in agreement, written consent was gained.  
 
Appointments at the patients’ homes were scheduled approximately 1-week pre-operatively, 
and again at 1, 3, 6, 12 and 24 weeks post-operatively.  Each visit, carried out by an 
Orthopaedic Specialist Registrar and another research team member, was designed to include 
3 sections; completion of gold standard assessment (questionnaires and the timed up and go 
test), brief clinical examination (including bilateral knee range of motion), and an activity 
protocol whilst wearing the e-AR sensor.  The control subjects were assessed once with an 
identical protocol.  
 
The questionnaires used included the short form health survey147 (SF-36), international 
physical activity questionnaire148 (IPAQ) and the Noble and Weiss Score149.  All 
questionnaires were previously validated to assess various aspects of physical functioning, 
including mobility disability,150 physical activity levels,148 and ability to perform various 
activities of daily living.151 The timed up and go test (TUG) is a simple clinical test used to 
assess balance and basic mobility skills required to perform activities of daily living.152, 153 
The task consists of 4 different movements, standing, walking 3m, turning (and returning to 
the chair), and sitting. 
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Clinical examination involved the measurement of bilateral knee range of motion (ROM) 
using a goniometer, as well as inspecting the operated knee for wound site complications and 
gross structural abnormalities.  Bilateral knee ROM was recorded at each visit, with further 
information being added as appropriate. 
 
 
 
 
 
 
 
 
Figure 4.3.  Using a Goniometer to measure the range of motion of the knee 
 
The activity protocol was based on the DynaPort KneeTest, for which construct validity has 
been proven by a strong correlation with the ratings of patients’ disability by physical 
therapists.154 
 
Table 4.2 Activity protocol (based on DynaPort Knee Test) 
 Locomotion  Transfers 
1 Walk 12 steps 13 Pick up and 4 kg object and walk 
2 Walk 12 steps and return 14 Pick up and 4 kg object and walk * 
3 Walk 12 steps (as 1) 15 Sit down and stand up (40cm chair) 
4 Walk >20 steps (where pos.) 16 Sit down and stand up (30cm chair) 
 Rise and descend  Lifting and moving objects 
5 Ascend and descend stairs 17 Forward slalom walk with trolley 
6 Ascend and descend stairs * 18 Backward slalom walk with trolley 
7 Ascend and descend 1.2m slope (33%) 19 Walk 12 steps carrying drinks tray 
8 Ascend and descend slope * 20 Walk 12 steps with 4 kg object 
9 Step up and down 20cm block 21 Walk 12 steps with 4 kg object * 
10 Step up and down 20cm block * 22 Timed up and go test 
11 Step up and down 30cm block   
12 Step up and down 30cm block *   
* Task repeated leading with/carrying on unaffected side   
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An experimental setup was put together including a 1.5m adjustable slope, drinks tray, 4kg 
dumbbell, and several 15cm coloured cones.  Equipment was kept in a conventional 2-
wheeled shopping trolley, which was used with the cones for the slalom task.   
 
Patients were asked to complete as many activities as they were comfortable with, in line 
with the conditions of the ethical approval.  During the protocol, patients were asked to wear 
the e-AR sensor. The e-AR sensor is a lightweight (7.4g) ear-worn activity recognition 
device.131 It contains a tri-axial Micro-Electro-Mechanical-Systems (MEMS) accelerometer 
(ADXL330) and wireless transmitting capabilities, which allows subjects’ movements to be 
recorded in a free-living environment, without the restrictions and costs associated with wired 
systems and gait laboratories.  A sampling rate of 50Hz was used, within an acceleration 
range of +/- 3g. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.  Ear-worn activity recognition sensor (e-AR, Imperial College London) 
 
 
A tablet computer (Acer ICONIA) operated by the attending researcher, received data from 
the e-AR sensor wirelessly.  To aid data analysis, activities were electronically tagged and 
segmented using a real-time marking system on the tablet.  The marker was a known number, 
recorded in a new column at the end of each row, corresponding to the activity. 
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4.2.3.  Data analysis 
 
The initial analysis was conducted in collaboration with machine learning expert, Dr Raza Ali 
of the Hamlyn Centre, Imperial College London. 
 
Producing sensor scores  
 
The raw signal from the e-AR sensor was partitioned using the sliding window technique, 
with each window corresponding to 128 samples of data.  The features extracted from each 
sensor channel were statistical and wavelet based.  Statistical features included signal energy, 
mean variance, kurtosis and skewness.  The wavelet features were comprised of the mean and 
standard deviations of the first two levels of the Haar wavelet transform for each sensor 
channel.  In addition to these single-channel features, the covariance between each pair of 
channels was also computed.  In total 36 features were extracted from each window of sensor 
data. 
 
To establish the underlying feature space for classification tasks, the feature space can be 
significantly reduced using a dimensionality reduction algorithm that proceeds by mapping 
the full feature space into a reduced dimensionality that preserves the essential variations of 
the dataset.  Isomap,155 a non-linear dimensionality reduction algorithm, was used to model 
the structure of the data using a manifold before embedding it in a small-dimensional space. 
In simple terms, a manifold is a method of plotting complex multi-dimensional data onto a 
2D plane.  This can help visualise or calculate the differences or similarities between 1 or 
more points on the same Euclidean plane (that one may measure between with a ruler).  One 
of the most basic examples of this is mapping the globe (3D earth) onto a 2D chart.  Each 
discrete area of the chart is mostly accurate, but the chart in its entirety is not.  A separate 
manifold was trained for each activity, and the first 10 dimensions of the manifold were used 
for further analysis.  In previous work this technique has been used for the detection and 
analysis of transitional activities, including walking, lying down, stair climbing, sitting and 
standing.156  
 
 
 
 !
! 102 
Classification 
 
Artificial Neural Networks (ANN) were used to classify manifold-embedded data into the 
stage of recovery.  ANN are typically bio-inspired models based on the animal nervous 
system.  The networks consist of several inputs (as with sensory nerves), with various 
weighted functions determined by the programmer (the brain), which will in turn lead to a 
desired output or decision. Specifically, a multilayer perceptron157 with a single hidden layer 
was trained, with 10-fold cross-validation for each classification task.  
 
 
To quantify the extent of recovery we computed a score (or distance) for each activity, patient 
and peri-operative time, relative to the healthy control group.   
 
 
Statistical Analysis 
 
Descriptive statistics (mean, standard deviation) were calculated for subject demographics 
and all outcome measures.  A partial psychometric assessment of the sensor values was 
conducted.  Spearman’s rho correlation coefficients were calculated between sensor values 
and gold standard measurements (TUG and ROM) to assess concurrent validity.  This test 
was chosen to account for the data which had a monotonic and polynomial distribution.  
 
The construct and ability of the sensor to distinguish between patients of expectedly 
dissimilar states (e.g. pre-op vs. 1-week post-op) was investigated using Wilcoxon signed-
rank tests. 
 
Statistical analysis was performed using the Statistical Package for Social Sciences version 
19.0 (SPSS, IBM corp, NY, USA). 
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4.3.  Results 
 
4.3.1.  Study participants  
 
Between February 2009 and February 2011, 14 patients undergoing TKA, and 15 healthy 
subjects were recruited by the sensing team at the Hamlyn Centre, in collaboration with Mr 
Dominic Spicer (Consultant Orthopaedic Surgeon).  The patient group included 6 males and 
8 females, with a mean age at the time of surgery of 69.3 ± 4.6 years (SD) (range 60 – 84).  
The mean Body Mass Index was 29.2 ± 2.8 kgm-2 (SD) (range 22.1 – 33.8).  Healthy subjects 
had a mean age of 27.1 ± 1.9  (SD) (range 23 – 49), and a BMI of less than 30 kgm-2. 
 
No subjects were considered lost to follow-up, but only 1 patient had full data collected at 
every time point.  Out of 84 planned data points, 54 were collected (64%).  Twenty-seven out 
of 84 (32%) questionnaires were completed and as such formal analysis was omitted.  
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4.3.2.  Main findings 
 
Patient function estimated by the sensor and measured by ‘gold standard’ tests (TUG and 
ROM) consistently declined following the operation, before gradually returning to a level 
similar or greater than that during pre-operative testing.  
 
 
 
Figure 4.5.  Peri-operative patient performance as measured by the sensor, TUG, and ROM, for all 
activities combined.  All data were normalised relative to the pre-operative performance (= 1) to 
improve the interpretation of the recovery curve. 
 
 
The biggest changes in performance were seen within the first 6 weeks of the surgery 
(including the pre-operative time point).  After 6-weeks patient performance appeared to 
plateau.  
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Table 4.3.  Longitudinal activity performance scores 
  Sensor (arb.) TUG (secs) ROM (deg) 
Pre-operative Mean (SD) 1.385 (0.562) 17.5 (5.12) 75 (19.6) 
 Difference (P) 0.161 0.069 0.021 
1-week Mean (SD) 1.610 (0.442) 31.3 (15.1) 49 (16.2) 
 Difference (P) 0.128 0.012 0.063 
3-weeks Mean (SD) 1.314 (0.250) 20.8 (13.1) 63 (15.4) 
 Difference (P) 0.028 0.035 0.013 
6-weeks Mean (SD) 1.228 (0.241) 15.6 (5.95) 83 (13.0) 
 Difference (P) 0.612 0.600 0.833 
12-weeks Mean (SD) 1.206 (0.253) 15.6 (7.49) 83 (23.7) 
 Difference (P) 0.225 0.068 1.000 
24-weeks Mean (SD) 1.290 (0.212) 11.8 (4.99) 82 (10.3) 
Timed up and go (TUG), Knee Range of Motion (ROM) 
 
Changes in patient performance estimated by the sensor followed the same trends as the TUG 
and ROM.  A moderate correlation was seen between TUG times and ROM (Spearman’s Rho 
= 0.324, p = 0.026).  Correlations approaching statistical significance were found between 
the sensor and TUG times (R = 0.245, p = 0.097) and ROM (R = 0.282, p = 0.057).   
 
 
Figure 4.6.  Cluster plot comparisons showing the relationships between all performance metrics   
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Gait analysis 
 
Longitudinal changes in performance of the activity protocol were visible on the raw e-AR 
sensor data.  During walking, for example, it was clear that the walking speed and confidence 
(reflected by sharpness and amplitude of the steps) reduced immediately after the operation, 
before gradually returning to a level similar or greater than that during pre-operative testing.  
 
 
 
 
Figure 4.7.  Raw data (arbitrary units) from e-AR sensor capturing during walking.  For illustrative 
purposes, this shows visual changes in the signal throughout recovery.  Each sensor axis is shown 
with a different colour (Blue – Medio-lateral, Red – Supero-inferior, Green – Antero-posterior).  Data 
collected at 50Hz, X-axis reflects time as data samples. 
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Considering walking (gait pattern) exclusively, similar trends were seen to that of all 
activities combined.   
 
 
Figure 4.8.  Peri-operative assessment gait as measured by the sensor, TUG, and ROM.  All data were 
normalised relative to the pre-operative performance (= 1) to improve the interpretation of the 
recovery curve. 
 
 
Changes in gait estimated by the sensor showed a moderate correlation to ROM (R = 0.462, p 
= 0.001) but only bared some visual resemblance to TUG (R = 0.108, p = 0.468).  
Differences in sensor-estimated performance for gait throughout the recovery curve were less 
pronounced than when considering all activities. 
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Pre-operative analysis 
 
Pre-operatively, the 2 ‘gold standard’ measurements (TUG and ROM) only showed a weak 
correlation (R = 0.323, p = 0.306).  No activities showed significant correlation with ROM.  
Gait, slope walking, tray carry and bag carry (4/10 activities) correlated with TUG, but the 
correlation between all activities combined and TUG did not reach statistical significance (R 
= 0.427, p = 0.167).  
 
Table 4.4.  Concurrent validity of pre-operative sensor scores vs. gold standards metrics  
  TUG ROM 
Gait Correlation coefficient 0.783 0.168 
 P 0.003 0.601 
Stairs I Correlation coefficient 0.469 -0.239 
 P 0.124 0.455 
Stairs II Correlation coefficient 0.301 -0.340 
 P 0.342 0.279 
Slope I Correlation coefficient 0.548 0.407 
 P 0.160 0.317 
Slope II Correlation coefficient 0.738 0.491 
 P 0.037 0.217 
Weighted slalom Correlation coefficient -0.200 -0.192 
 P 0.555 0.572 
Slalom Correlation coefficient 0.133 -0.060 
 P 0.681 0.854 
Tray carry Correlation coefficient 0.671 -0.014 
 P 0.017 0.965 
Bag carry I Correlation coefficient 0.427 -0.389 
 P 0.167 0.211 
Bag carry II Correlation coefficient 0.741 -0.007 
 P 0.006 0.983 
All activities Correlation coefficient 0.427 -0.340 
 P 0.167 0.279 
I – lead/carry with affected side, II – lead/carry with unaffected side   
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Case Comparison 
 
One patient (B) experienced and reported a complication approximately 10-weeks post-
operatively (persistent knee effusion).  This patient’s recovery curve was noticeably different 
to the typical recovery profile exhibited by the majority of the cohort, represented by patient 
A. 
 
 
 
Figure 4.9.  Case comparison – Patient A exhibits a typical recovery curve whilst patient B shows late 
signs of deterioration (reflected by both the sensor and knee range of motion) 
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Patient Classification 
 
At the defined time intervals, patients appeared to exhibit similar kinematic traits, which 
allowed subjects to be clustered and classified into normal, pre-operative and 24 week post-
operative groups with an accuracy of 89% (median). Classification accuracy was reduced to 
69% when including all post-operative time intervals.  Misclassification usually occurred into 
a chronologically adjacent group. 
 
 
 
 
 
Figure 4.10.  Walking at each stage of recovery is clustered in manifold space. The manifold provides 
artificial dimensions with no physical meaning, but which has input from all of the features used.  
This technique is the first step in classification testing, which is simply to illustrate the data points can 
be separated by the algorithm.  As the area of interest is recovery from surgery, the construction of the 
manifold and choice of dimensions is likely to amplify features that are related to the injury, e.g. 
asymmetrical repeating patterns.  The natural variation in the healthy cohort brought about by gender 
and physical fitness is poorly related to the mobility characteristics of the patient cohort, and as such, 
the normal cohort poorly defined.  
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Figure 4.11.  Chart showing the percentage accuracy of the algorithm for classifying subjects into 
groups, based solely on sensor data.  Grey columns reflect classification accuracy for each activity 
considering just 3 groups (normal, pre-op, and 24-weeks post-op).  White columns take into account 
all 6 peri-operative phases and normal.  
 
 
 
 
Post-operative 
week 1 3 6 12 24 
1 88.6 5.3 3.6 1.1 1.2 
3 6 72.2 12.3 5.6 3.6 
6 8.3 19.9 58.5 9.6 3.5 
12 3.6 8 10.9 62.7 14.6 
24 5.8 7.5 8.3 19.1 59.1 
 
Figure 4.12.  Aggregate of confusion matrices for classification of post-operative stage (for perfect 
classification only diagonal elements will prevail).  Off-diagonal elements signify the confusion 
between 2 classes of post-operative stage 
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4.4.  Discussion 
 
This study demonstrates the feasibility of using a lightweight ear-worn motion sensor to 
objectively assess patient mobility in the community setting.  Feature selection techniques 
were used to quantify the magnitude of movement abnormality, and produce patients scores 
based on distance from normal performance for each activity and overall.  Expected trends in 
patient performance were seen in the sensor data, which bared close resemblance to the gold 
standard measurements (TUG and ROM).  The sensor data was able to cluster and predict the 
patients’ stages of recovery to a high level of accuracy, and in one case identify a patient 
whose convalescence deviated significantly from that of the study cohort.  
 
Our results bear similarities to the, albeit sparse, related literature. Directly comparable 
studies with TKA and similar time intervals are not available, however, patients of a similar 
age range undergoing uni-compartmental knee arthroplasty showed similar trends in recovery 
to our cohort, in which the most significant improvements in function were also made in the 
first 12 post-operative weeks.49  
 
A common alternative to objective, functional assessments in research and clinical practice is 
the use of questionnaires for quality of life (e.g. SF-36) and/or knee function (e.g. Noble and 
Weiss score).158 Although it would be entirely feasible for patients to complete a 
questionnaire every day during rehabilitation, many groups have questioned the reliability of 
this method.159 Repeated completion of a questionnaire is likely to result in amplification of 
the subjectivity in response.  Functional tests such as the timed up and go, 6-minute walk and 
others may also be used.   However these test are somewhat unspecific, failing to provide 
details on difficult areas or tasks.  There is also a risk of factors unrelated to the knee, 
including behaviour and level of fitness, confounding the results.  
 
Studies that implement the DynaPort knee test sensing equipment in addition to the activity 
protocol usually conduct a similar analysis, in which the difference in patient performance 
compared to healthy controls is calculated.  The benefit of our method over the Dynaport 
knee test is that it requires just 1 sensor, rather than 6 sensors plus a data collection unit worn 
around the waist.  One would expect it to be more viable for a patient to collect daily 
movement data from a single ear-worn sensor, rather than several specifically placed sensors.  
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Reproducibility of results using multi-sensor systems, even with technical support, is 
challenging due to inconsistencies in sensor placement and time demand.  An ear-worn 
sensor has maximum placement consistency and patient usability, whilst causing the 
minimum restriction in activity. 
 
Interpretation of the data must be performed in the context of limitations in the study design.  
Recruitment was more difficult than anticipated, which resulted in less data and suboptimal 
certainty in our outcomes.  The eligibility criteria were designed partially to prevent the 
recruitment of patients whose recovery would be delayed by unrelated causes, such as 
contralateral knee pain.  Patients who had undergone previous lower limb surgery were also 
excluded.  More patients than expected had bilateral OA and were having both knees 
replaced consecutively, or had undergone arthroscopic examination or minor operations on 
the joint surfaces in advance of the TKA.   Furthermore, there was significant difficulty 
following up patients for all 5 post-operative visits.  Participant feedback suggested this was 
due to the length of each appointment, which lasted up to 1 hour.  Appointments were 
abbreviated by allowing patients to complete the questionnaires in their spare time, however 
this resulted in very few questionnaires being completed and returned.  
 
To provide a reference for comparison in our study, we recruited 15 healthy subjects to 
complete the activity protocol wearing the e-AR sensor.  However, the mean age of the group 
was significantly less than that of the TKA cohort.  Whilst this might not have been an ideal 
reference for direct comparison, once metrics had been developed, observation of changes in 
performance over time is unlikely to have been compromised.  
 
Collecting data in the home environment was suggested with the future in mind, based on 
recent proposals to shift healthcare services into the community, and into the hands of the 
patients whenever possible.  Whilst this is still very much the vision of established healthcare 
systems, it is prone to cause inconsistencies in research studies.  Variation in the home setting 
might be described as major or minor.  Major variations included homes with no access to 
stairs, resulting in the exclusion of that task.  Minor variations would be differences in the 
dimensions or material of the stairs, causing subtle yet important inter-subject performance 
differences.  However, so long as the environment is consistent, longitudinal follow-up need 
not be affected, though cross-subject comparison should be interpreted with caution. 
 !
! 114 
 
Lastly, the psychometric analysis was described as partial, due to the lack of reliability 
testing.  Ideally, subjects would have performed tasks twice on one or more occasions, yet 
due to the length of the protocol, as well as the post-operative state of the patients this was 
not deemed ethically appropriate. 
 
 
Potential Clinical impact 
 
Pre-operatively, the e-AR sensor was able to differentiate between pre-operative and healthy 
subjects.  This study suggests that if patients were to complete a short activity protocol 
wearing the sensor upon first noticing knee symptoms, it is feasible to suggest monitoring 
their biomechanical function up until a critical point where their level of impairment indicates 
a need for surgical intervention.  Four out of the 10 activities assessed by the sensor pre-
operatively correlated to TUG with statistical significance, and overall there was a weak 
correlation.  This may have been due to low specificity or sensitivity of the TUG in assessing 
knee function, and the vulnerability of the test to be affected by other factors, including 
interpretation of instructions, environment, and pre-existing health and fitness condition.  
Equally, some of the tasks in the study protocol may not have sufficiently challenged knee 
function. 
 
Post-operatively, results suggest that functional mobility can be monitored through a short 
activity protocol with the e-AR sensor.  In addition to the early detection of complications, 
regular patient-led assessment, combined with patient feedback, may provide a source of 
motivation to complete rehabilitation exercises.  Personalisation in this manner would update 
current follow-up regimes, with appointments no longer being arbitrarily timed but based on 
patient needs, improving the value of medical interactions.  Recovery data would also be 
available to the clinician at the appointment, allowing them to make more informed decisions 
on the continued management of the case.  It will be important to define what level of post-
operative data granularity is required from TKA patients to provide an adequate picture.  
 
A technology-based approach such as this falls in line with global healthcare reforms, 
whereby the patient’s participation and responsibility in their medical management is 
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increased, allowing appropriate care provision to be relocated from the hospital to the 
community setting.  
 
For such benefits to be realised, further work must address the need to develop an effective 
user interface and activity protocol to facilitate unsupervised data collection and upload.  
Only at this point could the effect of the e-AR sensor platform on patient outcomes and cost 
effectiveness be assessed.  Data analysis must evolve from calculating the magnitude of 
movement abnormality to providing mobility characterisation.  Although current methods 
shown in this paper would suffice for identifying gross complications requiring clinical 
contact or surgical revision, more subtle abnormalities such as asymmetrical loading or 
altered temporal gait features would provide more useful information to the patient and 
healthcare team.  This sort of information is more likely surpass the use of current clinical 
tests, and promote a better case for using the sensor when considering detailed assessment 
and personalised, dynamic rehabilitation strategies. 
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CHAPTER 5.   
DEVELOPMENT AND VALIDATION OF A MOTION 
SENSOR BASED MOBILITY ASSESSMENT FOLLOWING 
LOWER LIMB RECONSTRUCTION‡ 
 
 
Abstract 
 
Background:  Open tibial fractures are managed in a variety of ways, but current practice 
fails to objectively assess short and long-term outcomes.  Not only does this limit the scope 
for evaluation of management strategies, but it also prevents the provision of regular patient 
feedback and implementation of adaptive personalised rehabilitation programmes.  As a 
result, total recovery time and the extent of functional recovery are likely to be suboptimal, 
with consequential poor rates of return to work.   
 
Advances in miniaturised, wireless sensor technology allows resource-sparing, pervasive data 
capture of multiple patient features in a non-specialised environment. Our aim was to develop 
and validate a robust, objective assessment method using a novel motion sensing system 
worn by the patient for use in both clinical and community settings (Hamlyn Mobility Score - 
HMS). 
 
Methods:  We implemented a lightweight (7.4g) ear-worn accelerometer (e-AR sensor, 
Sensixa Ltd. and Imperial College London) and tablet interface into a short activity protocol 
made up of tasks previously validated to assess different aspects of functional mobility.  
Twenty 3-month post-open tibial fracture patients and 10 healthy subjects completed the 
protocol, as well as a short-form health survey (SF-36) for comparison.  Subjects’ 
performances were rated through extraction of multiple kinematic features from the 
accelerometer data; techniques were previously validated using high-speed cameras and a 
force plate-instrumented treadmill.  A psychometric evaluation was conducted to ascertain !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
‡ Chapter based on publication: Kwasnicki R M, Hettiaratchy S, Jarchi D, Nightingale C, Wordsworth M, 
Simmons J, Yang G Z, Darzi A. (2014) Assessing functional mobility after lower limb reconstruction: a 
psychometric evaluation of a sensor-based mobility score.  Annals of Surgery.  In press. 
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the reliability and validity of the HMS.  
 
Results:  The HMS demonstrated excellent reliability (Intraclass Correlation Coefficient > 
0.90, p< 0.001) and internal consistency (Cronbach’s Alpha = 0.94).  Concurrent validity was 
demonstrated by correlation between HMS and SF-36 scores (Spearman’s Rho = 0.668, p = 
0.005).  Significant differences in HMS scores between healthy subjects and patients, sub-
grouped according to Gustilo-Anderson fracture classification, were shown (KW-ANOVA, 
X2 = 18.6, p< 0.001).  The effect size of HMS between 3 – 6-month assessments was greater 
than that of the SF-36 (1.48 vs. 0.99).  
 
Conclusions:  The HMS shows satisfactory reliability and validity to be considered for 
implementation into routine follow-up of patients with open tibial fractures.  This will 
improve our ability to objectively profile and compare a wide variety of patient outcomes, 
whilst creating a platform for remote patient surveillance and early detection of 
complications.  Furthermore, the methods described provide a real opportunity to revamp the 
recovery paradigm through dynamic, self-directed rehabilitation, with huge potential for 
positive impact in the cost and care quality of everyday clinical services. 
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5.1.  Introduction 
 
Open tibial fractures (OTF) are defined as fractures of the tibia where the bone breaks the 
skin of the leg.  Although these injuries range in severity, an OTF is always considered to be 
leg-threatening.  As such, many clinicians and academics have analysed the various factors 
predicting patient outcome, in order to produce evidence-based management guidelines to 
optimise outcomes.   
 
Collecting clinical data related to OTF is difficult as a result of the relatively low incidence, 
and high variability in injury and management strategies.  A study utilising the Swedish 
National Hospital Discharge Register (SNHDR) found the incidence of OTF to be 2.3 per 
100,000 person years with higher incidence in males (3.4 vs. 1.4).  The median age for OTF 
was 40 but with large gender differences (28 in men, 51 in women).160 An earlier 
epidemiological study in Edinburgh quoted similar incidence of 5 per 100,000 person 
years.161 The mechanism of injury most often was road traffic accidents (43%), followed by 
falls on level ground (25%), and others such as sport and falls from a height.160 
 
Patients with OTF are expensive to manage.  A European group calculated average yearly 
treatment costs after the initial surgery in the UK, Germany and France as 45,000 euros.162 
Surgical management (IIIB fracture with free flap coverage) in a UK specialist centre is 
around £12,000. 163 
 
 
5.1.1.  Management of open tibial fractures 
 
The majority of patients in the UK with OTF present to local hospitals, which rarely have 
specialist extremity reconstruction units.  Patient outcomes, including surgical revision of 
fixation and flap failure, have been shown to be better in specialist centres.164 Early referral to 
a specialist centre to be managed by a senior orthopaedic and plastic surgical team with 
experience in extremity reconstruction is an essential step in the most recent best practice 
guidelines.165 
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Patient assessment 
 
It is important early on to establish a patient history.  This may come from the paramedics or 
a witness if the patient is unable to recall or report on the incident.  The mechanism of injury 
must be explained.  This will provide an indication of the level of energy of the trauma (road 
traffic accident vs. fall), possible contamination from the scene (gravel from the road, metal 
or chemicals from an industrial incident), any prolonged entrapment or immobility, and 
approximate limb ischaemia time if relevant.   
 
Next, or during the acquisition of the history, the patient should be examined.  As part of a 
major trauma call, this is likely to be somewhat determined by local protocols led by senior 
accident and emergency staff.  Aside from basic resuscitation measures, the wound should be 
assessed for signs of high-energy trauma, such as multiple bony fragments, large soft tissue 
wounds, evidence of crush or burst injury, and signs of degloving of the skin.  Compartment 
syndrome, caused by rising pressure in the fascial compartments due to bleeding or swelling, 
should be ruled out by assessment of the 6 p’s – pain, pallor, pulselessness, paraesthesia, 
paresis and pressure.  The integrity of vascular bundles should be assessed through palpation 
of pulses and distal capillary refill time.  Also, neurological examination of the region, 
particularly the plantar surface (posterior tibial nerve) should be conducted. 
 
The wound and surrounding area requires imaging.  Ultrasound may be used in the acute 
setting to identify active bleeding.  For assessment of the injury, often radiographs (X-ray) 
are sufficient, including a full-length antero-posterior and lateral view of the tibia, as well as 
similar views of the ipsilateral knee and ankle.  Three-dimensional imaging can be requested 
later if there is suspicion of joint involvement.  The fracture pattern, location and number of 
fragments should be documented.   
 
OTF Classification 
 
The Gustilo-Anderson classification for open fractures is the most commonly used scale, 
based on extent of fracture (periosteal stripping), soft tissue damage, contamination and 
vascular injury.166 The inter-observer reliability for this classification was investigated in 250 
orthopaedic surgeons, showing 60% total agreement over 12 cases.167 
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Table 5.1.  Gustilo Anderson Classification  
Gustilo-Anderson Classification 
Type I Limited periosteal stripping, wound < 1cm 
Type II Mild to moderate periosteal stripping, wound 1-10cm  
Type IIIA Significant periosteal stripping and soft tissue injury, 
evidence of high-energy trauma, bone coverage adequate 
Type IIIB Extensive periosteal stripping and soft tissue stripping with 
insufficient bone coverage 
Type IIIC As above, with vascular injury requiring repair to maintain 
limb viability 
 
 
Management plan 
 
At this point, specialist orthopaedic and plastic surgeons should devise a joint treatment plan.  
This must take into account the management of concomitant injuries, which occur in up to 
19% of OTF patients.161 
 
 
Figure 5.1.  A protocol for the management of open tibial fractures over the first five days165 
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Timing 
 
To reduce the risk of deep infection, soft tissue cover should occur within 5 days of the 
injury.  Delayed soft tissue coverage, even in the setting of negative pressure wound therapy, 
results in higher rates of infection.168 Timing of the initial debridement, however, is less 
important, with recent studies suggesting that the focus should be on adequate debridement, 
by a senior surgeon.169 Antibiotics should be administered as soon as possible after the injury, 
certainly within 3-hours.170 Also, vacuum assisted closure (VAC) using a foam dressing is 
recommended. 
 
 
Amputation or limb salvage 
 
This decision to amputate is not to be made early, unless the damaged limb is threatening the 
life of the patient (e.g. bleeding or infection).  Even type IIIC fractures are approached with 
salvage as the first intention.  Two systematic reviews have incorporated around 15-20 
studies comparing outcomes from amputation and limb salvage.171, 172 Although the level of 
evidence from several of the studies was not ideal (due the impracticalities of conducting a 
randomised controlled trial in the trauma setting), and the outcome measures were often 
subjective, both reviews showed no difference in long-term functional outcomes between 
amputation and limb salvage. This is probably a result of excellent prosthetic services 
available to patients,173, 174 and possibly the suboptimal physical therapy for limb 
reconstruction patients.  Similar outcomes were seen in duration of hospital stay and return to 
work, but the cost and length of rehabilitation for limb salvage patients was higher.   
 
The Mangled Extremity Severity Score (MESS) was developed to select trauma victims 
whose irretrievably injured lower extremities warranted primary amputation.175 This scale 
was based on skeletal/soft-tissue damage, limb ischaemia, shock and age.  This was tested in 
152 patients, in which all patients with a score of 7 or more required amputation; with some 
patients scoring less than 7 undergoing delayed amputation.176 
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Surgical Management 
 
In the operating room, the wound can be more thoroughly assessed.  This is facilitated by a 
longitudinal extension of the wound, being careful not to compromise the posterior-lateral 
regions of perforating arteries, which might be required for reconstruction.  The borders of 
the wound are excised, along with any local devitalised tissue.  The skin, muscle and bone 
should all be assessed for viability.  Although inexperienced surgeons often feel concerned 
about resecting bone at the site of the fracture, adequate debridement is essential.  Too little 
debridement may cause non-union and infection, whereas too much will just indicate the use 
of one of the many strategies available for reconstructing the defect.  Thorough lavage 
(irrigation) of the wound with 6 or more litres of warm normal saline solution is necessary. 
 
 
Fracture fixation 
 
The bone must then be stabilised.  There are several options available, and definitive fixation 
is not necessary at the first ‘look’.  External fixation (EF) provides fracture fixation based on 
the principle of splinting.  This method is useful for the more severe OTF, with multiple 
anticipated operations for serial debridement, microsurgical reconstruction and fasciotomies.  
EF is also useful in children as it avoids compromising the growth plate.  EF methods may be 
uniplanar, lying parallel to the tibia, or in the form of one or more rings (Ilizarov).  A 
frequently used device is the Taylor Spatial Frame, which consists of two or more lightweight 
rings connect by several struts.  Manipulation of the frame can be used to correct angular, 
translational, rotational and length deformities. 
 
Internal fixation (IF) following open reduction (ORIF) normally produces prompt return to 
functional weight bearing and rehabilitation.  There are many parts to the IF ‘tool-kit’ 
including wires, screws, plates and nails.  Wires are often used in conjunction with other 
fixation devices to reattach bony fragments or stabilise nailed long bone fractures.  Screws 
are used with plates to fix fractures.  Occasionally they cross the fracture line (inter-
fragmentary), and compress the two fragments, such as that used to fix inter-trochanteric 
proximal femur fractures.  Some screws are used to fix ligament grafts to bone, such as in 
anterior cruciate ligament repair.  Plates used to reduce fractures can either compress 
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fragments (‘compression plating’) or in the case of comminuted fractures plates are applied in 
a neutral mode to hold the fragments in place during healing.  Intramedullary nailing has 
become the standard treatment for diaphyseal fractures of the femur and tibia.  The technique 
facilitates early weight bearing and optimal biomechanical positioning, preventing bone 
torsion and bending.177 IF should be avoided in the setting of suspected wound contamination. 
 
 
Soft tissue reconstruction 
 
Open fracture wounds are rarely closed by primary intention (immediately).  Adhering to the 
steps listed above, the wound must be extended and excised to allow exploration and control 
of infection.  The fracture site should be covered by intact skin or ideally muscle to 
encourage healing and prevent infection.  The coverage options lie on a scale, often called the 
‘reconstructive ladder’.  The simplest options at the base include delayed primary closure 
(following reduction of swelling and infection control in lower grade fractures) and skin 
grafting, then this progresses to local tissue transfer, followed by free tissue transfer at the top 
of the ladder. 
 
Skin grafting can be used to cover large soft tissue defects, particularly when a meshing 
technique is followed.  However, skin grafts are not suited to bare bone or tendons, and often 
can result in a poor cosmetic outcome.  Local tissue transfers, or flaps, are often used to close 
defects as they are not technically demanding (though require some experience for success) 
and allow reoperation (unlike skin grafting).  Local flaps can often be unattractive and the 
donor site requires skin grafting.  Also, there are few options for local flaps near joint lines, 
particularly the ankle.  Free tissue transfers (free flaps) through microvascular anastomosis 
are often the only option for covering significant defects, particularly in the distal 1/3 of the 
tibia.  Free flaps involve harvesting tissue from a distant area, then transferring it along with 
its skeletonised vessels for implantation at the site of injury.  This requires joining the artery 
to the local blood supply, and one or more veins to the deep venous system.  As these vessels 
are often less than 3mm in diameter, an operative microscope and micro-instruments are used 
for a highly technical vascular anastomosis.  As with local flaps, the donor site defect must be 
closed appropriately.   
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Figure 5.2.  The reconstructive ladder shows escalation of technique choice complexity 
 
 
Follow-up 
 
Patient monitoring in the acute post-operative period is based around optimising systemic 
physiology to support wound healing, and maintaining a clean environment around the 
wound.  (More details of the monitoring process can be found in Chapter 7) 
 
Following hospital discharge, patients attend outpatient appointments at increasing time 
intervals.  At appointments, the patients’ general health and pain levels are checked verbally.  
The wound is examined for signs of infection or dehiscence.  The patient will normally 
undergo antero-posterior and lateral x-rays to provide the surgical team with information 
regarding bone healing.  Radiological results will then guide the following management 
steps, including advise regarding weight bearing, activity limitations, and the timing of the 
next appointment.  Most patients are referred to a local physical therapy service.  Depending 
on injury severity and post-operative convalescence, the patient will be followed up for 9-24 
months.  This may include further operations if an acceptable outcome hasn’t yet been 
achieved. 
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5.1.2.  Options for post-operative assessment 
 
There are multiple options for evaluating the outcomes following OTF.  Most centres capture 
gross outcome measures such as time to achieve union (fracture healing time), re-operation, 
deep infection (osteomyelitis), flap failure and secondary amputation.  Submission of this 
information to the Trauma Audit and Research Network (TARN) database has become 
mandatory for specialist centres.  These outcome measures are somewhat blunt, often 
providing only binary outcomes, e.g. yes or no for secondary amputation.  This is not a very 
sensitive measure, and would only separate patients into 2 groups, even though the 
convalescence of patients varies widely.  Binary outcome measures are however, easy to 
handle from a statistical point of view, allowing correlations or associations to be made with 
other management factors such as time from injury to definitive treatment. 
 
Questionnaires are used in multiple clinical settings.  They are often completed by the patient, 
but can be completed by a healthcare professional either over the telephone (entering the 
patient’s answers) or using their own opinion.  Some medical questionnaires are designed for 
all patients, focusing on health related quality of life (HRQoL).  For example, the Short Form 
health survey (SF-36) contains 36 questions split into 8 categories, assessing the various 
aspects of well being that translate to health status.  The SF-36 is completed by the patient, 
and takes approximately 5-10 minutes.178 
 
Other questionnaires are disease-specific, for example the Western Ontario and McMaster 
Universities Arthritis Index (WOMAC) is used to assess the condition of patients with 
osteoarthritis of the knee and hip.179 The questions forming WOMAC are focused on aspects 
of functional mobility and symptoms associated with osteoarthritis such as pain and stiffness 
of the joints.  
 
Some questionnaires are case-specific such as the Enneking Score.180 This score was designed 
to assess patients following musculoskeletal tumour excision and reconstruction.  It combines 
case specific questions regarding limb pain and function, with more general questions on the 
use of walking aids and emotional acceptance. 
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Although questionnaires play a major role in the assessment of patients, including those with 
OTF, they have several limitations.181 One issue is the often unfeasible ‘responder burden’, 
i.e. the time taken to complete the questionnaire, which can often be in excess of 15 minutes.  
Another practical issue is the frequent need for complicated formulas to calculate the final 
score, such as those found in the SF-36 and European Quality of Life (EuroQol) 
questionnaires.182 The nature of questionnaires introduces subjectivity on two levels: the 
patient’s interpretation of the question, and the patient’s interpretation of their symptoms.  
Not only does this mean that the answers given from different patients cannot be fairly 
compared, but also the responses given by a single patient on 2 separate occasions may not be 
entirely consistent.  For example, questionnaire scores have been shown to correlate with 
fatigue and psychological status.183 Furthermore, questionnaires such as the Arthritis Impact 
Measurement Scale (AIMS) have reported issues with reliability secondary to cultural 
differences in patients.184 Some case or disease-specific questionnaires can be affected by 
other conditions, for example the WOMAC score for osteoarthritis of the knee and hip has 
been shown to be vulnerable to the confounding effect of lower back pain. 185  
 
One solution to the limitations posed by questionnaires is to conduct objective assessments as 
a replacement or supplement.  Although this has the potential to be resource demanding, there 
are many simple methods of assessment, which may take less time than some of the 
questionnaires.  
 
Goniometry (the measuring of joint angles) is a very quick partial assessment of joint 
function and is often used in knee and hip pathologies.  Some joint angles prove challenging 
to measure and as such have lower levels of agreement between examiners.186 Strength testing 
either using free weights, body weight, or specialist equipment can also provide an objective 
assessment of musculoskeletal function. 
 
The World Health Organisation’s (WHO) definition of health is ‘a state of complete physical, 
mental and social well-being, and not merely the absence of disease of infirmity’.  A large 
part of this is being able to complete one’s activities of daily living (ADL).  This ability is 
based on functional mobility, and not simply joint angles and muscle strength (even if they 
can predict mobility levels).  Short tests have been designed to include several aspects of 
functional mobility.  One of the first such tests was the ‘timed up and go’ test (TUG), 
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designed originally to assess frailty in elderly patients.187 This test includes standing, walking, 
turning, and sitting, all being important in ADL.  This test has been validated as an 
assessment tool in a number of clinical settings, including lower limb trauma.188 Another test 
called ‘timed up and down stairs’ (TUDS), provides further information regarding the 
strength and coordination required to complete ADL.189 The TUG and TUDS, along with 
other similar tests, can also be combined to form more holistic mobility tests.190 
 
Gait analysis, which is the process of assessing human/animal walking patterns, can also be 
implemented.  Reliably, this can be done in 2 ways: 1. Optically, using several cameras, and 
2. Using a force plate (either on a walkway, or under a treadmill).  The optical method is 
often described as the gold standard as it allows quantification of full body kinematics in high 
resolution.  The modern day gait laboratory usually consists of a 5-10m walkway, and several 
(8-12) cameras.  The cameras can be standard video cameras, and/or infrared cameras.  The 
cameras are normally programmed to capture the 3D position of multiple retro-reflective 
markers applied to consistent bony prominences on the subject, e.g. hip (greater trochanter), 
shoulder (acromio-clavicular joint).  The relative distribution of the markers is used to 
reconstruct the bony skeleton at high frequency, and derive standard gait parameters.  
Parameters include joint angles, various segment accelerations, and foot/ground interactions.  
Synchronised force plates positioned on the walkway can be used to supplement the camera 
data, or used solely when full gait laboratory facilities aren’t available.  Information gathered 
from force plates only provides gait parameters associated with foot/ground interactions.   
 
Gait analysis is highly resource demanding, including the need for a large space, specialist 
equipment, a qualified technician, and up to 2 hours per patient.  Another limitation is the 
artificial environment in which the tests take place.  The unrealistic environment and 
adhesive markers are likely to affect patient behaviour and bias the test.  Furthermore, the 
platform is not portable, and therefore limits the access and frequency of use to the majority 
of patients.  
 
As a middle ground between gait analysis and mobility tests, wearable motion sensors can be 
utilised.  Sensors including accelerometers, gyrosensors, force sensors, strain gauges, 
inclinometers etc. can measure various aspects of human movement.191 Many of these sensors 
are found inside mobile phones, and can be used through custom-made or commercially 
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available applications.  For example, the gait patterns of 39 patients with rheumatoid arthritis 
were assessed using a smartphone on the waistband.  The parameters estimated corresponded 
with clinical parameters such as disease activity score and modified health assessment 
questionnaire.192 
 
Simple activity monitors can be packaged in everyday wearable apparel, such as the Nike 
Fuelband and Fitbit devices, which can be worn as a wristwatch or clip onto clothing.  
Sensors of this kind started as pedometers, with simple uniaxial accelerometers used to count 
steps, and have since progressed to incorporate tri-axial accelerometers to provide more 
accurate step counts and overall activity levels.  Many devices also provide real-time 
feedback of activity, which is potentially useful therapeutically, particularly when trying to 
encourage increased levels of activity.  Activity levels, as opposed to specific kinematic 
patterns (e.g. gait analysis) can still provide information regarding the mobility of patients, 
and predict medical and quality of life outcomes.193, 194 Furthermore, temporal distribution of 
activity can be used to monitor physical behavioural patterns, which may be useful to know 
when managing patients.156, 195 A minor limitation is the inability to perform a rapid 
assessment of mobility in the clinical environment, and reliance on long-term data collection, 
which is vulnerable to sensor loss and patient attrition, and reliant on coordinated patient 
participation. 
 
Specialist sensing systems have been developed for kinematic assessment, mostly based on 
gait analysis, but with potential for other applications.  The Intelligent Device for Energy 
Expenditure and Physical Activity (IDEEA) is one such system, based on 5 bi-axial 
accelerometers placed on the legs and trunk. In a cohort of patients with osteoarthritis of the 
hip, the IDEEA was validated against a gait walkway system to estimate several gait 
parameters including gait cycle, swing, cadence, and double support times, step length and 
speed.196 Although this appears to be immediately applicable to clinical practice, the 
practicalities of using a 5-sensor system are such that the uptake is likely to be limited.  
Inconsistency in sensor placement, and the influence of 5 wired sensors (as well as a micro-
processing unit) on the body is likely to affect the reliability of the estimated gait parameters. 
 
The latest DynaPort GaitMonitor system (McRoberts, The Hague, the Netherlands), is based 
on a single, trunk-worn tri-axial accelerometer, and has been validated in estimating a range 
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of spatio-temporal gait parameters.197 This simple design is more likely to be applied in the 
clinical setting due to its simplicity.  When tested in the setting of amputees, it showed 
accurate estimations of gait parameters, however it was noted that the patients had consistent 
gait patterns, and were only walking in short, straight lines in a very controlled 
environment.198 The potential advantage of the DynaPort GaitMonitor and other pervasive 
sensing systems over the gait laboratory is the ability to use them in flexible, realistic 
environments.  The highly controlled setting of the DynaPort experiments reduces the 
validity required to support clinical applications of the system.  Further, the device along with 
software costs $3,000, which is considerably more than other commercially available devices. 
 
Another system based on a single tri-axial accelerometer is the e-AR sensor (3.2.2).  The e-
AR sensor has been implemented in multiple laboratory and clinical settings including 
assessing energy expenditure,132 detecting exacerbations of respiratory disease,199 post-
operative monitoring195 and gait analysis.131, 141 
 
 
5.1.3.  Outline of the Clinical Problem 
 
Improved understanding of the myocutaneous blood supply to the leg,200 advanced 
microvascular reconstructive techniques, and the development of management guidelines165 
has resulted in more limb salvage opportunities.201 However, the evidence to date fails to 
show improved long-term functional outcomes in limb salvage compared to amputation.  In 
addition, there are no differences in length of hospital stay or return to work, but significantly 
higher costs and increased length of rehabilitation associated with limb salvage.171, 172  
 
There are multiple options for assessing patients following OTF, from simple questionnaires 
to detailed gait analysis.  The best practice guidelines from the British Orthopaedic 
Association and British Association of Plastic Reconstructive and Aesthetic Surgeons 
(BOA/BAPRAS)165 suggest using gross outcome measures such as time to union, flap failure 
and secondary amputation, but also to include a quality of life questionnaire (e.g. SF-36) as 
well as a limb function questionnaire (e.g. Enekking score).  The variety of questionnaires 
used in the related literature suggests that there is no specific questionnaire used as part of 
standard practice. 
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Assessment of outcomes, and progress towards the final outcome, is important for many 
reasons.  Firstly to consider the patient, an injury of this magnitude is likely to be an unusual 
event for them, and possibly for anyone they know within their lifetime.  Unlike healthcare 
staff, the patient is unaware of the timing and character of the projected post-operative 
recovery, naturally creating potential anxieties.  The step-down from hospital care to home 
care is pronounced, which can often result in patients experiencing feelings of abandonment.  
Practically, the unfamiliarity with symptoms and expected improvements may cause 
unnecessary appointments with the General Practitioner (or Accident and Emergency), or 
conversely, failure to report symptoms or signs of complications.  Furthermore, completion 
of rehabilitation exercises without regular assessment can be demotivating. 
 
For the team responsible for the patient, access to information regarding the progress of the 
patient is essential for updating the management strategy.  Without regular assessments of 
individual patients, the follow up strategy is generic, and slow to adapt to patient 
improvements.  The OTF patient cohort is highly variable, therefore managing a young 
sportsperson in the same manner as an elderly patient is likely to be detrimental to the final 
outcome, or the rate and extent of recovery.  In a similar vain, the allocation of outpatient 
appointments and other resources such as physical therapy is arbitrarily distributed across 
registered patients, rather than on a needs basis.  This level of service is unfeasible in most 
circumstances, however extra provisions are often available in military rehabilitation centres.  
In optimal settings, such as those supported by the US army, OTF patients with salvaged 
limbs have lower long-term disability ratings (Veterans Affairs System of Rating Disabilities, 
46% vs. 66%), and higher rates of return to duty (20.5% vs. 12.5%), compared to 
amputees.202 Although the mechanism and severity of injury differs between military and 
civilian cohorts,203 this data suggests that optimally managed patients in with equivalent 
injury severity scores achieve favourable outcomes following limb salvage. 
 
The challenge for providers such as the National Health Service (NHS) in the UK is to 
achieve optimal outcomes with limited resources.  One strategy being employed across 
multiple specialties is shifting appropriate care provision into the community, where patients 
and non-specialist centres take a more active role in the management of sub-acute 
conditions.204 Safe and cost-effective execution of this modern healthcare paradigm not only 
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requires suitable patient education, but importantly the installation of basic infrastructure and 
resources.205 
 
To best meet the clinical challenges, the system should be resource inexpensive (both cost 
and time), scalable (available to large patient cohorts), versatile (flexible protocols, taking 
into account case differences), suitable for use in both clinical and community setting, and 
holistic, combining subjective and objective information. 
 
 
5.1.4.  Hypothesis 
 
A wearable motion sensing system may provide a valid and reliable objective 
assessment method for patients undergoing lower limb reconstruction.  
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5.2.  Methods 
 
5.2.1.  Outline  
We implemented a lightweight (7.4g) ear-worn accelerometer (e-AR sensor, Imperial College 
London) into a short activity protocol made up of tasks previously validated to assess 
different aspects of functional mobility.  Following pilot testing, 20 3-month post-open tibial 
fracture patients and 10 healthy subjects completed the protocol, as well as a short-form 
health survey (SF-36) for comparison.  Subjects’ performances were rated through extraction 
of multiple kinematic features from the accelerometer data; techniques previously validated 
using high-speed cameras and a force plate-instrumented treadmill.  A psychometric 
evaluation was conducted to ascertain the reliability and validity of the Hamlyn Mobility 
Score (HMS) – a term defined by Prof GZ Yang and Mr R M Kwasnicki for general mobility 
assessment based on wearable BSN sensors. 
 
5.2.2.  Development of tool 
 
Sensor Requirements 
Our aim was to develop an assessment tool that could be used in various non-specialist 
environments, with minimal technical support.  The equipment should be simple and 
inexpensive, but able to provide reliable objective information regarding the patients’ 
functional mobility.  We also thought it as important to be able to use the tool quickly if 
necessary, to provide a 10-minute assessment of mobility.  The e-AR sensor was 
implemented.206  
 
 
5.2.3.  Laboratory validation of e-AR sensor for gait analysis  
 
The signal produced by the e-AR sensor during repetitive activities such as walking or stair 
climbing takes the form of a 3D activity signature.  Although the detail of this signature is 
unique for everyone, it contains consistent information about key kinematic events.  The 
exact kinematics of an activity cannot be captured from a single sensor, but detection and 
profiling of gait events such as heel contact and toe off can provide a good insight into the 
quality of movement.  This insight, with a low cost and time demand, should be sufficient to 
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capture and characterise performance differences between subjects, and monitor intra-subject 
changes during a course of treatment, such as a new Parkinsonian medication, or a 
reconstructive lower limb surgery. 
 
Detection of gait events 
 
To reliably select the correct patterns in the e-AR signal representing gait events, we 
collected a series of walking data using both the e-AR sensor and a high-speed camera 
(Photron FASTCAM SA3) operating at 250Hz.  The signals were synchronised using a sharp 
heel strike (stamp) at the start and end of a 20 second treadmill walk, seen as large spikes in 
the e-AR data (and visible on the high-speed camera).  The gait event of interest was located 
using the high-speed camera, and the corresponding point in the e-AR signal was labeled.  
This was done for 2 consecutive gait cycles for confirmation. 
 
 
Figure 5.3.  Synchronising data from the e-AR sensor and high-speed camera allows accurate 
identification and association of sensor signal characteristics with specific gait events, including right 
and left heel contacts and toe-off (R/LHC, R/LTO) 
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Gait analysis methods were developed in collaboration with Dr Delaram Jarchi of the 
Hamlyn Centre, Imperial College London.207 
 
All axes provide information regarding the timing of gait events.  The gait analysis approach 
starts with the detection of gait events (heel contact and toe-off) from the accelerometer data.  
Usually, heel contacts generate peaks which locally have minimum values in both supero-
inferior (SI) and antero-posterior (AP) axes.  These peaks are repetitive while the subject is 
walking.  To exploit the periodicity of these peaks, the dominant oscillations of the AP or AP 
and SI axes were used to identify these peaks as heel contacts.  Toe off events are detected by 
using the detected heel contacts in the first stage, before grouping a number of gait cycles and 
applying signal processing techniques.  Determination of left or right heel contacts or toe-off 
events is performed using the medio-lateral (ML) axis based on prior information derived 
from the high-speed camera.  After detection of gait events, a number of temporal gait 
parameters may be estimated. 
 
 
Figure 5.4.  Gait parameter estimation algorithm from Jarchi et al.207 
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Validation of gait parameter estimation 
 
To validate the gait parameters estimated by the e-AR sensor, 10 healthy subjects were asked 
to walk on a force-plate instrumented treadmill (Gaitway Treadmill, Kistler Instrument Corp., 
Amherst, USA), whilst wearing the e-AR sensor.  Each subject walked for 20 minutes at 
3.2Km/h, with increasing incline.  Gait parameters were derived from the e-AR sensor, and 
compared to the parameters calculated from the instrumented treadmill, as the gold standard.   
 
 
Figure 5.5.  Bland Altman plot showing the spread of errors in calculating gait parameters using the 
algorithm described.  Each data point refers to one estimation of a single gait parameter.  The position 
on the y-axis reflects the error, i.e. the difference between the parameter estimation from the sensor 
and the actual parameter value from the treadmill.  The x-axis shows the distribution of error 
according the magnitude of the parameter, allowing evaluation of error through the range of 
measurements.  
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Previous work by Dr Louis Atallah of the Hamlyn Center, Imperial College London, had 
performed a separate validation using similar methodology (force plate instrumented 
treadmill).131 Estimates of gait cycle duration from the e-AR sensor data were accurate to 
within 0.02 seconds.  This work also showed a statistically significant correlation between the 
e-AR sensor data amplitude and the ground reaction force as measured by the treadmill, 
particularly when combining the antero-posterior and supero-inferior axes.  This relative 
measurement of ground reaction force will be known solely as ‘Force’.   An improved 
version of this algorithm was used in patients undergoing hip and knee arthroplasty, showing 
high levels of validity compared to the instrumented treadmill.114 This allows both temporal 
and force aspects of the gait cycle to be considered during the assessment of mobility.  
 
 
5.2.4.  Activity Protocol 
 
Patients who sustain open tibial fractures experience significant disruption to their lives due 
to physical, and often mental, limitations.  Not only are patients unable to walk, but often 
they struggle mobilising from a chair, and completing other activities of daily living (ADL).  
At later stages, walking and simple mobilisation may become possible but more advanced 
activities such as using stairs might still be extremely testing.  As such, we developed a short 
activity protocol to provide a holistic assessment of functional mobility, including walking, 
mobilising from a chair and using stairs.  More specifically, this took the form of a 6-minute 
walk (6-MW), the timed up and go test (TUG) and timed up and down 10 stairs (TUDS). 
 
 6-Minute Walk (6-MW) 
 
The 6-MW is used mainly to measure walking endurance, by calculating the distance walked.  
The 6-MW, as well as adaptations such as the 2-minute walk and 9-minute walk tests, is a 
simple test to complete using a corridor or circuit of known length.  Amongst many 
applications, it can be used to assess the clinical severity of systemic or medical disease 37 or 
after surgical procedures such as knee and hip arthroplasty.208 
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Subjects were asked to “walk as far as possible in 6-minutes between point A and B 
(directing as appropriate).  You are free to rest, sitting or standing, at any point as many times 
as you like”.  The distance between the 2 points was at least 10m, but preferably over 15m, to 
retain some consistency in number of turns required per unit distance walked.  The subject 
was not pursued by the examiner in order to avoid influencing the chosen pace.  Walking aids 
used by the subject were noted.  When 2 crutches were used, the subject was instructed to 
walk as normal, using the crutches to support partial weight bearing, rather than hopping. 
 
 
Figure 5.6.  Short sample of gait data from the e-AR sensor.  Each line represents a sensor axis, AP = 
antero-posterior, SI = supero-inferior, and ML – medio-lateral.  Right and left heel contacts (RHC, 
LHC) have been identified using gait analysis software.  This subject walked between 2 points (17m 
length), and 2 turns are seen near the start and end of the sample (turns omitted in analysis).  X-axis = 
sample number (data collected at 100Hz), y-axis = raw data measurement (interpret as relative only).  
 
 
The standard parameter derived from the 6-minute walk is the distance walked.  A simple 
additional parameter is to ask to patient to rate their perceived level of exertion (i.e. How hard 
was that for you on a scale of 1-10?).  Other groups have taken more from the test, such as 
the Physiological Cost Index (PCI).  PCI is calculated by considering the subject’s change in 
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heart rate during the walk, as well as their average speed (PCI = HR while walking – HR at 
rest / distance / time).  This is used to examine the patient’s locomotor efficiency, i.e. how 
much effort is required to produce the given output.190 
 
As we were instrumenting this test with an accelerometer, additional parameters were based 
on this signal.  All methods were previously validated in the laboratory setting as 
demonstrated earlier. 
 
Using the timing and amplitude of heel contacts during walking, several parameters were 
calculated.  Parameters derived from toe-off were not included due to the relatively poor 
reliability in detecting the event (particularly in pathological gait samples). 
 
 
Temporal variation and asymmetry 
 
The step time was calculated for each foot, followed both derivation of step time variation 
and left/right step time asymmetry.   
 
For calculation of variation (Temp Var.), step times were considered as free from left/right 
identity. 
 
Step time (i): ts(HC(i+1))  -  ts(HC(i))     where i = index, ts = time stamp, HC = heel contact 
 
Variance (σ2) can be described as the sum of the squared distances of each term in the 
distribution from the mean (µ), divided by the number of terms in the distribution (N). 
 
σ2  =  Σ (X – µ)2 
        N 
 
For calculation of asymmetry (Temp Asym), step times were given a left/right identity 
 
Step time (R): ts(RHC)  -  ts(LHC)      
Step time asymmetry: ts(LHC(i)) - ts(RHC(i))  /  ts(RHC(i+1)) - ts(LHC(i))   
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where i = index, ts = time stamp, RHC = right heel contact 
 
Force variation and asymmetry 
 
Similar to temporal variation and asymmetry, force variation and asymmetry were calculated, 
except using the signal amplitude rather than the timing.  The value used is the sum of the 
heel contact magnitude in the AP and SI axes.  This method was chosen as in the validation 
paper written by Atallah et al., the sum of AP and SI axes corresponded most closely with 
force detected on the instrumented treadmill.131 
 
Heel contact force: L/RAAP  +  L/RASI  
where L/RAAP = left or right heel contact amplitude in the AP axis, L/RASI = left or right heel 
contact amplitude in the SI axis. 
 
 
 
Figure 5.7.  A close-up of the tri-axial e-AR signal captured during walking and the measurements 
used to derive gait parameters.  X-axis = sample number (data collected at 100Hz), y-axis = raw data 
measurement (interpret as relative only). 
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Parameters derived are distance, temporal variation, temporal symmetry, force variation, 
force symmetry. 
 
 Timed up and down stairs 
 
The timed up and down stairs (TUDS) test is designed to test strength and range of motion of 
the lower limb and trunk, co-ordination, and reactive postural control, by measuring time 
taken (normally 10 or 14 stairs).  It is hypothesised that the TUDS task “demands more 
balance, coordination, strength, and muscle control than walking demands.”209 Ascending the 
stairs requires the subject to lift their body weight with a single leg (partially propelled by the 
other leg) onto the step above.  Descending, one must use each leg to conduct a controlled 
lowering of their body weight onto the step below. 
 
There are a variety of methods possible for using stairs, including those developed through 
adaptation in the setting of pathology.  Functional mobility requires the subject to have a safe, 
reliable method of traversing this obstacle.  The relationship between forementioned aspects 
of functional mobility and performance on the TUDS test has been shown in elderly men and 
children.189, 210  
 
Subjects were instructed “Starting facing forward, walk up to the top of the flight of stairs, 
turn around quickly but comfortably, and return to the bottom of the stairs.”  The stairs 
measured 25cm vertically and 25cm horizontally.  The subjects were allowed to use one 
handrail (unable to reach both) and/or 1 or 2 crutches at their discretion.   
 
The standard parameter derived from TUDS is time-taken.  Similar to the 6-MW, we utilised 
the data recorded by the e-AR sensor to add more advanced kinematic performance 
parameters.  The parameters derived for TUDS were the same as for the 6-MW, but included 
ascending (Up), descending (down) and combined (comb.) values.  This was chosen due to 
the significant difference between the 2 parts of the task, and therefore potentially different 
aspects of mobility being tested. 
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Figure 5.8.  E-AR signal captured during the timed up and down stairs (TUDS) task.  Left and right 
heel contacts (i.e. each step) are marked with green or red crosses.  X-axis = sample number (data 
collected at 100Hz), y-axis = raw data measurement (interpret as relative only). 
 
 
The parameters calculated for TUDS are time taken (from first movement on sensor to quiet 
signal), temporal variation (up, down and combined), temporal symmetry (up, down and 
combined), force variation (up, down and combined), and force symmetry (up, down and 
combined). 
 
 Timed up and go (TUG) 
 
The timed up and go (TUG) test is frequently used in clinical practice due to its simplicity, 
and ability to assess balance and basic mobility skills of daily living.188 The task consists of 4 
different movements: standing, walking, turning, and sitting.  Although time-taken is the 
standard parameter measured for this task, other groups have investigated the various phases 
for more information on performance.  Faria et al. developed a 24 item ‘assessment of 
biomechanical strategies’, which involves an expert reviewing multiple, specific aspects of 
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the TUG performance.152 Another group assessed the validity of using the sensors within a 
smart phone to calculate multiple kinematic parameters during TUG, including sit to stand 
duration and step variability.211 
 
Subjects were told, “Starting sitting down, stand up and as soon as you are happy to do so, 
walk forward to the marker (3m ahead), turn around, and without pausing, return to the chair 
and sit down”.  The chair was 40 cm high, with no arm rests.   
 
Using the data from the e-AR sensor, time-taken from starting to the first heel contact (Stand 
to walk time, STW), and total duration.  The duration of the turn phase was measured, but 
this was unreliable in pathological subjects.  Gait parameters weren’t used as these were 
being assessed during the 6-MW.  Furthermore, assessment of gait over 3-4 steps shouldn’t 
be compared to gait analysis during free walking, due to the acceleration phase being 
immediately followed by deceleration as the subject approaches the 3m marker or the chair. 
 
 
Figure 5.9.  E-AR sensor signal capured during the timed up and go test, labeled to show derivation of 
both the total duration and stand to walk (STW) parameters.  X-axis = sample number (data collected 
at 100Hz), y-axis = raw data measurement (interpret as relative only). 
 
The parameters calculated for TUG were stand to walk time (STW) and total time taken. 
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Table 5.2.  All parameters derived from activity protocol 
6-MW TUDS TUG 
Temporal variation Temporal variation up Sit to walk time 
Temporal asymmetry Temporal variation down Total time 
Force variation Temporal variation combined  
Force asymmetry Temporal asymmetry up  
Distance Temporal asymmetry down  
 Temporal asymmetry combined  
 Force variation up  
 Force variation down  
 Force variation comb  
 Force asymmetry up  
 Force asymmetry down  
 Force asymmetry comb  
 Total time  
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5.2.5.  Conducting clinical trial 
 
Ethical Approval 
 
Before starting collecting data from patients, ethical approval was granted from the research 
ethics committee using the Integrated Research Application System (IRAS).  This process 
requires submission of a research proposal, and all related paperwork, including a participant 
information sheet, consent form, any questionnaires that will be given to participants, and a 
CV for both the named chief investigator (for ethics application this is the PhD student) and 
academic supervisor (Professor Darzi).  The Research Ethics Committee of West Scotland 
approved the application in April 2012 (ref: 12/WS/0066). 
 
 
Adoption by the NIHR Portfolio of clinical trials 
 
At the point of applying for ethical approval, the Joint Research Office at Imperial College 
London (sponsor) recommended that this study should be considered for adoption to the 
National Institute of Health Research (NIHR) portfolio.  A peer review was conducted by 2 
independent reviewers, which judged the research proposal satisfactory.  The study was 
adopted under ‘Investigating Lower Limb Trauma – study ID 12642’.   
 
NIHR portfolio adoption is an avenue for study support through research managers, research 
nurses and other resources, at a level according to patient recruitment numbers and 
participation, which are reported monthly.   
 
 
Registration of the clinical trial 
 
The study was also registered at clinicaltrials.gov, which is an open worldwide database that 
provides patients, family members, and the public with information about current ongoing 
clinical research studies.  The study was registered under ‘Investigating Lower Limb Trauma 
– protocol record CRO1934’. 
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Recruitment and eligibility 
 
All patients presenting to the Imperial College Healthcare NHS Trust trauma centre between 
August 2012 and April 2013 with lower limb injuries were assessed for eligibility.  The 
recruitment period was the time needed to recruit 20 patients.  After patient recruitment was 
completed, we recruited 10 healthy subjects with the aim to match age and sex.  
 
 
Table 5.3.  Eligibility criteria for recruitment 
Inclusion Exclusion 
Unilateral open tibial fracture 18  Age  65 
 Polytrauma (other fracture) 
 Need for admission to ITU 
 Other mobility disorder 
 Pre-existing cardio-respiratory disease 
limiting mobility 
 
 
Before discharge from hospital, a member of the direct healthcare team informed the patient 
about the study, and gained verbal consent for the researcher to contact them via telephone.  
Patients were telephoned approximately 6 weeks after their injury, and given more 
information about the study.  If they provisionally agreed to participate, an appointment was 
created at 3 months post injury.  Patients were seen at either St Mary’s Hospital, or Charing 
Cross Hospital.  At the first appointment, patients were initially given a participant 
information sheet and the opportunity to ask any questions.  Upon agreement to participate, 
written consent was taken by the researcher. 
 
In order to minimise participant attrition, all appointments were organised at the patients’ 
convenience.  This often required combining the study visit with a pre-existing appointment 
at the fracture clinic or physiotherapy.  
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Data collection 
 
Data was collected from patients at 3 and 6-months post-injury, and on one occasion for 
healthy subjects.  At the first appointment, participants provided demographic information, 
completed a short form health survey (SF-36) and completed a short activity protocol whilst 
wearing the e-AR sensor (6-MW, TUG, TUDS).  All subjects had leg length measured, and 
any discrepancy noted.  Participants were asked to complete the activity protocol twice, under 
the instruction of a different researcher each time.  The order in which the 2 researchers gave 
instruction to the participant was randomised using a random number generator.  The repeat 
was designed to allow reliability testing. 
 
Before and after completing each activity, the participant was asked to shake the sensor to 
provide a spike in the data that would allow easy identification and labeling of activities.  
Before each activity, patients were informed that use of aids (crutches, handrail etc) was at 
their discretion, and they were encouraged to use what they would normally use outside of 
the test environment.  All participants performed activities in the same order at each visit.  
The TUG and TUDS tasks were performed prior to the 6-MW, to ensure that any fatigue 
following the 6-MW did not affect other task performances.  Rests between tasks, or repeats, 
were at the participants’ discretion (at least a 10 minute rest was recommended between 
protocol repeats). 
 
The short form health survey (SF-36) consists of 36 multiple-choice questions, designed to 
evaluate the patient’s self-reported quality of life.  The questions fall into 8 categories: 
physical function, role functioning (physical), role functioning (emotional), vitality, mental 
health, social functioning, body pain, and general health.  Scores are derived for each 
category, and further composite scores are produced including physical, mental and overall 
scores.212 This tool has been validated for use in the trauma setting. 213 
 
 
Data Organisation 
 
The data collected from the e-AR sensor was extracted using a simple software package, to 
take the form of a comma separated value file (.csv).  Data initially contained 5 columns, 
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including date, time, axis 1, axis 2, axis 3.  The data were viewed graphically using MS 
Excel, to check quality, and to enable identification of activities.  Activities were labeled in a 
6th column of the data.  Parameters for each activity were calculated as outlined earlier. 
 
 
5.2.6.  Developing a Composite Score 
 
To allow the HMS to be translated from the research environment into a useful clinical tool, 
the output of the assessment must be easily interpreted.  Furthermore, in order to conduct a 
holistic assessment, 4 questions were included to supplement the performance data.  Both 
objective and subjective scores were aggregated to give 2 composite scores, and combined to 
give an overall score. 
 
 
Choosing parameters 
 
For each activity, the standard parameter was preserved, e.g. distance covered during 6-MW.  
Then for the 6-MW and TUDS, performance related to the timing of steps, as well as the 
force applied on each step, were utilised.  There were many options to choose from, with all 
potentially reflecting specific aspects of functional mobility.  It was decided that one 
temporal and one force parameter would be used for each activity, therefore the value for 
TUDS had to be combined up and down the stairs.  When deciding between variation and 
symmetry, it was noted that there might exist a scenario where a subject had mathematically 
high symmetry, but significant step variation.  Using symmetry in this case would 
misrepresent the subject’s level of function.  Conversely, low or high variation step timing or 
force would always reflect functional ability.  That is, there is no scenario where a subject 
walking well would have high variation, or a subject walking badly with a low variation.  As 
such, temporal variation and force variation were chosen for both the 6-MW and TUDS. 
 
For TUG, in addition to standard parameter (time taken), the stand to walk time (STW) was 
chosen to assess the speed of standing, as well as the time needed to prepare the subject for 
the first step. 
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The extent to which parameters under selection correlated to SF-36 scores was checked 
retrospectively.  However, this was not the most important criterion considered. 
 
Although a limitation of subjective data is the lack of meaningful comparison between 
subjects, and even with the same subject at a different time, 4 closed questions were asked to 
add context to the assessment.  The questions were adapted from the SF-36 questionnaire, 
including level of pain, supports used, participation at work and in sport, and satisfaction with 
recovery progress.  
 
 
Converting parameters into performance scores 
 
For ease of aggregation and interpretation, the raw parameters were converted into scores out 
of 5 (whereby 0 = poor performance and 5 = good performance).  To establish the initial 
boundaries for score conversion, a selection of subject performances were taken into account.  
A score of 5 was meant to represent a performance equivalent to that of the normal 
population (between age 18 and 65), and thus our healthy control group was the standard.  
The lower (in terms of performance, not necessarily the value) quartile of the healthy control 
was used approximately as the boundary for a top score (of 5).  The worst identified 
performance for each parameter at 3 months post-operative was used as the lower boundary 
(a score of 0).  Scores in between were not evenly distributed, as it was evident that with most 
parameters, poor scores were more variable.  As performance tended towards normal, the 
variation reduced, as so the score boundaries were designed to be closer.  All parameter 
boundaries are subject for review following further data collection.   
 
Excel macros were used to automatically convert raw values into performance scores (nested 
‘IF’ function).   
 
 
Total Score 
 
Similar to parameter performance scores, total scores were assigned corresponding levels of 
mobility. 
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Table 5.4.  Total HMS score boundaries 
HMS Mobility 
48 – 60 High 
36 – 47 Moderate 
24 – 35 Low 
12 – 23 Very Low 
< 12 Severely disabled 
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Table 5.4.  Hamlyn Mobility Score 
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5.2.7.  Data analysis 
 
A psychometric evaluation of the HMS was conducted.  Descriptive statistics were calculated 
for subject demographic characteristics and all outcome measures.  Inter-rater reliability was 
calculated using intra-class correlation coefficients (ICC) for all objective HMS parameters.  
The internal consistency of the HMS (i.e. the extent to which each individual parameter 
reflects the composite score) was examined using Cronbach’s alpha. 
 
The correlations of individual and combined HMA scores to the ‘gold standard’ SF-36 
questionnaire were assessed to determine the extent of concurrent validity.  Spearman Rho 
correlation coefficients were calculated to account for the use of discrete measures in the 
HMS, as well as data distributed both monotonic and polynomially. 
 
Construct validity of the HMS, i.e. the ability to discriminate between different levels of 
mobility, was investigated through performance comparisons of subject subgroups.  Patients 
were stratified according to the Gustilo-Anderson classification (severity) of their fracture.  
Kruskal-Wallis non-parametric one-way analysis of variation (KW-ANOVA) was used to 
assess whether the subgroup samples originated from the same distribution.  Further Mann-
Whitney U tests were used to analyse specific pairs of samples for significant differences.  
 
Wilcoxon signed-rank tests were used to evaluate the significance of changes in patient 
scores between 3 and 6-months.  The effect size (extent of relative change) was calculated to 
compare the sensitivity of assessment tools (i.e. HMS and SF-36).214 Effect size is equal to 
the difference between the 6m mean score and 3m mean score, divided by the standard 
deviation of the 3m scores.  An effect size of 1 = change of one standard deviation in the 
sample.  Typically, a change of 0.2, 0.5, and 0.8 reflect small, medium and high degrees of 
change, respectively. 
 
Logistic regression analysis was used to estimate the probability of limitation in activities of 
daily living from HMS performance. 
 
Statistical analysis was performed using the Statistical Package for Social Sciences version 
19.0 (SPSS, IBM corp, NY, USA).  
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5.3.  Results 
 
5.3.1.  Study participants 
 
Between August 2012 and April 2013, 51 patients with open tibial fractures were identified.  
Eight patients were over 65, 1 patient was less than 18.   Two patients underwent amputation 
for non-reconstructable injuries (1 Above Knee Amputation, 1 Below Knee Amputation).  
Fifteen patients had co-morbidities, including head injuries, bilateral lower limb fractures, 
ipsilateral foot fractures, pelvic fractures, and end stage liver disease.  Twenty-two patients 
were contacted.  Of these, 1 patient was unable to participate due to unmanageable language 
barrier, and 1 refused. 
 
 
 
Figure 5.10.  Participant enrollment 
 
 
51 patients with open tibial 
fractures identified!
25 patients invited to 
participate!
20 patients participated!
9 patients excluded due to 
age (18 ≤"A ≤"65)!
2 patients underwent 
amputation (1 AKA, 1 BKA)!
15 patients excluded due to 
co-morbidities!
3 patients unreachable, !
1 patient refused,!
1 patient excluded due to 
language barrier!
10 healthy controls recruited!
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Twenty patients (90% male; mean age 38.5, SD 15.8) and 10 healthy control subjects (90% 
male; mean age 34.7, SD 12.9) were recruited.  
 
Table 5.6.  Demographic data for patients and healthy controls 
 
Characteristics 
Patients 
Mean (SD) 
Controls 
Mean (SD) 
p-
value 
Gender    
    Male 18 (90%) 9 (90%)  
    Female 2 (10%) 1 (10%)  
    
Age 38.3 (15.8) 34.7 (12.9) 0.694 
    
Anthropometrics    
    Height (m) 1.79 (0.0833) 1.80 (0.0600) 0.799 
    Weight (Kg) 74.7 (9.18) 79.4 (12.1) 0.295 
    BMI 23.4 (2.20) 24.5 (2.72) 0.317 
    Leg length ratio 1.00579 (0.00549) 1.00663 (0.00983) 0.932 
    
Fracture classification 
(Gustilo-Anderson) 
   
    1 4 (20%) -  
    2 7 (35%) -  
    3 9 (45%) -  
    
Fracture Fixation    
    IM nail 9 (45%) -  
    Internal fixation  5 (25%) -  
    TSF 6 (30%) -  
    
Pedicled flap 3 (15%) -  
Free flap 6 (30%) -  
BMI – Body Mass Index (Kg.m-1), IM – Intra-medullary, TSF – Taylor Spatial Frame 
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At 3-months post-operative, 3 (15%) patients were wheelchair-bound so didn’t complete the 
activity protocol.  Ten (50%) patients (in addition to wheelchair users) used 1 or 2 crutches at 
3-months, which reduced to 4 (20% total) at 6-months.  Forty-nine out of 50 data samples 
were collected (98%).  One patient withdrew from the study after the 3-month appointment, 
reportedly due to depression.   
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5.3.2.  Main findings 
 
6-minute walk 
 
 
Figure 5.11.  E-AR signal captured during the 6-minute walk test from a healthy subject and a patient.  
It is clear to see that the frequency and amplitude of the steps is less in the patient.  There also appears 
to be some asymmetry in the timing of the steps and the character of the peaks.  X-axis = sample 
number (data collected at 100Hz), y-axis = raw data measurement (interpret as relative only). 
 
 
Control subjects tended to walk with consistent patterns, and minimal differences between 
left and right steps.  Patients exhibited more variation in their walking pattern, and visible 
asymmetry.  Slower, more timid walking styles produce signals of smaller amplitudes. 
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Table 5.7.  Performance scores from the 6-minute walk 
 
Parameter Healthy (n = 10) 
Mean (SD) 
Patient (n = 20) 
Mean (SD) 
p 
Distance    
    Raw score (m) 529 (41.4) 256 (99.9) 0.000 
    Performance score 5.00 (0.00) 1.85 (1.79) 0.000 
    
Temporal variation    
    Raw score (CoV) 0.0153 (0.00750) 0.146 (0.131) 0.000 
    Performance score 5.00 (0.00) 2.05 (1.96) 0.000 
    
Force variation    
    Raw score (CoV) 0.0669 (0.0443) 0.160 (0.0797) 0.018 
    Performance score 4.44 (0.527) 1.35 (1.66) 0.000 
    
Composite Score 14.4 (0.527) 5.25 (5.05) 0.000 
CoV – Coefficient of variation  
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Timed up and down stairs 
 
 
 
Figure 5.12.  E-AR signal captured during the timed up and down stairs test from a healthy subject 
and a patient.  The patient appears to be slower and show more variation in step pattern, particularly 
on descent.  X-axis = sample number (data collected at 100Hz), y-axis = raw data measurement 
(interpret as relative only). 
 
 
Control subjects ascended the stairs with very little variation.  The descent was slightly more 
variable, with some subjects favouring one leg (out of habit) with some resultant variation. 
Patient patterns depended largely on whether they were putting 1 or 2 feet on each step.  In 
general, performance on the descent was worse as patients were forced to accept large 
amounts of weight on the damage foot, or carry body weight whilst lowering the undamaged 
limb.  
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Table 5.8.  Performance scores from the timed up and down stairs 
 
Parameter Healthy (n = 10) 
Mean (SD) 
Patient (n =20) 
Mean (SD) 
p 
Time taken    
    Raw score (s) 12.2 (1.45) 32.0 (13.3) 0.000 
    Performance score 5.00 (0.00) 0.750 (1.29) 0.000 
    
Temporal variation    
    Raw score (CoV) 0.0807 (0.0373) 0.245 (0.132) 0.000 
    Performance score 4.89 (0.333) 1.20 (1.47) 0.000 
    
Force variation    
    Raw score (CoV) 0.132 (0.0559) 0.285 (0.0871) 0.000 
    Performance score 4.56 (0.726) 0.800 (1.28) 0.000 
    
Composite Score 14.4 (0.527) 2.75 (3.31) 0.000 
CoV – Coefficient of variation  
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Timed up and go 
 
Figure 5.13.  E-AR signal captured during the timed up and go test from a healthy subject and a 
patient.  The patient takes many more steps between standing and sitting that the healthy subject.  X-
axis = sample number (data collected at 100Hz), y-axis = raw data measurement (interpret as relative). 
 
Control subjects stood quickly, and almost immediately took their first step.  Approximately 
3-4 steps were required to cover the 3m walk, before a quick turn and similar return to the 
chair.  Patients took more time standing, and occasionally required a second attempt.  More 
steps were required to cover the distance, and turning often required 3-4 small steps.  There 
was also a tendency to pause before sitting.   
 
Table 5.9.  Performance scores from the timed up and go  
Parameter Healthy (n = 10) 
Mean (SD) 
Patient (n = 20) 
Mean (SD) 
P 
Total time taken    
    Raw score (s) 8.58 (1.31) 18.4 (8.42) 0.000 
    Performance score 4.89 (0.333) 1.70 (1.66) 0.000 
    
Stand to walk time    
    Raw score (s) 1.41 (0.214) 3.50 (1.93) 0.000 
    Performance score 4.78 (0.441) 1.65 (1.53) 0.000 
    
Composite Score 9.67 (0.500) 3.35 (3.15) 0.000 
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Force changes with speed 
 
With one healthy subject, the relationship between ground contact force and speed was 
considered.  The subject walked at 4 different self-determined paces in a free-living 
environment, repeating each speed. 
 
 
Figure 5.14.  (Top) e-AR sensor signal during walking at 4 different velocities (each repeated twice); 
(Below) corresponding antero-posterior, supero-inferior, and combined average gait amplitudes (force 
of heel contact) showing that combined there is a linear relationship between amplitude and velocity. 
 
As walking speed increases, the sum of the AP and SI amplitudes increase in a linear fashion.  
At lesser speeds, the SI axis contributes the majority of the overall amplitude.  AP amplitude 
appears to increase in a linear fashion, and is the main cause of increasing total amplitude at 
higher speeds.  
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Reliability  
 
Reliability testing revealed a median intraclass correlation coefficient (ICC) of 0.964 (p < 
0.001) for all chosen HMS parameters.  HMS showed very good internal consistency 
(Cronbach’s alpha = 0.897). 
 
Table 5.9.  Comparison of repeated assessment of parameters in the form of a reliability analysis 
 Parameter ICC p 
6-MW 
Distance 0.997 0.000 
Temp Var 0.994 0.000 
Temp Asym 0.767 0.001 
Force Var 0.726 0.003 
Force Asym 0.762 0.001 
TUDS 
Time 0.965 0.000 
Temp Var Up 0.899 0.000 
Temp Var Down 0.841 0.000 
Temp Var Comb 0.935 0.000 
Temp Asym Up 0.880 0.000 
Temp Asym Down 0.647 0.010 
Temp Asym Comb 0.813 0.000 
Force Var Up 0.784 0.001 
Force Var Down 0.915 0.000 
Force Var Comb 0.888 0.000 
Force Asym Up 0.696 0.007 
Force Asym Down 0.932 0.000 
Force Asym Comb 0.894 0.000 
TUG 
Sit to walk time 0.963 0.000 
Total time 0.966 0.000 
 Average 0.891  
  Intra-class coefficient (ICC) 
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Concurrent validity 
 
Statistically significant correlations were found between all but one (TUDS force variation) 
of the HMS parameters and SF-36 scores (average Spearman’s Rho = 0.582).  Combined 
activity scores including objective subtotal, subjective subtotal (patient features), and total 
HMS score all strongly correlated with SF-36 scores (average Spearman’s Rho = 0.657, p < 
0.01).  Moderate correlations were also found between the majority of parameters at the SF-
36 mental and physical health sub-scores. 
 
 
Table 5.10.  Concurrency between HMS parameters and SF-36 questionnaire (and subgroups) 
 SF-36 Mental 
health 
SF-36 Physical 
health SF-36 
6-minute walk 0.678** 0.490* 0.636** 
    Distance 0.571* 0.479* 0.564* 
    Temporal Variation 0.749** 0.457 0.668** 
    Force Variation 0.555* 0.428 0.531* 
TUDS 0.655* 0.540* 0.648** 
    Time 0.497* 0.521* 0.538* 
    Temporal Variation 0.666** 0.504* 0.640** 
    Force Variation 0.414 0.281 0.384 
TUG 0.628** 0.492* 0.604** 
    Stand to walk time 0.592** 0.476* 0.574* 
    Total time 0.646** 0.495* 0.617** 
    
Objective subtotal 0.684** 0.519* 0.654** 
Patient features subtotal 0.641** 0.581** 0.653** 
    
Hamlyn Mobility score 0.687** 0.544* 0.666** 
* P < 0.05, ** P < 0.01.  Short form healthy survey (SF-36) 
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Figure 5.15.  A cluster plot to show the correlation between HMS and SF-36 measurements of 
mobility, proving concurrent validity (R = 0.666, p < 0.01) 
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Construct validity  
 
Patient HMS scores were significantly lower than those of the healthy control group (mean 
19.7 vs. 58.2, p < 0.001).  Significant differences in HMS were found between the control 
group and gustilo-1 (G1) patients (58.2 vs. 34.5, p = 0.005), and between G2 and G3 patients 
(23.6 vs. 7.2 p = 0.044), and approaching significant between G1 and G2 (34.5 vs. 23.6, p = 
0.054).  Significant differences in SF-36 results were found between the control group and 
G1 patients (92.0 vs. 46.8, p = 0.005) and between G2 and G3 patients (53.8 vs. 32.6, p = 
0.005), but there was no difference between G1 and G2, or G1 and G3. 
 
Kruskal-Wallis non-parametric one-way analysis of variation (KW-ANOVA) showed that 
there was a significant difference in HMS performance scores between all subgroups (X2 = 
21.5, p < 0.001), and also for SF-36 scores (X2 = 21.7, p < 0.001). 
 
 
 
Figure 5.16.  Subgroup performance score comparison  
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Responsiveness to change 
 
Wilcoxon signed-rank tests showed significant improvements in all HMS activities and 
composite scores, including an average improvement from 20/60 to 40/60 in total score 
between 3 to 6-months (p = 0.000). 
 
The effect size (extent of relative change)214 is 50% greater in HMS compared to SF-36 (1.49 
vs. 0.99).   
 
 
Table 5.11.  3 – 6-month patient HMS scores 
 3-months 
(n=20) 
Mean (SD) 
6-months (n=19) 
Mean (SD) P 
Mean 
change 
Effect 
size 
6-MW (15) 5.25 (5.05) 10.5 (3.92) 0.001 5.28 1.04 
TUDS (15) 2.75 (3.31) 9.71 (4.40) 0.000 6.96 2.10 
TUG (10) 3.35 (3.15) 7.41 (2.60) 0.001 4.06 1.29 
Objective subtotal (40) 11.3 (11.02) 27.7 (10.2) 0.000 16.4 1.48 
Patient features (20) 8.40 (3.28) 12.7 (2.37) 0.000 4.31 1.31 
Total HMS (60) 19.7 (13.9) 40.4 (12.1) 0.000 20.7 1.49 
SF-36 (100) 41.9 (18.0) 59.7 (20.7) 0.001 17.9 0.99 
 
 
 
Evaluating HMS scale 
 
Histograms plotted for 3 and 6-month HMS results show an absence of floor or ceiling 
effects, i.e. the tendency for subjects to score the highest or lowest mark possible, when some 
subjects might score higher or lower should the scale allow. 
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Figure 5.17.  Histograms for 3 and 6-month HMS 
 
 
 
Logistic Regression 
 
A logistic regression model showed that HMS at 3-months could independently be used to 
predict self-reported limitations in performing ADL at 6-months with 85% classification 
accuracy compared with 55% by chance.  An increase in HMS by 1 point (out of 60) resulted 
in the patient being 18% less likely to be limited in ADL.  Furthermore, a patient found to be 
1 mobility classification higher than another (e.g. low to moderate mobility) is 4.5 times less 
likely to be limited in ADL (p = 0.02), controlling for age, smoking and pre-trauma exercise 
frequency.  SF-36 scores were not significant predictors of 6-month prognosis (p = 0.159). 
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5.4.  Discussion 
 
This chapter documents the psychometric evaluation of a new robust, objective assessment 
for functional mobility.  The assessment protocol includes 3 popular mobility tests, with 
advanced kinematic performance parameters derived from the addition of a pervasive 
wearable sensor.  Subjective patient features were incorporated into the assessment as a 
minor proportion, to reflect quality of life, and practical features that were unobtainable from 
the sensor, but judged to be important follow-up parameters.  All aspects of the HMS were 
shown to be reliable under repetition with different instructors, and all parameters showed 
strong internal consistency.  The total HMS, as well as all sub-categories, showed moderate 
to strong correlation with the SF-36, proving concurrent validity.  Furthermore, HMS 
demonstrated the ability to distinguish between patients with injuries within different classes 
of severity.  Floor or ceiling effects from composite performance scores (developed from raw 
parameters) were absent.  HMS values varied widely amongst patients in line with the 
expectations of the investigators.  
 
The HMS corresponds closely to the ideal post-operative follow-up measures recommended 
in the best practice guidelines (BOA/BAPRAS), which include assessing health status as well 
as measures of limb function.  Adhering to guidelines, these measures would normally be 
attained through the provision of 1 or 2 questionnaires.  The HMS offers several advantages 
over said questionnaire-based assessments.  The major advantage is the acquisition of 
objective data with regards to functional mobility.  Unlike the subjective interpretation and 
response to questions by patients, results from the HMS can be fairly compared between 
different patients, and longitudinally for 1 patient.  The score is not affected by the transient 
psychological state of the user, nor vulnerable to misunderstanding in the presence of 
language barriers or cultural differences. 
 
These benefits might be sacrificed against the, albeit minimal, resource demand of the HMS.  
However, the temporal responder demand was not dissimilar for HMS and SF-36.  Also, in 
the OTF cohort, the effect size for HMS was significantly greater than SF-36, reflecting a 
higher sensitivity to change in mobility.  In addition, though a questionnaire might be 
sufficient to assess a patient at infrequent intervals for a rough measure of progress, the 
results aren’t particularly useful when it comes to designing or updating management 
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strategies.  The HMS allows the healthcare team to characterise and quantify the patient’s 
limitations, facilitating the development of a personalised management plan, for enhanced 
recovery.  These performance scores can be reassessed following the prescription of a 
treatment, such as physical therapy, to determine the efficacy of the treatment. 
 
As previously outlined, there are other wearable mobility assessment devices available, such 
as the IDEEA and DynaPort GaitMonitor.  The HMS requires only a single wireless sensor, 
with simple and consistent accessory-free (belt, strap, adhesive) placement behind the ear.  
The advantage over other single sensor systems is 3-fold.  Firstly, the assessment protocol 
allows kinematic features from 3 activities to be estimated, rather than just gait analysis.  The 
TUG and TUDS activities have been described to assess other aspects of functional mobility 
that gait precludes.  Secondly, the parameters used in the HMS are derived from kinematic 
analysis, but are presented to the user without the same level of complexity in interpretation.  
Meaningful results are more likely to be acted upon, especially if they offer tangible 
rehabilitation targets. And thirdly, the HMS combines key patient details such as supports 
used and pain scores into the overall score, resulting in a more holistic picture of recovery 
status. 
 
A robust measurement of outcomes could also provide centres with the means to assess the 
overall quality and cost-effectiveness of their service, including assessing the effect of small 
changes to local protocols.  Understanding the profile of patient recovery will also allow 
centres to plan the provision of resources, and make more educated decisions regarding the 
timing and frequency of outpatient appointments. 
 
The interpretation and application of results should be done so in the context of study design 
limitations.  The validation of kinematic parameter estimation from the e-AR sensor was 
based on treadmill walking, which has some minor differences compared to walking in a 
free-living environment.  For the validation of ground reaction force estimation as well as 
temporal parameters, a controlled, reproducible environment such as that of a force plate-
instrumented treadmill is ideal.  Furthermore, raw signal features utilised for temporal 
variation estimation (heel contacts) were highly pronounced during walking and using stairs.  
More complicated gait events such as toe-off, which may have been more prone to invalidity 
between treadmill and free-living scenarios, were not required for parameter estimation.  
 !
! 170 
Similarly, the estimation of kinematic parameters during the TUDS task is outside the level 
of validity demonstrated in the laboratory setting.  Should the study claim absolute 
quantification of these parameters, this would be invalid.  However, the interpretation of 
relative variation in ground contact amplitude and frequency, relative to other similar patients 
and natural variation in a healthy cohort, is acceptable. 
 
For patients using mobility aids such as crutches, or the handrail during the TUDS test, the 
sensor signals were more unusual, which tested the versatility of the analysis algorithm.  This 
resulted in some data points being confirmed or reassigned manually, introducing the 
potential for human error.  Walking aids also allowed patients to adopt gait or stepping 
patterns with less variability.  Although this was taken into account through the introduction 
of a performance score penalty associated with each walking aid, the interpretation of raw 
scores in these patients was misleading.   
 
Healthy subject TUDS times were not consistent with studies such as that by Zaino et al., in 
which subjects were completing 14 stairs in around 8 seconds.  The median time for healthy 
subjects in our study using 10 stairs was 12.2 seconds.  This inconsistency was caused by the 
instructions given, in which subjects were asked specifically to walk up and down the stairs.  
Subjects’ locomotion in the study by Zaino et al. were not restricted to walking.  The 
rationale for specifying walking was to collect a more homogeneous data set, allowing inter-
subject comparison of kinematic parameters in addition to task duration.  Additionally, one of 
the parameters for TUDS (force variation) did not reach a statistically significant correlation 
with SF-36 score.  A possible explanation was the variety of personal coping strategies 
patients had developed when ascending and descending stairs that were more prominent at 3-
months post-trauma.  These included variable use of crutches and the handrail, and a 
changeable number of feet on each step.  Although there exists some intra-subject variation in 
parameters, the positive reliability analysis conducted by repeating measures maintains the 
validity of the protocol. 
 
As expected, there was a small amount of variation in the performance of healthy subjects.  
Some of this could be attributed to arthropometric differences and age, but the variation seen 
in kinematic features requires further explanation.  Possible theories include previous 
injuries, learnt behaviour/dominant foot preferences, or leg length discrepancy (LLD).  The 
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latter has shown to affect both ground reaction force, and temporal gait parameters,215, 216 
although no significant correlation was seen in this cohort.  For patients with OTF, LLD is 
more common, particularly in high-grade fractures with bone loss. As such, LLD should be 
displayed alongside patient results, more importantly in the latter stages of recovery, as it is 
likely that those patients will have a persistent limp as a result of LLD. 
 
The boundaries used to translate raw scores into more meaningful performance scores were 
based on results from the primary data collection.  These reference values may need to be 
amended retrospectively when additional longitudinal data is available for this patient cohort.  
 
The recruitment rate of eligible patients was high, with only 1 patient refusing to participate 
due to work commitments.  Subject attrition was very low with only 1 out of 20 patients 
being absent from the 6-month data collection.  Regardless of consistent statistical 
significance in the psychometric analysis, a larger sample size might improve subgroup 
analyses.  This can be attributed to the relatively low incidence of OTF in the community.   
 
The HMS has demonstrated satisfactory reliability and validity to be considered for 
implementation into routine follow-up of patients with OTF.   The HMS displays, and has the 
potential for, several user benefits over both questionnaire and other sensor-based 
assessments.  High levels of internal consistency within the score provide options for 
abbreviated use, such as just the TUDS aspect of the functional tests along with the patient 
features section.  The TUDS (using all 3 parameters, rather than just time) showed an effect 
size double that of the SF-36 between 3 and 6-month performances.  However, some patients 
showed particular weakness in specific areas of the 3 HMS activities, and improved at 
different rates.  Thus, although an abbreviated HMS may remain valid for the assessment of 
patients with OTF, removing certain aspects would reduce its utility in guiding personalised 
rehabilitating strategies. 
 
Specifications for the HMS development included use in the clinic or community 
environments.  Although on occasion the assessment was performed in the community 
setting, semi-supervised data analysis prevents an assessment-to-results process occurring in 
the absence of technical support.  This technical advance will be undertaken in the next phase 
 !
! 172 
of development to help realise the potential of the HMS for remote patient surveillance as 
well as an interventional adjunct.   
 
In the following chapter, the HMS will be applied to provide novel insights into the OTF 
recovery process, as well as identifying and characterising post-operative complications, and 
predicting long-term outcomes.   
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CHAPTER 6. 
RE-EXPLORATION OF THE POST-OPERATIVE ROUTE 
TO FUNCTIONAL MOBILITY AFTER LOWER LIMB 
RECONSTRUCTION§ 
 
 
Abstract 
 
Background:  Although trauma and reconstructive services continue to advance, there 
remains little change or evidence regarding post-operative monitoring and rehabilitation 
strategies.  The aim of this study was to implement the newly validated Hamlyn Mobility 
Score (HMS) to quantify and characterise the recovery process following post-traumatic 
lower limb reconstruction 
 
Methods:  Twenty patients who had undergone post-traumatic lower limb reconstruction 
were followed up at 3-monthly intervals for 1-year.  At each time point, an ear worn motion 
sensor (e-AR, Sensixa Ltd. and Imperial College London) was used to assess the performance 
of subjects during a short activity protocol.  The HMS and several kinematic features were 
calculated longitudinally, allowing analysis of mobility throughout recovery as well as 
between subjects with varying severity of injury. 
 
Results: The functional mobility of the patient cohort according to the HMS improved 
throughout the full study follow-up period.  Patients with more severe fractures recovered at a 
slower rate, with Gustilo-1 fractures (G1) completing the majority of their recovery in the 
first 3-months, G2 until 6-months, and G3 patients continuing to recover through the 9-month 
time point.  All activities making up the HMS contributed similarly to the recovery patterns 
with strong inter-activity correlations (Spearman’s Rho = 0.726, p < 0.001).  Gait analysis 
during the 6-minute walk (6-MW) revealed that walking quality continues to improve 12-
months post-operatively, whereas walking capacity (distance) plateaus after 6-months.  The !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!§!Chapter based on publication:  Kwasnicki R M, Hettiaratchy S, Okogbaa J, Yang GZ, Darzi A. (2014) Re-
Exploration of the Post-Operative Route to Functional Mobility After Lower Limb Reconstruction. Annual 
meeting of the American Society of Plastic Surgeons. (Chicago, USA). Plastic and Reconstructive Surgery 
Suppl. 
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HMS detected late complications where subject recovery trajectories deviated more than 0.5 
SD below that of the cohort.   
 
Conclusions:  This study provides the first objective longitudinal report on return to 
functional mobility following post-traumatic lower limb reconstruction.  The low cost and 
objectivity of the HMS makes it suitable for a variety of clinical and research applications, 
including home monitoring for personalised rehabilitation, early detection of complications, 
and evaluation of clinical management strategies. 
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6.1.  Introduction 
 
Post-operative assessment of patients varies throughout the phases of recovery, with multiple 
different strategies employed depending on the patient’s needs.  Although post-operative 
monitoring in the acute period has many similarities irrespective of case type, long-term 
follow-up is more specific, and late complications arising are most likely to be of a specialist 
nature.  Post-operative assessment does not solely exist to detect complications requiring 
intervention.  In the context of lower limb reconstruction, as fractured bones and soft tissues 
begin to heal, proactive measures are necessary to optimise both the rate, and extent of return 
to function.  Appropriate rehabilitation cannot be issued in the absence of thorough 
assessment.  Furthermore, monitoring the patient’s response to therapy is difficult without 
longitudinal data representing quantifiable performance metrics or quality of life. 
 
End point patient outcomes are essential to evaluate the success of a clinical service.  Such 
outcomes are often easier to attain than those spanning multiple time points, and are therefore 
frequently quoted in clinical reports and trials.  There have been several reports of patient 
outcomes following open tibial fractures, most of which are retrospective. 171 Outcomes are 
reported in many ways, including hospital statistics such as duration of stay, complications, 
and rehabilitation duration, or quality of life and limb function scores.  Quality of life is 
measured using questionnaires such as the Short Form health survey (SF-36) which contains 
36 questions split into 8 categories, assessing the various aspects of wellbeing that translate to 
health status.178 Limb function can be measured with a variety of metrics such as goniometry 
(joint range of motion),186 functional tests of activities of daily living,187-190 or more resource-
demanding investigations such as gait analysis or activity monitoring.193 As the majority of 
clinical studies are retrospective, outcomes stated are often long-term, static values, with 
mean follow-up times of between 2-5 years post-injury.  Although this manner of evidence 
fails to provide insight into the recovery process, it does allow for long-term comparisons of 
management strategies such as amputation versus limb salvage in severe fractures.217, 218 
 
Evidence including more thorough assessment of patient kinematics is scarce.  Work 
originating from the Lower Extremity Assessment Project (LEAP) and 2 papers from de 
Visser show gait and functional changes following lower limb reconstruction at a single post-
operative time point.  De Visser implements a force-plate instrumented treadmill for 
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objective gait analysis, showing that walking speed is reduced, alongside increases in 
temporal variation, particularly under cognitive or visual constraints.219, 220  Archer takes a 
study sample from the LEAP database at 24-months post-operatively, which shows frequent 
presence of gait deviation (by subjective analysis) and impaired walking speed amongst 
patients.221 The authors regret that “while instrumented gait analysis is the criterion 
standard,222 a 3-dimensional technique was impractical and too costly for the present study”. 
 
Although there exists extensive literature on limb function and gait following amputation, 
little is know about the recovery process following limb reconstruction (echoed by Archer in 
aforementioned paper).  Macri, de Visser, Aranzulla and Joslin all show some form of 
functional mobility change during recovery, though often with limitations in study size, 
analytical methods or data reporting.  
 
Amongst the most informative evidence on the subject, Macri et al223 studied and recognised 
the improvement of gait throughout recovery, where the number of patients able to walk 
without signs of pain increased from 45 - 79% from 3 to 6-months post-injury.  However, gait 
analysis in this case was conducted by 3 independent video reviewers, using a somewhat 
vague grading scale of 1-4 according to speed of locomotion and signs of pain.   
 
De Visser’s later work used cognitive dual-tasks and visual restrictions to assess recovery of 
gait post-operatively in the setting of lower-limb soft-tissue tumours.  A modest cohort 
(n=10) of patients were followed-up every 2-months between months 5 and 15 post-
operatively with instrumented treadmill gait analysis.  Although graphical results appear to 
show improvements in walking speed plateauing after 6 months, the statistical analysis only 
verified gross changes from first to last time points.224 
 
Aranzulla demonstrates the application of a portable, non-pervasive, monitoring system for 
measuring weight bearing during tibial fracture healing.  Three patients were assessed at 
several time points throughout recovery, depending on injury severity.  A patient with a 
severe tibial fracture exhibits a plateau in walking speed at 30 weeks (6-months) yet 
continues to improve gait quality (weight bearing) for 48 weeks (12-months) post-
operatively.225 Joslin also provides longitudinal data regarding post-operative weight bearing 
using a commercial force plate, in which patients with low-grade closed tibial fractures show 
 !
! 179 
improvements in weight bearing symmetry until 14 weeks post-injury.  This paper however 
focuses more on the ratio between fracture stiffness and weight bearing, where results are 
provided in more detail.226 
 
Recent guidelines from the British Orthopaedic Association and British Association of Plastic 
Reconstructive and Aesthetic Surgeons (BOA/BAPRAS) suggest collecting a selection of 
follow-up data, including gross outcome measures such as time to union, flap failure and 
other complications, and also quality of life metrics (e.g. SF-36) alongside limb function 
status.165 Documentation and submission of such information is required in the UK to secure 
the premium operation tariffs, offered only to specialist centres or those complying with best 
practice guidelines.  Though this is well established, the standard and nature of long-term 
post-operative therapy is not.  This may be one reason why patients undergoing limb 
reconstruction fail to consistently achieve higher function and return to work rates than 
amputees.171, 172   
 
Advances in pervasive sensing technologies facilitate objective, resource sparing methods of 
post-operative assessment.  Such opportunities promise to address the data limitations stated 
by the LEAP group, and also allow implementation of strategies outside of the research 
setting.  One such example is the HMS, a validated assessment method for patients 
undergoing lower limb reconstruction using a novel, wearable motion sensing system.  The 
HMS contains both subjective and objective aspects of mobility, allowing fair comparisons 
between patients.  Unlike questionnaires, it is less vulnerable to changes in patient mental 
state or culture, allowing longitudinal use, e.g. daily assessments.  Compared to common 
functional tests such as the 6-MW, it not only provides a score, but characterises mobility 
limitations using a range of kinematic parameters over 3 activities of daily living. 
 
 
6.1.1.  Hypothesis 
 
The HMS is able to quantify and characterise a patient’s return to functional mobility 
following post-traumatic lower limb reconstruction.   
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6.2.  Methods 
 
6.2.1.  Outline 
 
Twenty patients who had undergone post-traumatic lower limb reconstruction were followed 
up at 3-monthly intervals for 1-year.  At each time point, an ear worn motion sensor (e-AR) 
was used to assess the performance of subjects during a short activity protocol.  The HMS, as 
well as several kinematic parameters, was used to quantify and characterise the recovery of 
functional mobility.  Differences between patients with varying severities of injury were 
investigated and complications were identified. 
 
Hamlyn Mobility Score (HMS) 
 
The HMS was developed to provide a robust, objective assessment method for patients 
undergoing lower limb surgery.  Its proposed applications include clinical testing of 
functional status or post-intervention progress, patient use in the community setting for 
motivation and personalisation during rehabilitation, early detection of complications, and 
evaluation of clinical services. 
 
The assessment protocol includes 3 popular mobility tests, with advanced kinematic 
performance parameters derived from the addition of a pervasive wearable sensor.  
Subjective patient features that are unobtainable from a sensor, but deemed important follow-
up factors, are incorporated as a minor proportion to provide a holistic assessment. All 
aspects of the HMS have been shown to be reliable under repetition with different instructors, 
and all parameters show strong internal consistency.  The total HMS, as well as all sub-
categories, show moderate to strong correlation with quality of life indices (SF-36 and 
variations), proving concurrent validity.  The HMS also demonstrates the ability to 
distinguish between patients with injuries within different classes of severity.  
 
The activities include a 6-minute walk (6-MW), timed up and down stairs (TUDS) and timed 
up and go (TUG) tests.  Parameters can be found in the table below.  Force parameters refer 
to relative ground reaction forces outlined in section 5.2. 
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Table 6.1.  HMS parameters 
6-minute walk TUDS TUG 
Distance Duration Stand-to-walk duration 
Temporal variation Temporal variation Total duration 
Force variation Force variation  
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6.2.2.  Conducting clinical trial 
 
N.B. This trial acts as a continuation of that described in the previous chapter, where full 
details of the following methodology are available (5.2.5). 
 
Ethical Approval 
 
Ethical approval was granted from the Research Ethics Committee of West Scotland in April 
2012 (ref: 12/WS/0066). 
 
 
Adoption by the NIHR Portfolio of clinical trials 
 
The study was adopted by the National Institute of Health Research (NIHR) portfolio.  The 
Study reference is ‘Investigating Lower Limb Trauma – study ID 12642’.   
 
 
Registration of the clinical trial 
 
The study was registered at clinicaltrials.gov, under ‘Investigating Lower Limb Trauma – 
protocol record CRO1934’. 
 
 
Recruitment and eligibility 
 
All patients presenting to the Imperial College Healthcare NHS Trust trauma centre between 
August 2012 and April 2013 with lower limb injuries were assessed for eligibility.  The 
recruitment period was the time needed to recruit 20 patients.  After patient recruitment was 
completed, 10 healthy age and sex-matched subjects were recruited.  
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Table 6.2.  Eligibility criteria for recruitment 
Inclusion Exclusion 
Unilateral open tibial fracture 18  Age  65 
 Polytrauma (other fracture) 
 Need for admission to ITU 
 Other mobility disorder 
 Pre-existing cardio-respiratory disease 
limiting mobility 
Intensive Therapy Unit (ITU) 
 
Data collection 
 
Data was collected from patients at 3-monthly intervals post-injury, and on one occasion for 
healthy subjects.  At the first appointment, participants provided demographic information, 
completed a short form health survey (SF-36) and completed the HMS activity protocol (6-
MW, TUG, TUDS) whilst wearing the e-AR sensor.  All subjects had leg length measured, 
with any discrepancy noted. 
 
Before and after completing each activity, participants were asked to shake the sensor to 
provide a spike in the data that would allow easy identification and labeling of activities.  
Patients were informed that use of aids (crutches, handrail etc) was at their discretion, and 
they were encouraged to use what they would normally use outside of the test environment.  
All participants performed activities in the same order at each visit.  The TUG and TUDS 
tasks were performed prior to the 6-MW, to ensure that any fatigue following the 6-MW did 
not affect other task performances.  Rests between tasks were at the participants’ discretion. 
 
The SF-36) consists of 36 multiple-choice questions, designed to evaluate the patient’s self-
reported quality of life.  The questions fall into 8 categories: physical function, role 
functioning (physical), role functioning (emotional), vitality, mental health, social 
functioning, body pain, and general health.  Scores are derived for each category, and further 
composite scores are produced including physical, mental and combined scores.212 This tool 
has been validated for use in the trauma setting.213 
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Subjects also completed feedback forms related to the sensor, activities and post-operative 
care in general. (Appendix) 
 
 
Data Organisation 
 
The data collected from the e-AR sensor was extracted using a simple software package, to 
take the form of a comma separated value file (.csv).  Data initially contained 5 columns, 
including date, time, axis 1, axis 2, axis 3.  The data was viewed graphically using MS Excel, 
to check the data quality, and to enable identification of activities.  Activities were labeled in 
a 6th column of the data.  Parameters for each activity were calculated as per the HMS 
protocol. 
 
Amendments to gait analysis methodology 
 
Derivation of gait parameters using methods described by Jarchi et al. (5.2.3) was performed 
over the full 6-minute walk, rather than just 1 length of the corridor.  Gait parameters were 
also calculated for each individual minute to allow assessment of any intra-test changes.  
Data analysis was performed using a custom-made software programme based in Matlab.  
 
 
Gait analysis software 
 
Data is formatted appropriately in a comma separated values (.csv) file and accessed.  The 
entire data collection period is initially visible, with high amplitude sections caused by 
shaking sensor before and after completing tasks (assisting activity segmentation).  A zoom 
function is implemented to explore the raw data in the graph.  The start of the 6-mw is 
identified.  A data sample shortly preceding the start of the 6-MW is entered, and a second 
sample 60 seconds (6000 samples) after to produce a 1-minute data window.  A second graph 
is also produced showing the repetitive gait pattern (including denoising). 
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Figure 6.1.  A custom-made software platform based in Matlab was used to identify and analyse 
relevant segments of data (top left and right).  The bottom graph shows the use of Single Spectrum 
Analysis to denoise the data, as described by Jarchi et al.46 
 
 
The data segment is analysed, with metrics for each step listed in a table.  Algorithms have 
been written and implemented to deduce clinical gait parameters from the entire segment, yet 
in this case it would provide erroneous results due to the turns at each end of the corridor.  As 
such, the data quality is checked using the graph in the top right of the figure, and step values 
are exported to a spreadsheet for further processing.  Data for each minute of the 6-MW was 
exported to a spreadsheet, including step times and step forces (amplitude).  Simple line 
graphs were generated from the data, facilitating the identification of turns.  Turns identified 
are omitted by deleting corresponding data samples.  To minimise the introduction of human 
bias a strict system was followed including identification of sample furthest from mean, and 
deleting samples on either side, up to maximum 5 samples per parameter.  Outlying data 
samples between turns were untouched unless indicated by an event during the test such as 
the need to avoid an obstacle in the corridor (documented in notes).  
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6.2.3.  Statistical Analysis 
 
Descriptive statistics were calculated for subject demographic characteristics, clinical 
information, and all outcome measures.   
 
Multiple Friedman analyses were conducted to ascertain the time point at which recovery 
curves plateau.  The plateau was noted where subsequent improvement in functional mobility 
failed to show statistical significance.  
 
Wilcoxon Signed-rank tests were used to evaluate the significance of changes in patient 
scores (related samples) between 2 time points. 
  
Patients were grouped based on Gustilo-Anderson classification (severity) of their fracture.  
Kruskal-Wallis non-parametric one-way analysis of variation (KW-ANOVA) was used to 
assess whether the subgroup samples originated from the same distribution.  Further Mann-
Whitney U tests were used to analyse specific pairs of samples for significant differences.  
Similar analyses were used for comparing results from the 3 activities. 
 
The F-ratio was used to compare the magnitude of variation in 2 data samples, calculated by 
forming a ratio between standard deviations, and using an F-ratio table within limits of 
appropriate degrees of freedom (determine by sample size) to assess statistical significance. 
 
Correlations between parameters were assessed using Spearman’s Rho correlation coefficient 
to account for the use of discrete measures in the HMS, as well as data distributed both 
monotonically and polynomially. 
 
Statistical analysis was performed using the Statistical Package for Social Sciences version 
19.0 (SPSS, IBM corp, NY, USA). 
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6.3.  Results 
 
6.3.1.  Study participants 
 
Between August 2012 and April 2013, 51 patients with open tibial fractures were identified.  
Eight patients were over 65, 1 patient was less than 18.   Two patients underwent amputation 
for non-reconstructable injuries (1 Above Knee Amputation, 1 Below Knee Amputation).  
Fifteen patients had co-morbidities, including head injuries, bilateral lower limb fractures, 
ipsilateral foot fractures, pelvic fractures, and end stage liver disease.  Twenty-two patients 
were contacted.  Of these, 1 patient was unable to participate due to an unmanageable 
language barrier, and 1 refused. 
 
Twenty patients (90% male; mean age 38.5, SD 15.8) and 10 healthy control subjects (90% 
male; mean age 34.7, SD 12.9) were recruited.  
 
 
Missing data, mobility aids and attrition 
 
One patient withdrew from the study after 3-months due to depression.  After 6-months, 1 
patient left the country and another was unreachable.  After 9 months, several patients were 
discharged and some lived too far away to justify (in their opinion) the clinical trial 
appointment.  One patient was diagnosed with a soft tissue tumour in their thigh requiring 
radiotherapy so was excluded from the study. 
 
Table 6.3.  Missing data, mobility aids and attrition 
 3 months 6 months 9 months 12 months 
Data samples 20 19 17 11 
Mobility aids (%) 65 21 12 0 
Attrition (%) 0 5 15 45 
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Table 6.4.  Demographic data for patients and healthy controls 
 
Characteristics 
Patients 
Mean (SD) 
Controls 
Mean (SD) 
p-
value 
Gender    
    Male 18 (90%) 9 (90%)  
    Female 2 (10%) 1 (10%)  
    
Age 38.3 (15.8) 34.7 (12.9) 0.694 
    
Anthropometrics    
    Height (m) 1.79 (0.0833) 1.80 (0.0600) 0.799 
    Weight (Kg) 74.7 (9.18) 79.4 (12.1) 0.295 
    BMI 23.4 (2.20) 24.5 (2.72) 0.317 
    Leg length ratio 1.00579 (0.00549) 1.00663 (0.00983) 0.932 
    
Fracture classification 
(Gustilo-Anderson) 
   
    1 4 (20%) -  
    2 7 (35%) -  
    3 9 (45%) -  
    
Fracture Fixation    
    IM nail 9 (45%) -  
    Internal fixation  5 (25%) -  
    TSF 6 (30%) -  
    
Pedicled flap 3 (15%) -  
Free flap 6 (30%) -  
BMI – Body Mass Index (Kg.m-1), IM – Intra-medullary, TSF – Taylor Spatial Frame 
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6.3.2.  Main findings 
 
Hamlyn Mobility Scores 
 
The HMS produced expected recovery curves.  Multiple Freidman analyses confirmed that 
improvements in functional mobility continued throughout the full post-operative year (p < 
0.05).  At 3-months, KW-ANOVA showed a significant difference between patients sub-
grouped according to fracture severity (X2 = 0.6432, p = 0.04).  At 6-months, this is reduced 
to only a difference between Gustilo-3 (G3) patients and all other patients (Mann-Whitney U 
Test – p = 0.035).  Between 9 and 12 months, there is reduced difference in functional 
mobility between patients sub-grouped according to fracture severity (X2 = 3.941, p = 0.139, 
and X2 = 1.689, p = 0.43). 
 
 
Figure 6.2.  Post-operative return of functional mobility in OTF patients as measured by the Hamlyn 
Mobility Score.  Varying rates of recovery are shown by both the median scores and the increased 
standard deviation in the more severe fractures (Gustilo 3). 
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Table 6.5.  Longitudinal Hamlyn Mobility Scores with sub-group according to fracture severity  
 HMS mean (SD) 
 3 months 6 months 9 months 12 months 
G1 33.0 (8.29) 46.8 (0.957) 50.0 (3.16) 51.0 (4.24) 
G2 24.8 (11.9) 46.2 (7.73)* 48.5 (10.3) 52.0 (8.71) 
G3 13.8 (12.6) 31.9 (16.0)* 37.7 (14.1)♯ 46.8 (5.08) 
All 20.4 (13.7) 38.9 (14.0)* 43.1 (12.5)* 49.0 (6.02)* 
* p < 0.05, ♯ p = 0.074, significant transition from previous time point 
 
 
Patients with G2 fractures improved the most during the 3-6 month transition (Wilcoxon 
Signed Rank), with G1 and G3 patients both showing significant improvements (p < 0.05).  
The G1 group started off with a higher mean HMS, suggesting substantial improvements in 
function between 0 – 3-months.  The G3 group improves significantly between 3 – 6-months 
and approaching significance between 6 – 9-months (p = 0.074) suggesting a later 
improvement compared to G1 and G2 patients.  
 
 
Table 6.6.  Improvements in functional mobility 
 Transition 
 3-6 months 6-9 months 9-12 months 
G1 13.8 (8.81) 3.2 (3.77) 0.5 (0.71) 
G2 21.4 (6.99)* -1.0 (8.04) 4.00 (4.24) 
G3 17.4 (10.3)* 5.9 (9.40) 4.0 (5.69) 
All 16.5 (10.5)* 3.7 (8.20)* 3.0 (4.58)* 
       * p < 0.05 
 
 
Recovery trends were seen with the quality of life index, SF-36, though large variation within 
sub-groups averted further analysis. 
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Figure 6.3.  Post-operative return of functional mobility in OTF patients as measured using the Short-
form health survey (SF-36).  Although there is some difference in fracture severity subgroups, the 
level of overlap and wide standard deviation makes the trends difficult to interpret. 
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Activities 
 
All activities scores strongly correlated (Mean Spearman’s Rho = 0.726, p < 0.001), showing 
similar patterns in recovery curves. 
 
 
Figure 6.4.  Comparison of post-operative return of functional mobility in OTF patients according to 
HMS activity.  The TUG score was converted from x/10 to x/15 to improve visual comparison on the 
graph.  
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Gait (6-minute walk) 
 
Average step time and force were not included as parameters, yet both correlated strongly 
with distance walked (R= -0.818, p < 0.001, and R= 0.666, p < 0.001) and so were somewhat 
represented.  Step time and force also correlated (R= -0.582, p < 0.001). 
 
 
Figure 6.5.  Relationship between step time and force, showing that as step time duration decreases 
(normally due to increased walking velocity), the ground reaction force increases. 
 
 
Force variation showed inconsistent results in patients and healthy subjects.  Although raw 
data values appear to improve throughout recovery, there is no significant trend in the 
recovery curve.  Temporal variation and distance walked both improved throughout recovery.  
Multiple Friedman analysis revealed that distance walked plateaus at 6-months post-op, 
whereas temporal variation continues to improve until 12-months. 
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Figure 6.6.  Post-operative temporal variation and distance walked by subjections during the 6-minute 
walk.  Multiple Friedman analyses show that temporal variation (a measure of walking quality) 
continues to change until 12-months post-op, whereas distance walked (walking quantity) plateaus 
after 6-months. 
 
 
Sub-group analysis of temporal variation during gait showed no difference between gustilo 
groups at any time point.  However, at 3-months post-operatively, patient performance within 
the G1 group exhibited minimal variance (standard deviation), compared to both G2 and G3 
groups.  At 6-months, variance in the G2 group was minimal, with only the G3 group still 
showed a wide array of results.  At 9-months onwards variation was minimal amongst all 
groups.  This observation was investigated statistically using the F-test (a comparison of 
variance between 2 samples).  At 3-months, the F-ratio between the G1 and G2 groups was 
high but non-significant (F ratio = 3.91, p = 0.146), and very high between G1 and G3 (7.88, 
p = 0.050).  At 6-months, the F-ratio between the G3 group and other patients remained high 
(5.00, p = 0.0118).  This suggests later improvements in temporal variation of gait in patients 
with more severe fractures. 
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Figure 6.7.  Post-operative temporal variation in gait following OTF, split according to fracture 
severity (Gustilo classification).  Although there aren’t large differences in median temporal variation 
between groups, this graph demonstrates the wide variation in performance within groups, particularly 
for severe fractures in the early stages of recovery. 
 
 
 
Minute-by-minute analysis of the 6-minute walk revealed no significant changes in patients 
or healthy subjects in any parameters throughout the walk.  However, the patterns associated 
with turning, accelerating and decelerating should be investigated further.  
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Table 6.7.  Raw gait parameters during 6-MW throughout recovery, split according to fracture 
severity (Gustilo classification)  
 Raw score - Mean (SD) 
 3 months 6 months 9 months 12 months 
Step time (s)     
G1 0.670 (0.072) 0.588 (0.023) 0.596 (0.037) 0.568 (0.019) 
G2 0.678 (0.096) 0.557 (0.040) 0.543 (0.054) 0.527 (0.018) 
G3 0.628 (0.052) 0.622 (0.080) 0.639 (0.128) 0.552 (0.035) 
All 0.661 (0.073) 0.661 (0.176) 0.602 (0.098) 0.548 (0.031) 
     
Temporal variation      
G1 0.092 (0.032) 0.082 (0.061) 0.087 (0.084) 0.045 (0.004) 
G2 0.146 (0.125) 0.050 (0.019) 0.049 (0.013) 0.032 (0.004) 
G3 0.278 (0.252) 0.152 (0.215) 0.088 (0.042) 0.061 (0.028) 
All 0.178 (0.176) 0.106 (0.152) 0.078 (0.051) 0.050 (0.024) 
     
Force     
G1 14.7 (6.12) 20.1 (3.26) 22.0 (2.07) 22.05 (3.22) 
G2 16.9 (3.93) 23.4 (7.27) 25.3 (11.2) 29.8 (4.55) 
G3 16.4 (3.79) 17.6 (6.68) 18.4 (7.75) 21.9 (6.25) 
All 16.0 (4.45) 20.1 (6.36) 21.2 (7.92) 24.0 (6.18) 
     
Force variation     
G1 0.201 (0.050) 0.158 (0.036) 0.141 (0.048) 0.113 (0.007) 
G2 0.308 (0.182) 0.172 (0.100) 0.134 (0.055) 0.113 (0.037) 
G3 0.190 (0.117) 0.186 (0.091) 0.168 (0.067) 0.123 (0.028) 
All 0.239 (0.145) 0.175 (0.081) 0.153 (0.058) 0.118 (0.026) 
     
Distance (m)     
G1 325 (97) 406 (48) 400 (41) 418 (3) 
G2 228 (94) 423 (100) 415 (125) 477 (60) 
G3 235 (107) 322 (71) 376 (111) 437 (38) 
All 258 (102) 371 (87) 392 (97.8) 445 (44) 
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Timed up and go 
 
The TUDS task saw patients improve throughout recovery.  Temporal variation and duration 
provided the most significant trends, yet both plateaued at 6-months post-operatively. 
 
 
Figure 6.8.  Post-operative recovery in the timed up and down stairs (TUDS) task (a. Temporal 
variation, b. Force variation, c. duration), subgrouped according to fracture severity (Gustilo 
classification). 
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Table 6.8.  TUDS raw parameters throughout recovery, split according to fracture severity (Gustilo 
classification) 
 
TUDS Raw score - Mean (SD) 
 3 months 6 months 9 months 12 months 
Temporal variation     
G1 0.159 (0.072) 0.068 (0.014) 0.072 (0.044) 0.102 (0.004) 
G2 0.316 (0.143) 0.086 (0.028) 0.081 (0.049) 0.089 (0.063) 
G3 0.230 (0.113) 0.154 (0.068) 0.136 (0.0587) 0.174 (0.137) 
All 0.240 (0.126) 0.112 (0.062) 0.105 (0.058) 0.138 (0.109) 
     
Force variation     
G1 0.254 (0.025) 0.193 (0.034) 0.177 (0.067) 0.102 (0.004) 
G2 0.254 (0.093) 0.233 (0.055) 0.236 (0.091) 0.200 (0.029) 
G3 0.249 (0.160) 0.250 (0.081) 0.239 (0.082) 0.261 (0.047) 
All 0.252 (0.104) 0.232 (0.066) 0.222 (0.080) 0.233 (0.049) 
     
Duration (s)     
G1 22.4 (7.6) 15.2 (1.0) 14.3 (0.7) 14.5 (1.8) 
G2 35.0 (12.5) 14.3 (3.0) 17.3 (7.3) 13.3 (1.6) 
G3 29.4 (17.7) 21.1 (7.7) 25.7 (16.9) 16.3 (4.7) 
All 29.4 (14.2) 17.7 (6.3) 21.1 (13.5) 15.1 (3.7) 
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Timed up and go 
 
The TUG test also showed recovery trends in both parameters (stand to walk duration and 
total duration) which plateaued 6-months post-operatively.  No significant differences were 
found between Gustilo groups although there appeared to be more variation in the G2 and G3 
groups during early recovery. 
 
 
 
Figure 6.9.  Post-operative recovery as measured by the timed up and go (TUG) task parameters (a. 
Stand-to-walk duration, b. Total duration), split according to fracture severity (Gustilo classification).  
Statistical analysis shows that both of these parameters plateau at 6-months post-op.  At 12-months 
post-op there appears to a difference in STW duration according to fracture severity.  
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Table 6.9.  TUG raw parameters throughout recovery, split according to fracture severity (Gustilo 
classification) 
 
TUG Raw score - Mean (SD) 
 3 months 6 months 9 months 12 months 
Stand to walk duration (s)     
G1 2.46 (0.45) 1.88 (0.48) 1.81 (0.62) 1.46 (0.15) 
G2 3.65 (1.78) 2.10 (1.06) 1.88 (0.82) 1.78 (0.62) 
G3 3.99 (2.10) 2.17 (0.62) 3.26 (3.20) 1.99 (0.32) 
All 3.47 (1.72) 2.08 (0.71) 2.59 (2.42) 1.83 (0.42) 
     
Total duration (s)     
G1 13.95 (3.29) 9.97 (1.42) 9.58 (0.94) 8.70 (1.41) 
G2 18.49 (8.45) 10.09 (2.54) 9.59 (2.63) 9.28 (2.03) 
G3 19.70 (8.51) 15.18 (10.81) 13.79 (6.76) 9.66 (1.03) 
All 17.76 (7.39) 12.61 (8.00) 11.81 (5.39) 9.38 (1.30) 
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Detection of Complications 
 
Two patients developed complications.  These were detected by considering their change in 
recovery trajectory relative to the total patient cohort.   
 
 
 
Figure 6.10.  This graph shows how late complications in 2 patients (coloured lines) results in their 
performance falling outside of the expected recovery trajectory (dashed line represents +/- 0.5 SD of 
the cohort scores) 
 
 
Patient 1 had a G2 fracture managed with a Taylor Spatial Frame bone fixation and free flap 
soft tissue reconstruction.  He was unwell with long-term post-operative urinary retention 
requiring catheterisation, preventing return to normal activities.  He was in considerable pain 
at the 9-month data point and in need of urgent referral to address rehabilitation and systemic 
complications.  The HMS allows different aspects of functional mobility to be assessed and 
therefore provides information into the nature of the patient’s decline.  In the case of patient 
1, the 6-MW score had remained fairly constant, with both TUDS and TUG scores falling by 
53% and 56% respectively.  These issues could be targeting specifically by the physio, 
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potentially expediting identification of pathology and designing a personalised recovery 
strategy.  
 
Patient 2 had a G3 fracture managed with an intra-medullary nail and reversed sural artery 
flap soft tissue reconstruction.  Due to early flap compromise requiring surgical 
decompression, the patient had very poor mobility at 3-months and was still in a wheel chair.  
At 6-months post-operatively however she was recovering well, until she sustaining a fall, 
which hindered her recovery.  As with patient 1, the TUDS was most affected in the 
subsequent mobility assessment.  
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User interface 
 
A questionnaire was designed and distributed to 15 staff members including surgeons (of 
variable seniority), nurses and physiotherapists, regarding the use of electronic records, 
devices, and methods of mobility assessment currently used.  Results from the questionnaire 
were used in part to design a conceptual user interface for staff, and possibly patient use. 
 
The application would allow the user to access longitudinal performance scores, including 
composite scores and separate activities and parameters if desired.  It may also serve as a 
useful method of communication between teams and services, e.g. physio to surgeon.  
 
 
 
Figure 6.11.  A conceptual HMS user interface for patients and healthcare workers 
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Patient feedback 
 
Questionnaire 
 
After 2 sessions, patients were asked to complete a feedback form, focusing on various topics 
related to their clinical experience and opinions of the sensor (see Appendix).  Regarding the 
sensor, all patients agreed that it was easy to put on/take off and it didn’t affect their 
activities.  All patients would be happy to wear the sensor at home for assessment once a day, 
but there were mixed opinions when asked if they would wear the sensor all of the time.  Half 
of the patients (54%) didn’t mind if they were tested at home or the clinic and of those who 
held a preference, 83% chose the clinic.  
 
More than half of the patients (54%) did not see a physiotherapist within 3-months of their 
injury and the majority of patients (77%) wanted more physiotherapy. 
 
 
Qualitative feedback 
 
“…to actually see movement and a score makes you want to improve.  I would be pushing 
myself harder because I would have a target to beat.” - Patient a 
 
“Everything is a bit of a blur when it comes to progress.  When it comes to setting goals, it’s 
really important to have something to strive towards” – Patient b 
 
“The sensor is monitoring [me] in much more detail, up and down, forwards backwards 
movements, which you can only just about visually see, but the sensor picks up every little 
detail.  So even a slight weight adjustment, putting more weight on one leg than the other, I 
would think it virtually undetectable, to me it’s undetectable when I’m walking, I’m not 
conscious of it, so even a slight detail like that, you wouldn’t pick up if it wasn’t for the 
sensor.’ – Patient c. 
 
“It’s hard for [the doctors] to really say how well I’m doing, the best place for that is here.  I 
can see my progress and see I’m getting better” - Patient d  
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6.4.  Discussion 
 
The study aims of quantifying and characterising the recovery process following post-
traumatic lower limb reconstruction were met with several interesting and significant 
findings.  The functional mobility of the patient cohort according to the HMS improved 
throughout the full study follow-up period (1-year).  Upon stratification of subjects according 
to fracture severity (Gusilo-Anderson classification), patients with more severe fractures 
recovered at a slower rate.  In general, patients with G1 fractures completed the majority of 
their recovery in the first 3-months, G2 until 6-months, and G3 patients continuing to recover 
through the 9-month time point.  Quality of life indices (SF-36) showed trends of 
improvement over time, but with large variance in the data.  All activities making up the 
HMS contributed similarly to the recovery patterns with strong inter-activity correlations.   
 
Gait (6-MW) analysis provided the most interesting additional findings, where parameters 
derived from the sensor appeared to offer more information than standard task metrics.  Gait 
analysis revealed that walking quality continues to improve 12-months post-operatively, 
whereas walking capacity (distance) plateaus after 6-months.  It also discriminated between 
patients by fracture severity by inter-subject performance variance.  Late complications 
documented in patient notes were detected by the HMS, where subject recovery trajectories 
deviated more than 0.5 SD away from that of the cohort.  Further interrogation of patient 
results at the time of complications provided excellent detail as to which aspects of functional 
mobility were most affected. 
 
Patient remarks about the sensor and the information the tests provided were extremely 
positive with regards to practicalities of sensor use, as well as the potential benefits to 
rehabilitation it holds.  This was particularly favourable in light of concurrent reports 
highlighting the lack of post-operative support and physical therapy. 
 
Building on findings from the validation of the HMS, the score appears to provide a useful 
method for monitoring patients post-operatively, maintaining advantages over subjective 
questionnaires and assessments by healthcare staff ranging in experience.  It is sensitive and 
objective considering the detection of complications, and would therefore be suitable in the 
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community environment.  Furthermore, ease of use and patient preferences for daily 
assessments at home make it a practical adjunct at the point of hospital discharge.    
 
Pervasive sensing allows acquisition of novel data, capable of providing unique insight into 
the rehabilitation process.  The activities that make up the HMS are commonly used, and 
have been validated in multiple clinical settings.  Whilst they remain useful in their current 
form, additional parameters in this case have demonstrated their relative lack of sensitivity, 
which may even be misleading.  Patient recovery, as measured by the conventional 6-MW 
metrics (distance), plateaus after 6-months.  However this study reveals that walking quality 
continues to improve for much longer.  With patients able to walk long distances at early 
post-operatively stages, it is possible that poor gait habits may become engrained, which 
without support may impede recovery and cause long-term complications.  
 
The majority of studies documenting patient outcomes following lower limb reconstruction 
are retrospective, and provide a single long-term outcome often derived from questionnaires 
or hospital data.  These reports fail to provide objective insight into the resultant functional 
mobility of patients or the rate of progress measured throughout the recovery process.  
Limited work by Macri et al demonstrated the return to normal gait between 3 and 6-months 
post-injury.  Although only subjective analyses of gait were used, results were consistent with 
that of this study, whereby healing rates and gait improvements were substantially quicker 
with fractures of lower severity.  At 6-months post-operatively, only the G2 or G3 fractures 
remained non-united with corresponding gait deficits.223 Additional well aligned outcomes 
were described in early work by Aranzulla, whereby patients with severe tibial fractures were 
shown to experience a plateau in preferred walking speed at 30-weeks, with continued 
improvement in walking quality through 48-weeks and beyond.225  
 
The results of this study, to the best of our knowledge, contribute to the literature the most 
detailed and objective information yet regarding the recovery process following lower limb 
reconstruction.  Even so, interpretation of the findings should be done so transparently 
alongside study limitations.   
 
Due to the severity of many of the injuries, completion of the activity protocol at 3-months 
post-operatively was not possible for all subjects.  For other subjects, the use of mobility aids 
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such as crutches or the handrail during the TUDS task was necessary.  Although this was 
addressed in the HMS through penalties, these subjects were either excluded from raw 
parameter analysis, or included even though they were not independent of supports.  This is 
likely to cause under-representation of patients at the lower end of the mobility spectrum.  
Similarly, during the latter time points, patient who had been discharged from outpatient care 
were less likely to attended study appointments, particularly considering many patients had 
been brought to Imperial College Healthcare NHS Trust as a major trauma centre, not 
because it was local.  Therefore late-stage participant attrition is likely to be skewed towards 
those with higher function.  
 
In order to achieve the most representative value for gait parameters, every step of the 6-MW 
was identified and analysed automatically using validated methods.  The software 
implemented allows an intermediary phase whereby each step can be checked manually.  
This feature of the software identified periodic changes in gait attributed to turning at the end 
of the corridor, which were subsequently removed.  However, participants behave differently 
and unpredictably when turning, accelerating and decelerating during this task, making the 
manual omission of turns vulnerable to bias.  It has been established, and is logical that the 
length of corridor and therefore number of turns may affect total distance walk.227 The 
kinematic trends originating from sensor data regarding acceleration should be explored 
further, as it may provide further insight yet into the recovery of functional mobility.  Also, 
kinematics associated with the TUDS task including the turn at the top of the stairs and 
separate results for ascending and descending may be useful.  Considering the poor 
correlation between force variation up and down stairs there may further information to 
retrieve.  This study was designed initially to validate the HMS, and also assess the feasibility 
of its implementation over long-term follow-up.  As such, it was not powered to assess 
differences between sub groups, which was made difficult statistically particularly due to the 
small number of patients with G1 or G2 fractures.   
 
The HMS proves to be a useful tool for monitoring and characterising the recovery of 
patients following post-traumatic lower limb reconstruction.  The method is low cost and 
objective, making it suitable for a variety of clinical and research applications, including 
home monitoring for personalised rehabilitation, early detection of complications, and 
evaluation of clinical management strategies.  Addressing the technical challenges associated 
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with unsupervised applications, and developing the necessary service infrastructure will be 
required to realise the potential healthcare impact of wearable sensors in clinical practice.  
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CHAPTER 7. 
SENSOR-GUIDED FREE FLAP SURVEILLANCE IN THE 
ACUTE POST-OPERATIVE PERIOD** 
 
 
Abstract 
 
Introduction 
Free flap reconstruction is the preferred technique for many trauma and cancer operations.  
Post-operatively there is a risk of flap failure, which has significant cost and patient 
implications.  New technologies facilitating continuous free flap monitoring have been shown 
to improve failed flap salvage rates.  However, these technologies are often large and 
expensive, negating the advantages they deliver. 
 
The aim of this study was to optimise the cost-effectiveness and accessibility to continuous 
flap monitoring through the development and validation of a wearable optical sensor. 
 
Methods 
A flap failure model was designed using a brachial pressure cuff inflation protocol.  Twenty 
healthy subjects were recruited.  The forearm of each subject was monitored throughout the 
pressure cuff protocol using a bespoke optical sensor (Imperial College London), and the 
current gold standard equipment (O2C).  Data were processed to provide quantitative 
deoxygenation episode comparisons between inflations, and sensor modalities.   
 
Results 
The correlations between O2C and optical sensor oxygenation measurements were moderate 
to strong, and statistically significant for all 15 subjects, with Spearman’s rho values ranging 
from 0.418 to 0.862 (average 0.672, p < 0.001).  Incremental increases in cuff inflation 
duration resulted in a linear increase in deoxygenation values with both O2C and optical !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
** Chapter based on publication: Chen C-M, Kwasnicki R M, Lo B, Yang, GZ. (2014) Wearable Tissue 
Oxygenation Monitoring Sensor and a Forearm Vascular Phantom Design for Data Validation.  11th 
International Conference on Wearable and Implantable Body Sensor Networks (Zurich, Switzerland) 
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sensors.  There was a significant difference in the extent of measured deoxygenation between 
consecutive cuff inflations with both sensors (p < 0.005).  Secondarily, the presence or 
absence of pulsatile blood flow was correctly determined throughout the protocol. 
 
Discussion 
This study demonstrates the ability of a low power, wearable optical sensor to detect and 
quantify tissue oxygenation changes, and assess the presence of pulsatile blood flow.  This 
provides pervasive means for free flap monitoring in the acute post-operative period, which is 
likely to improve flap salvage rates and therefore the cost-effectiveness of the reconstructive 
service. 
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7.1.  Introduction 
 
Reconstructive practices are ever-present in the clinical environment.  At one end of the 
spectrum, an accident and emergency nurse may be closing a minor facial laceration by 
opposing the skin edges with an adhesive dressing; in the middle, a general surgeon may be 
refashioning the deep inguinal ring during hernioplasty; and at the far end, a plastic surgeon 
may be performing a post-mastectomy breast reconstruction using tissue harvested from the 
abdomen.   
 
The principles underlying plastic and reconstructive surgery apply to every clinical scenario.  
Said principles are often referred to in their respective position on the ‘reconstructive ladder’, 
describing the surgeon’s climb through increasingly complex wound management strategies 
to close a soft tissue defect and restore function.228 Traditionally, this begins with primary 
and secondary closure, followed by skin grafting, regional and local pedicled flaps, and free 
tissue transfer.  Although these techniques will be described, it is worth noting that further 
concepts including the reconstructive elevator,229 and more recently the reconstructive 
clockwork,230 have been proposed to incorporate adjuvant options or methods such as robotic 
surgery, composite tissue allografting (e.g. hand transplant), and tissue engineering 
techniques (e.g. stem cell therapy).  
 
 
7.1.1.  Reconstructive techniques 
 
When a soft tissue defect is unable to be closed primarily without excessive tension, and is 
too large to allow secondary closure, skin grafting is the first ‘port of call’.  This process 
involves harvesting skin from a donor site and transferring it to the primary defect.  Skin 
grafts may be classed as full thickness (FTSG) or split thickness (STSG), depending on the 
extent of dermis harvested.  FTSG are excised using a scalpel, and require the donor site to be 
closed (often using direct closure or STSG), and are therefore most suited to small defects 
requiring a high quality substitute, such as a facial neoplasm).  STSG are harvested using a 
dermatome instrument that rolls over the skin taking thin layers in a controlled manner.  
Dermal adnexal remnants at the donor site all regenerate and thus delimit the size of graft, 
making STSG suitable for coverage of large defects.  All skin grafts rely on successful 
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reattachment and revascularisation to survive, referred to as ‘take’.  Limitations include the 
creation of a secondary defect, inability to cover bare bone or tendons, and graft contractures 
resulting in poor functional and aesthetic outcomes.  
 
Tissue flaps unlike skin grafts are reliant on their original blood supply, or at least an end 
artery and vein connected to a recipient vessel.  The tissue is too large to rely on the same 
revascularisation process as skin grafts.  As such, the effectiveness of the circulation through 
the vasculature will determine flap survival, and the success of the soft tissue reconstruction.  
Raising a tissue flap for donation inherently leaves a secondary defect requiring closure or 
coverage with a skin graft 
 
Flaps can be named and classified according to multiple features including: 
• Local (pedicled) or distant (free) 
• Tissue transposition or rotation (local) 
• Vascular pattern (e.g. axial – design based on reliable arteriovenous territories; 
random – relying on maximum length:breadth rules)  
• Tissue composition (e.g. skin, subcutaneous tissue, muscle, bone, combination) 
 
Special consideration of all aspects, in the context of the patient’s systemic factors, must be 
undertaken during flap design.  Mechanisms of flap failure are also related to flap 
architecture.  Fasciocutaneous flaps are vulnerable to tension or kinking of the tissue causing 
vascular insufficiency.  Flaps containing muscle are often compromised due to compression 
from oedema, seroma or haematoma, or other tissues squeezing the muscle and the vascular 
pedicle in tunneled flaps.  Free flaps are at most risk from anastomotic site complications and 
external pressures on the relocated flap pedicle (including kinking). 
 
The ability to transfer tissue from one area of the body to another revolutionised 
reconstructive surgery.  Not only does free flap reconstruction facilitate the coverage of large 
defects, but also allows the resection of larger tumours with wider healthy margins.  This 
form of reconstruction relies on demanding micro-vascular anatomotic techniques, first 
described by Alexis Carrel in 1902, for which he received a Nobel Prize.231 
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Free flap reconstruction 
 
The first step is patient education.232 The consultation should explain the procedure in 
appropriate detail and clarity, including the donor site morbidity.  Informed consent requires 
the surgeon to convey the risks and benefits of the proposed surgical plan, as well as 
alternative treatment options.  Preoperatively, the patient should receive prophylactic broad-
spectrum antibiotics, discontinued 1 day after the operation, to minimise risk of infection.  
Furthermore, recommendations from the American Society of Plastic Surgeons include either 
pharmacological or mechanical deep venous thrombosis prophylaxis until the time of 
discharge.233 
 
Other factors to be considered include cardiac health,234 smoking history,235 age,236 systemic 
disease,237, 238 obesity,239 previous irradiation and trauma,240 all of which have documented 
associations to flap failure and outcomes, albeit with a suboptimal level of evidence.  
 
Equipment required for micro-vascular anastomosis varies between practices, and there is no 
evidence to suggest which instruments provide the best outcomes.  Instruments are typically 
micro-versions of cautery forceps, suction, forceps, scissors, needle holders and vascular 
clips/clamps.  Many instruments are designed with spring mechanisms, to allow precise tip 
control.  This is vital for handling delicate vessels, and minimising risk of thrombosis as a 
result of vessel wall trauma and inflammation.  Visualisation during microsurgery can be 
achieved using loupe magnification or an operative microscope.  The ambient temperature of 
the theatre should be warm to reduce blood stasis and clotting, and optimise tissue perfusion.  
 
During preparation for anastomosis, vessels of adequate size and orientation should be 
identified.  This is particularly important in end-to-end anastomosis, where discrepancy in 
gauge is likely to cause turbulent blood flow and hence thrombosis.  End-to-side anastomosis 
is more frequently used as it does not require sacrificing local perfusion routes.  Sutures are 
very fine, most commonly 8-0 to 11-0 non-absorbable monofilaments with a 130µm needle.  
Several interrupted sutures are used, carefully balancing between leakage with too few, and 
excessive trauma from too many (both causing thrombosis).  In most cases, 1 artery is joined, 
and 1 or more veins, depending on the flap size, and the size and availability of the vessels.  
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Variation in recipient vessel exposure and flap preparation exists between methods and 
personal preferences. 
 
 
Figure 7.1.  Microvascular anastomotic techniques 
 
 
Exemplar cases 
 
Lower limb trauma 
 
Open tibial fractures require extensive soft tissue debridement to prevent catastrophic deep 
tissue infection (including that of the metal work).  This often results in a large defect, which 
can’t be closed directly.  Recent best practice guidelines from the British Orthopaedic 
Association and British Association of Plastic Reconstructive and Aesthetic Surgeons 
(BOA/BAPRAS)241 recommend that all open fractures are covered with vascularised soft 
tissue.  Low energy tibial fracture such as those caused by a fall, are often covered by local 
fasciocutaneous flaps as the vascularity of the local tissue is unlikely to be comprised.  High-
energy fractures are more frequently covered by free flaps, especially those around the ankle.    
 
A flap raised from the anterolateral thigh (ALT) was first reported by Song in 1984.242 The 
ALT flap is often used to reconstruct lower limb defects, due to its size, reliability and 
versatility.  The flap is supplied either by perforating branches of the descending or 
transverse branch of the lateral circumflex femoral artery.  The major perforators tend to lie 
End-to-side 
End-to-end 
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on the midpoint of a line between the anterior superior iliac spine and the lateral patella, and 
are identified using Doppler ultrasound.  A fasciocutaneous flap can be raised if adequate 
septocutaneous perforators are present, otherwise a segment of vastus lateralis muscle may be 
included to ensure a sufficient vascular pedicle is attached.  The secondary defect is closed 
directly unless an especially large graft is taken.  The recipient vasculature is dependent on 
fracture location, but in the leg is often based on the posterior tibial vessels. 
 
The incidence of open tibial fractures is approximately 5 per 100,000 person years,161 and 
treatment is ideally focused in regional specialist centres.  Across the major trauma units in 
London, approximately 150 lower limb traumas requiring free flap reconstruction present per 
year (based on 2012 figures from the London Orthoplastic Network).  Free flap failure rates 
vary between centres, flap selection and reconstructed lesions, with most case series reporting 
in the region of 10%.243, 244 The average cost of lower limb reconstruction with free flap is 
£12,000 per case,163 with an additional £45,000 in the remainder of the year.162  
 
Breast reconstruction 
 
Cancer provides the other major source of reconstructive surgery.  Breast cancer accounts for 
23% of all cancers, including 1.38 million new cases per year worldwide.245 Breast 
reconstruction restores breast symmetry after a mastectomy by creating a breast mound that is 
similar in shape, size and contour to the contralateral breast.246 Reconstruction is associated 
with improve body image, quality of life, self confidence and wellbeing, and therefore it is 
unsurprising that breast reconstruction rates increased from 10% to 21% in the last decade.247 
 
Options for breast reconstruction include implants, tissue flaps (pedicled or free), or a 
combination.  Although implant-based reconstructions are relatively low cost and require 
short hospital stay, autologous (flap) reconstructions are reported to provide a more 
consistent and durable reconstruction, with higher long-term satisfaction.248 The abdomen 
provides multiple options for reconstruction due to high tissue availability and locality. The 2 
most common flaps are the Transverse Rectus Abdominis Muscle (TRAM) or Deep Inferior 
Epigastric Perforator (DIEP) flap.  The TRAM flap can be pedicled or free, with the main 
limitation being complications as a consequence of a de-muscularised abdominal wall.  The 
DIEP flap consists of skin and subcutaneous fat only, preserving the rectus abdominis 
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muscle.  Where specialist equipment and personnel are available (and a suitable patient), 
DIEP flap is the preferred reconstructive technique.  The DIEP flap is based on the vessels 
that perforate the rectus abdominis to supply the skin and subcutaneous flat of the abdomen.  
The flap is raised as an ellipse across the inferior abdomen, and transferred to the internal 
thoracic vessels in the chest to reestablish blood supply.  Liposuction can be used to reduce 
the size of the flap to match the contralateral breast size.  Alternatively, contralateral breast 
mammoplasty (reduction augmentation) can be performed to achieve symmetry.  The average 
cost of DIEP breast reconstruction in the UK is £10,910. 
 
 
7.1.2.  Clinical Challenge 
 
Tissue reconstruction following trauma or cancer through free flap transfer generates multiple 
treatment options and provides improving patient outcomes.  However, the cost associated 
with specialist procedures and the rising incidence of breast cancer in our ageing population 
makes it a significant resource demand.  The major challenge is preventing flap failure, and 
recognising flap failure promptly to support successful flap salvage.249  
 
Flap failure not only increases demand economically, but also on the patient’s remaining 
tissue.  The physiological challenge of the primary, and now secondary defects is significant, 
and fewer options exist for further reconstruction.  It is therefore vital that flap success rates, 
and flap salvage rates following flap failure, are maximised.  
 
As previously mentioned, factors such as age, smoking, irradiation, trauma, systemic disease 
and obesity may all affect free flap outcomes and should therefore be considered upon 
developing patient management strategies.  Once the decision to perform a free flap 
reconstruction has been made, the post-operative strategy is the final avenue for optimisation 
of outcomes. 
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Post-operative flap management 
 
The first 48-72 hours post-operatively are when the majority of flap-compromising 
complications occur.  Careful support of patient physiology and flap monitoring occurs 
during this period, with some patients being taken back to theatre for flap exploration and 
salvage.  Complications after 72h are less frequently salvaged, possibly due to reduced 
surveillance or mechanism of failure.250 
 
Some specific efforts are made post-operatively to minimise risk of flap failure.  One of the 
more well known, yet scientifically unjustified, methods is dependency for lower limb flaps.  
This involves a series of controlled ‘danglings’ of the limb over the side of the bed to 
increase blood flow and ‘train’ the flap ready for ambulatory conditions.251 A survey of 
plastic surgeons revealed that the most common protocol for dependency is for 1-5 minutes, 
once a day, after 48h and until discharge.  However there was much variation in opinion, with 
some surgeons abstaining from any limb dependency.252 Further efforts to optimise blood 
flow and patency of the vascular pedicle have been documented including post-operative 
pharmacological regimen,253 and medicinal leech therapy.254 Both may be intensified during 
flap compromise (particularly venous congestion), but neither have been shown to have a 
significant effect on patient outcomes or flap success rates. 
 
The vast majority of related literature is based on flap monitoring strategies, working towards 
early detection of a failing flap in order to increase salvage rates.  The importance of flap 
monitoring is highlighted by the fact that in the US, over 75% of surgeons (consultants) 
personally monitor their flaps, with only half allowing their junior staff to assist.252 Most 
surgeons rely on clinical observation to monitor the flap. 
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Figure 7.2.  Consultant led flap monitoring using clinical signs 
 
Conventional flap monitoring starts immediately post-operatively, and occurs approximately 
every 30 minutes in the first day, reducing to hourly until day 4, when monitoring becomes 
less frequent.  This involves standard examination techniques, starting with inspection of the 
flap for changes in colour.  A pale flap suggests reduced perfusion and may indicate arterial 
occlusion, whereas a deep red flap may indicate venous congestion.  This is investigated 
further be assessing capillary refill, flap turgor (firmness), and temperature.  Some surgeons 
will prick the flap with a needle to examine the bleeding characteristics, though not 
necessarily every 30 minutes.  A common adjunct (enough so to fall under conventional 
monitoring, at 75% 252) is the use of a hand-held Doppler probe to test for the presence of 
blood flow in the pedicle.   
 
Conventional monitoring is resource demanding and somewhat dependent on prior 
experience.  Furthermore, flap changes may be subtle and difficult to identify.  This challenge 
is exaggerated when monitoring personnel are working shifts, as the new staff member may 
not have a thorough knowledge of the flap’s natural history including the healthy baseline 
characteristics.  It is difficult to justify reoperation from subjective clinical findings, yet delay 
is more likely to result in failure to salvage the flap.  A popular mantra is ‘when in doubt, re-
explore’.  The Doppler probe provides more information about the pedicle, yet this can be 
misleading.  Firstly, the operator can’t be certain that the signal they are receiving is from the 
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correct vessel.  Secondly, it is not possible to fully assess venous outflow due to the lower 
pressure and flow rate.  Additionally, it may be that the clinical picture contradicts 
information from the Doppler probe, which may create a management dilemma.  These 
challenges have been addressed with a variety of technologies, of which all are yet to be 
integrated into routine clinical practice.255 
 
 
Figure 7.3.  Nurse assessing a patient’s free flap with a hand-held Doppler probe 
 
 
7.1.3.  New technologies in free flap monitoring 
 
The ideal free flap monitoring device was outlined by Creech and Miller in 1975; ‘It should 
be harmless to patient and flap, rapidly responsive, accurate, reliable, and applicable to all 
types of flap.  Furthermore, it should be equipped with a simple display so that even 
relatively inexperienced personnel can alert the development of circulatory impairments’.256 
 
Temperature can be used to monitor flaps using temperature probes,257 or even simple 
temperature-sensitive tape that change colour upon a change in temperature of 2°C, which is 
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sensitive enough to detect failing flaps.258 However, sufficient temperature changes in large 
flaps may not occur before clinical changes are present.259 
 
Microdialysis for flap monitoring involves the intermittent placement of a specialised 
catheter into the flap using a venous cannula, and sampling the local tissue biochemistry 
across a dialysis membrane.260 Concentration estimates of multiple markers can be made, 
including glucose, lactate, pyruvate, and glycerol.  Rising levels of lactate suggests anaerobic 
respiration and therefore flap ischaemia.261 The sampling protocol is time and resource 
demanding,262 however, the lack of need for a sampling surface (unlike other monitoring 
techniques) makes microdialysis particularly useful for buried flaps. 
 
Another device of value with buried and other flap is the implantable Doppler system.  Rather 
than recording surrogate signs of tissue perfusion, this sensing apparatus directly and 
continuously monitors blood flow through the vascular pedicle (vein or artery).  The sensor 
consists of a silicon cuff that is surgical wrapped around the vessel intraoperatively, and an 
ultrasonic Doppler crystal connected to the cuff on a wire than exits the body through the skin 
wound.263 The device is connected to a portable monitor that transmits an audible venous 
signal for the healthcare staff and patient.  The crystal is ejected from the cuff atraumatically 
following use by pulling the wire; a process which, as well as cuff placement, has reportedly 
high safety rates.  
 
A variation on implantable Doppler is Laser Flowmetry, which in contrast provides a non-
invasive assessment of tissue perfusion from the skin surface.264 A probe both emits and 
collects light from the tissue, analysing any frequency shift as a result of moving cells within 
the tissue.  Although individual readings may be devalued by motion artifact or sensor 
malposition, trends in longitudinal data may provide information regarding tissue perfusion 
status.  Similarly, colour duplex sonography can combine blood flow speed, with flow 
direction (velocity) to assess anastomotic patency.265 
 
Near-Infrared Spectroscopy (NIRS) is another non-invasive tissue sampling technique, which 
provides estimates of tissue oxygenation and capillary blood volumes.  The difference in 
absorption properties of oxy- and deoxy-haemoglobin for red and infrared light allow 
inference of oxygenation from backscattered light detected at a photodiode.  NIRS provides 
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early signs of flap failure from any aetiology, allowing high flap salvage rates.266 Multiple 
studies have shown both positive and negative predictive values of 100% using this 
monitoring modality.266-268 One retrospective study of 128 free flaps showed an improvement 
in success rates of almost 10% when NIRS was added to conventional monitoring, which 
included handheld Doppler (98.7% vs. 90.6%, p = 0.05).  This was mostly due to the high 
flap salvage rate (87.5%, 6/7) with NIRS compared to the conventional monitoring group 
(0%, 0/5).269 
 
 
Summary of monitoring techniques 
 
All of the above techniques have been reported to detect flap failure in advance of 
conventional monitoring methods.  NIRS and flowmetry are the least invasive, though 
consequently they are unable to monitor flaps without a visible surface.  Implantable Doppler 
doesn’t require large upfront costs, and can be added to a case without significant training 
(although placement is likely to influence results).  There have however been some reports of 
low positive predictive values for flap failure in case series whereby the device was 
monitoring the vein or artery, which may cast some doubts.270 Microdialysis is not 
continuous and requires intermittent sample collection which is technically challenging, time 
demanding and expensive.   
 
The majority of the literature focuses on reporting the feasibility or safety of devices, rather 
than evaluating cost-effectiveness through comparative studies.  A single cost effectiveness 
analysis, based on data from studies where the implantable Doppler was used, showed that 
with a mean flap salvage rate 21% higher (81.4 vs.s 60.4%) it’s use would prevent 
reoperation in 2 out of every 100 cases (increased to 4 in buried flaps).    
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Table 7.1.  Modified with permission from ‘Advances in flap monitoring techniques’, Smit el al 
(2010) 255 
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The cost of using the implantable Doppler (£300) for 100 cases would be mostly recovered 
by avoiding the 2 revision surgeries.  In the case of buried flaps, a reduction of 4 revision 
surgeries would lead to a saving of £125 per patient.271 
 
From the comparative data available regarding the use of NIRS, approximately 10% of flaps 
fail, and of those, NIRS resulted in an 87.5% salvage rate vs. 0% using conventional 
monitoring techniques.  If each operation costs £11,000 (initial or redo), losing 10 flaps out of 
100 cases would cost the hospital approximately £110,000.  Should the use of NIRS increase 
the rate of flap salvage to 87.5%, only 1 case would need to be redone, costing £11,000.  This 
saving of £99,000 should be off-set against the cost of using NIRS in 100 cases, which is 
approximately £100 per case (after purchasing the monitoring equipment), and therefore 
£10,000 total.  This hypothetically would give cost savings of £89,000 per 100 cases (£890 
per case). 
 
In practice, flap failure and salvage rates differ considerably between units, which would 
underpin the cost-effectiveness of additional flap monitoring techniques.  Should the 
implementation of a technique be such that the cost-effectiveness was neutral (as it may be in 
a specialist centre), other gains should be highlighted.  For the patient, this may mean the 
avoidance of further surgery, tissue loss, and the stress on top of the current scenario of 
cancer or trauma.  For the surgeon, continuous monitoring with data transmission may 
provide peace of mind after hours, and might lead to more challenging cases being attempted.   
 
Challenges remaining include minimising costs (particularly up-front expenditure), 
equipment size, providing an easy-to-interpret display, and facilitating access to flap data 
remotely. 
 
 
Hypothesis 
 
A miniaturised, low-power NIRS device is capable of detecting pulsatile blood flow and 
quantifying changes in tissue oxygenation. 
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7.2.  Methods 
 
7.2.1.  Outline 
A miniature wireless sensor was developed to continuously monitor the oxygenation of tissue 
samples.  A free flap failure model was designed using a pressure cuff protocol on the upper 
limb of healthy subjects.  Twenty subjects were recruited and underwent the cuff protocol 
whilst the superficial forearm vasculature was monitored.  Monitoring was conducted using 
the optical sensor and the current ‘gold standard’ combined photo spectrometer and laser 
Doppler equipment (O2C, Medizintecknik, LEA, Germany) simultaneously.  Comparisons in 
response to incremental cuff inflations were made to assess the validity of optical sensor data. 
 
 
7.2.2.  Development of optical sensor 
(Hardware development by Dr Ching-Mei Chen of the Hamlyn Centre, Imperial College 
London) 
 
A bespoke flap monitoring sensor was developed to meet the following requirements: 
 
• Provision of regular tissue oxygenation readings, preferably indicating the presence or 
absence of pulsatile blood flow 
• Minimal footprint to allow placement on the flap without disturbing the skin wound, 
or being obstructed by in situ fracture fixation frames 
• Battery life (or charging/replacement function) conducive to 24-hour monitoring over 
3-5 days 
• Wireless connectivity with other monitoring devices, capable of transmitting to secure 
smartphone application, or at a minimum the central station of the ward 
• Long-term data storage, data trend analysis, and critical tissue oxygenation alert 
 
 
Tissue oxygenation principals 
 
Flap viability requires adequate blood flow into and out of the flap.  This requires both patent 
vasculature, and limited external compressive forces on the transplanted tissue.  Tissue 
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oxygen saturation (StO2) represents the ratio of oxygenated haemoglobin to total 
haemoglobin in the microvasculature of the tissue.  This is an ideal metric for assessment of 
free flaps as it is sensitive to changes in local conditions, and doesn’t require pulsatile blood 
flow, unlike pulse oximetry (SpO2), which measures the systemic oxygen saturation of 
arterial blood.  
 
In most circumstances there is only 1 surface of the flap to interrogate.  As such, the sensor 
must emit and survey light on the same sensor plane.  Red and infra-red LEDs emit light from 
the skin-surface of the sensor, a proportion of which is backscattered (diffuse reflection) and 
measured at the photodiode situated close to the LEDs.  The difference in absorption 
properties of oxy- and deoxy-haemoglobin for red and infra-red light allow inference of StO2 
from light detected at the photodiode using equation: 
 
StO2 = 100%  X  HbO2 / (HbO2 + Hb) 
 
 
 
Figure 7.4.  Absorption spectra for oxy- (HbO2) and deoxy-haemoglobin (Hb), and are opposite for 
red and IR light. 
 
The PCB (Printed Circuit Board) dimension of the sensor is 19.6x12.4x0.8mm, and includes 
2 light emitting diodes (LEDs): red (660nm), and infrared (940nm).  The sensor also contains 
a photodiode (PD) that captures light at up to 1kHz sampling frequency.  
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Figure 7.5.  Optical sensor platform and functional schematic of on-board electronics 
 
 
Gold standard comparator – Oxygen-to-See machine (O2C) 
 
The O2C consists of a computer and wired probe, mounted on a portable trolley with 
approximately 1m2 footprint, and weighing in excess of 70Kg.  O2C software allows 
construction of bespoke tissue monitoring protocols, which may include alerts when values 
cross pre-defined thresholds during clinical application.  A simple continuous monitoring 
protocol is suitable for research applications, such as comparative studies. 
 
12.4mm&
19.6mm&
LED& &PD&
LEDs& &PD&
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Similar to the optical sensor, the O2C measures microvasculature oxygen saturation using 
backscattered spectrophotometry.  White light is emitted from the sensor probe using a glass 
fibre probe.  The backscattered light spectrum is measured over a 500-630nm range through 
the same glass fibre probe.  Haemoglobin and oxyhaemoglobin are the main absorbers of 
light, and by fitting measured spectra with spectra of known oxygen saturation, the oxygen 
saturation of the microvasculature can be calculated.272 The measurement mainly reflects 
vessels < 100μm as light entering larger vessels is completely absorbed.273 Further, 
considering a majority of blood is pooled in the venous microvasculature, spectrophotometry 
measurements mainly reflect venous oxygen saturation.  The tissue is sampled at 2 different 
depths, facilitated by 2 distinct groups of PDs on the probe.  The PDs closest to the light 
source main capture light reflected from 3mm depth (superficial), whilst the PDs furthest 
away capture lighted reflected from 7mm depth (deep).  The superficial measurements 
largely represent the dermis of the skin, whereas the deep measurements tend to reflect the 
intramuscular region or hypodermis, depending on the thickness of the local subcutaneous 
fat. 
 
 
 
Figure 7.6.  Skin layers and approximate thickness 
 
 
The probe also contains an integrated laser-doppler flowmeter.  Tissue is illuminated with 
coherent laser light at 830nm and 30mW of a laser diode through a fibre-optic light guide.  
EPIDERMIS!
DERMIS!
HYPODERMIS!
INTRAMUSCULAR!
LAYER! THICKNESS (MM)!
0.05 – 0.2!
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3.0 - 100!
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The same probe collects backscattered light, and frequency-shifted light is extracted by a 
heterodyne light-beating technique.  The power-spectral density of shifted light is a linear 
function of the average velocity of moving cells within the tissue.274 
 
 
 
Figure 7.7.  O2C (Oxygen to see, Medizintechnik, LEA, Germany) probe (left) and display (right) 
 
 
Summary of O2C metrics: 
• Oxygen saturation (StO2) (spectrophotometry) – capillary venous oxygen saturation, 
indicative of local tissue hypoxia 
• Relative Haemoglobin (rHb) (spectrophotometry) – amount of haemoglobin in tissue, 
or the filling of the microvasculature, useful in diagnosis of venous congestion  
• Flow (laser Doppler) – shows volume flow in relative units, indicating hypo- or 
hyperperfusion 
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O2C Fields of application 
 
The O2C has been implemented in numerous clinical applications and research protocols.  
This includes investigating tumour biology,275 pathophysiology in the critical care setting,276 
musculoskeletal and sports medicine,277 and wound healing processes.278 Another well-suited 
application is free tissue transplant monitoring.  The O2C provides continuous tissue viability 
measurements, as well as indications of mechanism of flap failure through flow and rHB 
metrics.  For example, a deoxygenated flap failing due to venous congestion will exhibit 
rising rHB levels, unlike in the setting of arterial occlusion which will see rHb fall. 
 
 
Table 7.2.  O2C metrics during different flap conditions 
 Oxygen saturation Relative Haemoglobin Blood Flow 
Healthy flap ++++ ++ ++++ 
Venous congestion + ++++ ++ 
Arterial occlusion + + + 
 
 
 
7.2.3.  Flap simulation protocol 
 
In the absence of a validated flap failure model, the O2C was used to develop a protocol that 
would produce consistent, incremental changes in tissue oxygenation.  The forearm was 
decidedly an acceptable and practical location for sensor placement, allowing change of 
position and potentially the addition of a standard brachial pressure cuff.  Based on previous 
work in the Department of Plastic and Reconstructive Surgery at Imperial College Healthcare 
NHS Trust,279 a combined arm placement and tourniquet protocol was developed.  
Positioning the arm at 0, 90 and 180 degrees causes changes in blood flow, however on close 
assessment of study data it was made apparent that changes in oxygenation are minor and 
inconsistent.  As reliable oxygenation changes were required, this part of the protocol was 
removed.  
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Preliminary data collection 
 
A small sample data set was collected using pressure cuff inflations.  The cuff was 
sequentially inflated to sub-diastolic (SD) pressures to prevent venous return and, after 
normalisation of metrics, supra-systolic pressures (SS) to occlude arterial blood delivery. 
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Figure 7.8.  Preliminary data from O2C monitoring the forearm under cuff inflation conditions (from 
top: oxygen saturation, relative haemoglobin, blood flow). Sup and deep = superficial (3mm), deep 
(7mm) measures (function of the dual probe photodiodes at difference distances from the light source)   
Sub-systolic!
cuff!
Supra-systolic!
cuff!
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Preliminary data provided important information that would be used to finalise the study 
protocol.  It appeared particularly for oxygenation that superficial metrics were more reactive 
to cuff inflations than deep measurements, making it a more ideal comparator for the study.  
Also, during SS inflation, oxygenation decreased linearly before beginning to plateau at low 
levels.  This predictable change would allow incremental decreases in oxygenation upon 
incremental increases in SS inflation duration.  This might facilitate quantitative validation of 
the optical sensor oxygenation prediction, beyond recognition of simple desaturations 
(decreasing oxygenation).  Similar pressure cuff protocols have been used previously to 
induce forearm ischaemia,280 providing a reliable, non-animal trial flap failure model. 
 
 
Evaluation of final protocol 
 
The pressure cuff protocol facilitated repeatable, graduated changes in tissue oxygenation as 
shown by the reference measurement from the O2C machine.  The mechanism of change of 
oxygenation was explained and reinforced by the laser Doppler estimation of blood flow, 
which followed the anticipated motif. 
 
 
Figure 7.9.  O2C metrics from final pressure cuff protocol showing reproducible, incremental changes 
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Table 7.3.  Final pressure cuff protocol 
Phase Cuff pressure (mmHg) Duration (s) 
Stabilisation 0 Variable 
SD-150 60 150 
SS-30 180 30 
SS-60 180 60 
SS-90 180 90 
SS-120 180 120 
SS-150 180 150 
Sub-diastolic (SD), supra-systolic (SS) 
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7.2.4.  Conducting laboratory trial 
 
Ethical approval 
 
Before starting collecting data from healthy subjects, ethical approval was granted from the 
research ethics committee using the Integrated Research Application System (IRAS).  Ethical 
approval for the ESPRIT programme was granted in December 2010 (ref: 10/H0808/124) by 
NHS South East London Research Ethics Committee 3.  
 
Recruitment and eligibility 
 
Twenty healthy adult subjects were recruited between April 2013 and November 2013.  The 
only predefined exclusion criteria was aged over 65, however, each subject was interviewed 
by a medical doctor to assess the effect of any previous or current medical conditions on their 
participation.  The decline in autonomic function and therefore vascular response warranted 
exclusion of those aged over 65.   
 
All subjects were given an information sheet and the opportunity to ask any questions.  Due 
to the relatively benign nature of the study, a 24h consideration period was not enforced, 
however subjects were welcome to take time to decide whether or not to participate.  Upon 
agreement to participate, written consent was taken by the researcher. 
 
Experimental set up 
 
Each subject was sat with their left arm resting pronated on a table at chest height.  
Participants were asked to expose their arm distal to the elbow.  Pushing or rolling up long 
sleeved clothing was permitted so long as the material was loose around the upper arm.  A 
manually operated brachial pressure cuff was placed on the upper arm.  The optical sensor 
and O2C probe were placed on the extensor surface of the mid-forearm parallel to each other 
in the longitudinal axis.  During placement, care was taken to avoid visible or palpable 
superficial vasculature (particularly the cephalic vein), whilst maintaining maximum distance 
between the sensors to minimise ‘cross talk’ from sensor light sources.  An opaque adhesive 
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dressing was used to stabilise the sensor placement and control the ambient light conditions.  
Room temperature was controlled at 21°C.  
 
 
Figure 7.10.  Experimental setup – both sensors are placed on the extensor surface of the forearm and 
fixed using opaque adhesive tape.  The blood pressure cuff is in situ on the upper arm, and the hand 
and forearm are resting comfortably and horizontally on the table at chest height. 
 
The flat LF-2 O2C probe was connected to a PC running a standard monitoring protocol on 
the O2C software (Oxygen to see, Medizintecknik, LEA, Germany).  The optical sensor was 
wired via USB to a PC laptop running bespoke software.  Both software packages allowed 
real-time data interrogation and estimation of tissue oxygen saturation, facilitating sensor 
repositioning and/or repeated cuff inflations upon artifactual measurements (following 
ambient light calibration). 
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A 1-2 minute data stabilisation phase was conducted upon initiating data collection, before 
commencing the cuff inflation protocol.  Stabilisation (not necessarily return to baseline) of 
metrics was observed before subsequent cuff inflations and upon completion.  
 
Data processing 
 
Data from the O2C were exported to a csv file containing a timestamp, and values for 
superficial oxygenation, relative haemoglobin and blood flow.  Red and infra-red values from 
the optical sensor were used to calculate an oxygenation value.  This was downsampled from 
1KHz to 1Hz to match O2C data format.  The 2 datasets were aligned using the data 
timestamp, and manually realigned according to consistent data trends.  Baseline parameters 
from both sensors, as well as changes during the cuff inflation protocol, were tabulated and 
prepared for statistical analysis. 
 
 
7.2.5.  Statistical analysis 
 
The correlation of optical sensor oxygenation measurements to that of the ‘gold standard’ 
O2C was assessed to determine the extent of concurrency.  Data from O2C and optical 
sensors were plotted against each other to determine the nature of the relationship.  In the 
case of monotonic distribution, Pearson of Spearman’s Rank correlations were appropriate.  
Deciding which correlation depended on whether a linear or polynomial line of best fit gave 
the highest R2 value.  Due to data being monotonic and polynomially distributed, Spearman’s 
Rho correlation coefficients were calculated for both general data trends, as well as tissue 
changes during the cuff inflation protocol for each subject.   
 
Pre- and post-protocol metrics were compared using Wilcoxon signed-rank tests.  For 
comparisons regarding samples considered independent, Mann-Whitney U tests were 
implemented. 
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7.3.  Pilot study results 
 
Five subjects were initially recruited to allow further evaluation of the protocol and sensor 
function.  Oxygen saturation values from the O2C machine and our optical sensor showed 
similar trends.  Internal validity of the optical sensor was demonstrated by a strong positive 
correlation between O2C and optical sensor oxygenation values (average Spearman’s Rho = 
0.672, p < 0.001).  External validity was also shown by consistent correlation in each subject, 
whereby the poorest correlation was still strong (R = 0.536, p < 0.001). 
 
 
Figure 7.11.  Comparative oxygenation estimates from the optical sensor and O2C in 5 subjects 
undergoing the 30 minute pressure cuff protocol.   
!"#
!$#
%"#
%$#
&"#
&$#
"#
!"#
%"#
&"#
'"#
$"#
("#
)"#
*"#
!# &"!# ("!# +"!# !%"!# !$"!# !*"!#
!"#
!!#
!$#
!%#
!&#
'"#
'!#
'$#
'%#
'&#
$"#
"#
("#
!"#
'"#
$"#
)"#
%"#
*"#
(# '"(# %"(# +"(# (!"(# ()"(# (&"(# !("(# !$"(# !*"(#
!"#
!$#
$"#
$$#
%"#
%$#
&"#
&$#
'"#
("#
)"#
!"#
$"#
%"#
&"#
*"#
+"#
'# )"'# %"'# +"'# '("'# '$"'# '*"'# ('"'# (!"'#
!"#
$%#
$$#
$&#
$'#
$"#
(%#
($#
(&#
('#
("#
%#
!%#
$%#
(%#
&%#
)%#
'%#
*%#
!# (%!# '%!# +%!# !$%!# !)%!#
!"#
$"#
%"#
&"#
'"#
("#
)"#
"#
*"#
!"#
$"#
%"#
&"#
'"#
("#
)"#
*# $"*# '"*# +"*# *!"*#
OPTICAL 
O2C 
 !
! 240 
 
Figure 7.12.  Comparative oxygenation data from optical sensor and O2C for 1 patient demonstrates 
concurrent validity in measurements. 
 
 
Table 7.4.  Spearman’s rho correlation coefficients for pilot subjects 
Subject Spearman’s Rho p 
1 0.745 < 0.001 
2 0.536 < 0.001 
3 0.695 < 0.001 
4 0.705 < 0.001 
5 0.680 < 0.001 
Average 0.672  
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Tissue changes during cuff inflation protocol 
 
NB – % Change = Change / Baseline  
 
Oxygen Saturation 
 
Table 7.5.  Oxygenation saturation changes during cuff inflation protocol (O2C) 
 
 
 
Table 7.6.  Oxygenation saturation changes during cuff inflation protocol (Optical sensor) 
 
 
 
Baseline oxygenation levels varied considerably between subjects.  Cuff inflation resulted in 
a reduction in oxygenation of the forearm.  The relative changes in oxygenation were 
proportional to the duration of cuff inflation, appearing to have a linear relationship with 
time.  Oxygenation change was significantly less during SD-150 compared to SS-150 from 
the O2C, but not so with optical sensor measurements.  Reflex hyper-oxygenation occurred 
following cuff deflation, likely due to increased oxygenated blood flow. 
 
Comparison of relative changes in tissue oxygenation during the cuff inflation protocol 
showed a moderate correlation between O2C and optical sensor results which, within the 
pilot cohort, reached statistical significance (Spearman’s Rho = 0.432, p = 0.022). 
SO2
Subject Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch
1 42 26 58 17 37 19 46 26 59 28 65 26 72 41
2 68 25 37 15 24 24 36 32 47 41 59 51 76 65
3 25 13 52 7 25 15 50 24 71 24 83 26 81 39
4 40 20 50 15 36 25 52 31 66 33 66 37 82 42
5 29 11 62 17 57 23 70 30 100 33 100 31 100 32
Average 40.8 19.0 51.8 14.2 35.8 21.2 50.8 28.6 68.6 31.8 74.6 34.2 82.2 43.8
Baseline Post
SDC150 SSC30 SSC60 SSC90 SSC120 SSC150
SO2
Subject Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch
1 31 8.3 27 n/a n/a 5.8 18 6.6 21 9.7 30 11.2 34 33
2 57 12 21 6.3 11 7.1 13 7.5 14 10 17 17 24 70
3 29 6 21 1.1 4 2.4 8 2.8 10 3.1 10 3.6 12 31
4 24 8.5 35 1.2 5 2.3 9 3.8 15 5.6 21 9.1 26 26
5 43 18 42 7 16 9.8 21 13.8 32 14.6 30 n/a n/a 45
Average 36.8 10.6 29.2 3.9 9.0 5.5 13.8 6.9 18.4 8.6 21.6 10.2 24.0 41.0
SS>150
PostBaseline
SD>150 SS>30 SS>60 SS>90 SS>120
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Figure 7.13.  Percentage reduction in tissue oxygenation values during cuff inflation protocol for 
optical sensor and O2C 
 
Other O2C metrics 
 
Relative Haemoglobin 
 
Table 7.7.  Relative rHb elevations during cuff inflation protocol (O2C) 
 
 
During D-150, relative haemoglobin increased significantly as a result of venous congestion.  
Erythema of the hand and forearm was visible, as well as prominent superficial vasculature.  
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rHb
Subject Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch
1 59 12 21 8 13 55 58 55 58 n/a n/a n/a n/a 64
2 59 23 28 5 9 5 8 7 12 8 13 5 8 60
3 71 15 21 1 1 2 1 3 2 2 1 2 1 71
4 60 25 42 4 6 9 15 10 16 7 12 11 21 54
5 46 25 54 8 15 4 8 5 13 6 14 4 9 46
Average 59.0 20.0 33.2 5.2 8.8 3.0 4.8 4.0 7.0 5.8 10.0 5.5 9.8 59.0
Baseline Post
SD5150 SS530 SS560 SS590 SS5120 SS5150
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During systolic cuff inflation, small increases were seen in relative haemoglobin, including 
an additional peak on cuff deflation.  Response did not seem to be duration dependent.  
 
Blood Flow 
 
Table 7.8.  Relative blood flow changes during cuff inflation protocol (O2C) 
 
 
Baseline blood flow varied between subjects considerably.  Cuff inflation led to a reduction 
in blood flow to the forearm by almost 100%.  During all SS-phases, blood flow was reduced 
to near 0 within approximately 20 seconds following cuff inflation.  During SD-150, the 
reduction in blood flow was slower as the arterial flow was not occluded, but the venous 
outflow was obstructed.  Following cuff deflation, blood flow returned with a reactive 
hyperaemia, except following SD-150. 
 
 
Figure 7.14.  Hand and forearm appearance during sub-diastolic inflation (left) and supra-systolic 
inflation (right).  The skin is far more congested when just the venous return is obstructed, similar to a 
congested free flap. 
Flow
Subject Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch Change %.Ch
1 25 22 88 19 100 17 100 20 95 21 95 14 93 27
2 18 17 94 8 100 12 100 10 91 19 100 18 100 17
3 6 4 80 7 100 9 100 7 100 8 100 6 100 11
4 20 19 95 14 100 24 100 26 97 24 100 26 100 22
5 29 11 62 17 57 23 70 30 100 33 100 31 100 32
Average 19.6 14.6 83.8 13.0 91.4 17.0 94.0 18.6 96.6 21.0 99.0 19.0 98.6 21.8
Baseline Post
SDC150 SSC30 SSC60 SSC90 SSC120 SSC150
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Deoxygenation curves 
 
It appeared from pilot data that the shape of deoxygenation curves seen during SS cuff 
inflation showed inter-subject variation.  Some subjects exhibited ‘sharp’ troughs, i.e. 
deoxygenation is linear until cuff deflation, followed by immediate re-oxygenation, whereas 
others were ‘softer’ with an apparent plateau before cuff deflation.  This pattern was mirrored 
in both optical and O2C datasets. 
 
 
 
Figure 7.15.  Inter-subject variation in deoxygenation curves during cuff inflation are consistent for 
both optical and O2C measurements. 
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7.3.1. Post-pilot modifications 
 
The experimental setup and cuff protocol provided data for sensor validation purposes.  One 
change recommended was the amendment of LED wavelengths in order to reduce 
measurement errors at lower oxygen saturations.  Numerical modeling and animal testing 
have both shown that sensors fabricated with 735 and 890nm LEDs are more accurate than 
the conventional wavelengths of 660 and 940nm at lower oxygen saturations.281 To optimise 
the sensor for the purpose of the application (detecting desaturation of tissue flaps), the red 
and infra-red LEDs were changed to 740nm and 880nm.  This change also provides the 
advantage of minimising tissue sampling heterogeneity as lights at closer wavelengths share 
more similar tissue penetration characteristics.  
 
Further recruitment and data collection began using previously described protocols (7.2.4). 
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7.4.  Results 
 
7.4.1.  Study participants 
 
In November 2013, 15 further healthy subjects were recruited.  All subjects followed the 
previously described protocol including informed consent and a series of cuff inflations.  
However, a 2nd version of the optical sensor was implemented as described above.  The 
average age of the subjects was 26, ranging from 24 to 44. 
 
 
 
Figure 7.16.  Project flow diagram 
 
 !  
Pilot study 
 
•  5 subjects 
•  Evaluate protocol 
•  Assess optical sensor 
response 
Validation study 
 
•  15 subjects 
•  Evaluate concurrency 
between optical sensor 
and O2C 
Amendment of optical 
sensor design 
Protocol development 
 
•  Investigate effect of arm 
position and cuff on O2C 
metrics 
•  Optimise sensor placement 
Remove arm position changes.  
Add incremental inflations 
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7.4.2.  Main Findings 
 
Tissue Oxygenation 
 
Oxygen saturation values from the O2C machine and our optical sensor showed similar 
trends during the cuff inflation protocol.  The correlations between O2C and optical sensor 
oxygenation measurements were moderate to strong, and statistically significant for all 15 
subjects, with Spearman’s rho values ranging from 0.418 to 0.862; with an average of 0.672 
(p < 0.001).  (Figure 6.17) 
 
 
Figure 7.17.  Comparative oxygenation data from optical sensor and O2C during the pressure cuff 
protocol demonstrates concurrent validity 
 
Baseline tissue oxygenation estimations from O2C and optical sensors correlated strongly (R 
= 0.915, p < 0.001).  During the pressure cuff protocol baseline oxygenation values increased 
significantly, with O2C rising from 37.0 to 43.1 (p = 0.03) and optical rising from 36.5 to 
46.1 (p = 0.002).  Post-protocol baseline oxygenation values saw the correlation between 
O2C and optical sensors retained (R = 0.813, p = 0.001).  
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Figure 7.18.  Oxygenation measurements showing a rising baseline throughout cuff inflation protocol 
in both sensors. 
 
Incremental increases in cuff inflation duration resulted in a linear increase in deoxygenation 
values with both O2C and optical sensors.  There was a significant difference in the extent of 
deoxygenation between consecutive cuff inflations with both sensors (p < 0.005). 
 
 
Table 7.9.  Oxygenation saturation changes during cuff inflation protocol 
 SS-30 p SS-60 p SS-90 p SS-120 p SS-150 
O2C  
Mean (SD) 
36.9 
(9.80) 
0.001 55.5 
(5.8) 
0.001 67.5 
(4.0) 
0.003 76.5 
(6.8) 
0.005 82.2 
(7.7) 
Optical 
Mean (SD) 
6.77 
(2.33) 
0.002 10.15 
(2.73) 
0.001 12.96 
(2.96) 
0.004 15.82 
(3.50) 
0.004 18.10 
(3.23) 
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Figure 7.19.  Percentage reduction in tissue oxygenation values during cuff inflation protocol for 
optical sensor and O2C  
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O2C rHB and flow data trends 
 
Relative haemoglobin changes were similar during all SS inflations.  The increase in relative 
haemoglobin during SD-150 was significantly greater than during SS-150 (27.1 vs. 9.3, p = 
0.001).  There was no change in net rHB (63.6 vs. 62.6, p = 0.232).  Reduction in blood flow 
during all SS inflations, apart from SS-30, was close to 100%.   In comparison, SD-150 
showed significantly less reduction in blood flow (74.4% vs. 98.6%, p < 0.001).   There was 
no difference in baseline and post blood flow (11.2 vs. 11.7, p = 0.323). 
 
Table 7.10.  Relative haemoglobin and blood flow changes during the cuff inflation protocol 
 
 
 
Figure 7.20.  Relative haemoglobin changes during cuff protocol as measured by the O2C.  During the 
sub-diastolic inflation, the rHb increases as the forearm becomes congested, whereas minimal change 
is recorded for suprasystolic inflation. 
SD#150 SS#30 SS#60 SS#90 SS#120 SS#150
rHb 63.6/(5.8) 27.1/(11.3) 6.0/(2.6) 7.4/(2.7) 8.9/(3.5) 8.9/(3.3) 9.3/(4.0) 62.6/(6.7)
Flow 11.2/(7.1) 74.4/(9.9) 92.3/(7.6) 96.5/(5.8) 98.3/(3.2) 98.1/(3.8) 98.6/(3.0) 11.7/(7.5)
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Figure 7.21.  Blood flow reduction during cuff protocol as measured by the O2C.  During sub-
diastolic inflation the vascular congestion and compression of smaller arteries reduces blood flow, but 
there is still measurable pulsatile blood flow. 
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Detection of pulsatile blood flow 
 
At rest, the alternating component of the sensor signal showed variation of approximately 
0.03, caused by pulsatile blood flow.  Upon inflating the cuff, the variation was reduced to 
less than 0.01, reflecting absence of pulsatile flow (also visible from the raw signal trace).  
The original signal resumed following cuff deflation.  
 
 
 
Figure 7.22.  Presence of pulsatile flow detected by optical sensor during supra-systolic cuff inflation 
(40-second sample, variation calculated over 2 second window).  X-axis is time represented by 
samples (100Hz), and y-axis is derived from raw photodiode data (arbitrary). 
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7.5.  Discussion 
 
This chapter provides the rationale and preliminary validation results for a miniaturised flap 
monitoring sensor.  The results demonstrate how this bespoke sensor was able to detect and 
quantify changes in tissue oxygenation, as compared with the current gold standard 
equipment (O2C).  Concurrency was seen in 20 subjects of different gender, age and skin 
colour, proving external (in addition to internal) validity.   
 
Changes in tissue oxygenation were brought about by a pressure cuff model, designed to 
simulate flap failure conditions.  Supplementary to oxygenation values, the O2C provided 
measurements of relative haemoglobin (rHb) and blood flow within sampled tissue.  Relative 
values of the 3 available measurements have previously been shown to detect and 
characterise flap failure mechanisms, including distinguishing between venous or arterial 
aetiologies.  This allowed the pressure cuff protocol to be evaluated with regards to the 
similarity with which it simulated flap failure.  The arterial occlusion model, simulated by 
supra-systolic (SS) cuff inflation caused a triad of rapidly decreasing tissue oxygenation, 
slightly elevated rHb and complete cessation of blood flow.  Conversely, the venous 
congestion model, simulated by sub-diastolic (SD) cuff inflation, caused a more slowly 
decreasing tissue oxygenation, significantly elevated rHb and a reduced, yet present, blood 
flow.  These changes are close to expected, apart from the raised rHB in the SS model, which 
is discussed later.  Furthermore, the appearance of the superficial tissue distal to the cuff 
bared similarity to flap changes during the SS and SD cuff inflations, as shown in Figure 
7.14.  In summary, the cuff protocol was consistent, clinically representative, and provided 
the ideal model for validating the sensor.   
 
The study also met the secondary aim of detecting pulsatile blood flow.  This feature 
complements tissue oxygenation measurements by suggesting mechanism of deoxygenation, 
differentiating between arterial and venous occlusion or congestion, acting as a substitute for 
the O2C rHB and flow measurements. 
 
The results of this study support the theory that a miniaturised sensor could be used to detect 
failing flaps.  There is already evidence whereby similar technologies have been used in 
clinical trials to accelerate the detection of flap failure, and consequently enhanced flap 
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salvage rates.269 This sensor provides comparative tissue oxygenation measurements as O2C 
in a miniature wearable device, without the need for bedside equipment, and potentially is 
fully wireless.  The advantages this sensor boasts are plenty.  The currently available flap 
monitoring equipment requires both a wired probe, and an expensive bedside unit.  The new 
sensor does not require this bedside unit, which reduces upfront equipment costs, and 
improves the access of flap monitoring in smaller centres, or those with multiple 
simultaneous free flap cases.  The sensor can remain in place whilst the patient is mobilising 
on the ward, or during flap training protocols (dependency).  Theoretically, there is minimal 
risk of surgical site contamination or additional cables interfering with the patient due to the 
wireless design.   
 
As demonstrated by other sensors based on the BSN architecture, this device not only 
monitors flap oxygenation, but may also provide a continuous data stream to appropriate staff 
members at remote locations.  This gives rise to opportunities including push notifications to 
surgeons to recommend inspection of the flap, or overnight data feeds to relieve the on-call 
team from regular inspections of the flap and disrupting the patient.  This could be 
implemented through a secure phone application or web page.  In addition to accessing real-
time oxygenation measurements, all data collected for each case will be available to the 
surgeon, facilitating trend analysis.  This may provide answers to other questions regarding 
flap design, such as vein : flap size requirements, and how far the flap can be pushed through 
early post-operative training regimes without inducing failure.   
 
Free flap case series often report success rates of above 90%,255 with some specialist centres 
boasting close to 100%, with excellent salvage rates.  Cost-effectiveness figures from Poder 
et al, in which implantable Doppler technology was used to improve flap salvage rates, made 
the case that the cost of disposable monitoring equipment need be reduced from £300 to £200 
in standard cases to become cost-neutral.  Similar calculations from NIRS monitoring 
techniques predict much greater savings, should the service be available for less than £890 
per patient.  Specialist centres, including the extremity reconstruction unit at Imperial College 
Healthcare NHS Trust, often have large case volumes and expert surgical teams, resulting in 
the highest standards of flap design, anastomosis and post-operative care.  In such settings, 
generating a cost-effective model with net savings using improved free-flap surveillance 
technologies is difficult.  These centres may find alternate benefits from this technology, for 
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example, the safety net that high salvage rates provides might permit surgeons to complete 
higher risk reconstructions when amputation seems imminent.  Furthermore, surgeons might 
feel more comfortable allowing trainees to become more involved in microvascular 
anatomoses, widening teaching opportunities. 
 
Interpretation of the results must be conducted in the context of the limitations in study 
design.  Although the pressure cuff model was evaluated positively, it remains a model and 
therefore it is the simulation, rather than a failing flap in which the sensor was validated.  
Two weaknesses in the model were the rate of deoxygenation, and the elevated rHb on SS 
inflations.  The model created an ‘all-or-nothing’ scenario, in which the vessel went from 
patent to occluded in both arterial and venous simulations.  The result was rapid 
deoxygenation, easily detect by both sensors.  While this served its purpose for validation, 
slower, and possibly fluctuating oxygenation levels caused by a transiently obstructed vessel 
or an expanding haematoma exerting external compressive forces may not be detected with 
as much confidence.  Also, the forearm model has an intact autonomic nervous system 
allowing some vascular reactivity, which would be less pronounced in a free flap, relying on 
local mechanisms only.  Furthermore, relative oxygenation changes from the O2C were 
bigger, with a proportionally smaller standard deviation compared to the optical sensor.  
Whilst the low power design may make the optical sensor less sensitive to changes, the 
deoxygenation episodes were still reliable and quantitative.  As such, a balance must be 
struck between use of power for signal amplification to improve response, and power 
conservation to optimise battery life. 
 
Regarding elevated rHb on SS inflations, it was hypothesised that the time taken to manually 
inflate the cuff (c.15 seconds) may have created a brief period of venous occlusion with 
arterial patency, causing the elevation.  The extent of the elevation was significantly less than 
that of the SD inflation, maintaining a distinction between the simulations. 
 
One anticipated phenomenon occurring throughout the cuff protocol was a slowly rising 
baseline after successive inflations.  This was more apparent from the optical sensor data, but 
present (visible and statistically) in O2C data as well.  The ischaemia simulation prevents the 
forearm from aerobic production of adenosine triphosphate (ATP), resulting in a cellular 
switch to anaerobic metabolism.  This process produces lactic acid and cell function is 
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compromised, resulting in the release of chemicals that cause vasodilation (as does 
decreasing pH).  This process is responsible for the hyperperfusion of the limb upon deflation 
of the cuff, but the slower acting (less reversible) vasodilators may also accumulate in the 
limb causing baseline perfusion and oxygenation values to rise until ischaemic insults are 
ceased.  To account for this, reductions in oxygenation were measured from the new baseline.  
It would have been unfeasible for subjects to wait for significantly longer periods of time for 
initial baseline levels to be reached between each inflation.  
 
In practice, the technology underlying the sensor function will only work on those flaps with 
an accessible surface.  As the sensor is designed for wireless function, the electronics 
responsible for processing the signal and transmitting the data are all attached to the ‘probe’.  
Whilst this negates the need for a bedside computer and electric cabling, it adds some size to 
the parts in contact with the skin.  As such, more inaccessible locations such as intraoral, 
perineal area, or those surfaces in close contact with the bed or chair are likely to be 
unsuitable.  That being said, prototypes with a short, wired connection between a thin 
interrogating probe and the remainder of the electronics are entirely feasible.  
 
Implementing the sensor in the clinical setting initially need not immediately change practice, 
with information gathered primarily acting as supplementary to conventional monitoring 
strategies.  As with all new technologies, there will be a learning curve before the full extent 
of benefit is realised.  This will require all healthcare team members having the sensor 
demonstrated and explained, including highlighting the rationale for its use and taking any 
questions or concerns.  There is the potential for any monitoring equipment to be misleading, 
therefore patience and perseverance must be encouraged to avoid any associated adverse 
events. 
 
Further development of the sensor prior to clinical trials can be organised into technical, and 
practical processes.  Technical steps needed include the incorporation of a battery and 
wireless communication module.  The selection of battery should be made considering the 
consequential impact on overall sensor size, and clinical practicalities.  The flap is at highest 
risk for failure within the first 72-hours post-operatively, a duration which may be covered 
with a single battery if sampling at low frequencies.  Options such as sensor battery charging 
in situ, or battery replacement may be considered, taking into account the opinions of 
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patients, and a range of healthcare staff.  For data transmission, low power Bluetooth may 
offer a solution where an intermediate device is used as a local processing unit before the 
information is available remotely.  This device can be as simple as a mobile phone, or tablet 
on the same ward as the patient.   
 
The sensor housing should be safe and functional.  Safety requires medical grade materials, 
testing to gauge the temperature of the lights, absence of sharp edges or exposed electronic 
circuitry.  Although the sensor need not be in contact with the wound site, the ability to 
decontaminate the sensor thoroughly should also be reached.  Functionality requires materials 
that wont prevent signal transmission, will allow a mechanism of adherence to the skin to 
prevent motion artifact or sensor migration, and that will keep the centre of mass close to the 
skin whilst maintaining minimal footprint to improve wearability and stability. 
 
Feasibility studies with the wireless device in healthy subjects over 24-72 hours should be 
conducted to identify technology limitations associated with long-term data collection. 
 
This study provides encouraging data advocating the further development of a miniaturised 
sensor for application in free flap monitoring.  Results from previous clinical trials 
implementing similar flap monitoring technologies reveal potential cost-savings, should the 
price of equipment remain low.  In centres where flap success rates are particularly high, the 
proposed monitoring techniques may facilitate higher risk reconstructions and widen access 
to training opportunities.  
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CHAPTER 8 
CONCLUSIONS AND FUTURE WORK 
 
 
This PhD thesis was planned aiming to build on work conducted at both the Division of 
Surgery and Pervasive Sensing group at the Hamlyn Centre, and the related scientific 
community, addressing specific clinical challenges throughout with bespoke Body Sensor 
Networks (BSN) solutions.   
 
 
8.1.  Functional mobility assessment 
 
The main body of work looked to utilise a wearable motion sensor to inform clinical 
unknowns, and develop a patient assessment tool.  This took the form of clinical studies with 
significant patient and healthcare staff involvement.   
 
 
Objective mobility assessment in the home is feasible using wearable sensor technology 
 
First the sensor was used in the home environment with patients who were recovering from 
knee replacement surgery.  Data was collected before formal analysis methods were 
established, however this was necessary to provide clinical data with which to test data 
mining strategies.  In the first instance, data patterns were characterised by abstract signal 
features, and compared to those from healthy subjects.  This method demonstrated the 
feasibility of using wearable sensors to differentiate between patients and healthy subjects, 
grossly quantify stages of recovery, and identify patients non-adherent to expected 
rehabilitation trajectories in the setting of post-operative complications.  However, peer 
review by clinicians highlighted limitations in the applicability of abstract performance 
metrics. 
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A wearable motion sensing system may provide a valid and reliable objective assessment 
method for patients undergoing lower limb reconstruction.  
 
Clinical review informed the subsequent chapter and clinical trial, in which the Hamlyn 
Mobility Score (HMS) was developed and validated.  The HMS is the first assessment to take 
a combination of well-known functional tests and implement a wearable sensor to extract 
additional kinematic metrics.  In theory, this would allow one to not only assess mobility 
quantitatively in non-specialist environments, but also to characterise mobility limitations 
using constituent parameters.   
 
 
The Hamlyn Mobility Score is able to quantify and characterise a patient’s return to 
functional mobility following post-traumatic lower limb reconstruction.  
 
Application of the HMS proved useful in a prospective 12-month follow-up study of patients 
undergoing post-traumatic lower limb reconstruction.  The score was able to differentiate 
between recovery pathways in patients with fractures of varying severity.  Furthermore, the 
collection of prospective, longitudinal post-operative data in this patient cohort was novel, 
providing unique insight into the recovery process.  A significant finding was the plateau of 
walking speed at 6-months post-operatively, with the continuation of improvements in 
walking quality through to the 12-month time point.  This finding exposes the limitations 
with standard metrics of functional tests when monitoring the latter stages of rehabilitation.  
It also supports the requirement of physical therapy even in the setting of normal walking 
capacity and return to work, to prevent bad habits from becoming fixed. 
 
The HMS has been adopted by collaborators as a useful outcome measure to compare 
surgical management strategies, and pre-operatively as a predictor of post-operative 
morbidity and mortality in elderly patients.  Dissemination of this work and improving the 
availability of the e-AR sensor (or other compatible sensors) may lead to further uptake in 
various healthcare scenarios. 
 
 
 
 !
! 261 
8.2.  Free flap monitoring 
 
A miniaturised, low-power NIRS device is capable of detecting pulsatile blood flow and 
quantifying changes in tissue oxygenation. 
 
While immersed in the extremity reconstruction service, and documenting post-operative 
complications in patient subjects, the role of BSN in the acute setting became more apparent.  
As technology evolves, opportunities for the application of well-established techniques 
outside of the laboratory emerge.  Personal curiosity in 4 large trolley-mounted machines in 
the hospital storage room (later identified as O2C units) led in part to the production and 
development of a wearable tissue oxygenation sensor capable of free-flap surveillance.   
 
Initially, the absence of a reproducible free flap failure model in the literature led to the 
development and evaluation of a new model.  This simple brachial pressure cuff model 
provides incremental changes in distal tissue oxygenation, with both arterial occlusion and 
venous congestion aetiologies simulated by different cuff inflation pressures.  The flap 
monitoring sensor prototype was validated against gold standard equipment using this 
bespoke model.  The sensor was able to quantify the relative reduction in tissue oxygenation 
under controlled laboratory conditions.  Additionally, the ability to detect the presence of 
pulsatile blood flow allows this sensor to differentiate between flap failure aetiologies.  
 
Whilst the associated thesis chapter only reveals the pre-clinical validation of said sensor in a 
flap-failure model, the potential clinical impact is significant.  Typical of BSN, the 
underlying technology has already been proven to improve the detection of flap failure, but 
this sensor overcomes the limitation of current delivery mechanisms including size, cost, and 
data interpretation.  
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8.3.  Future 
 
Functional Mobility Assessment 
 
These works make significant steps towards addressing clinical challenges regarding 
subjective assessments of mobility, the lack of information needed to personalise and adapt 
rehabilitation strategies dynamically, and the detection of complications in the community 
setting.  As with Body Sensor Networks in general, there are multiple opportunities for 
impact in healthcare research and practice.  The absence of quality evidence regarding post-
operative recovery after lower limb injuries makes the e-AR sensor and the HMS a precious 
resource.  Multiple kinematic parameters featured in the HMS are unattainable in traditional 
research environments such as gait laboratories on a large scale.  Reliable and accurate 
mobility assessments could be used to re-establish differences in post-interventional patient 
outcomes, such as amputation versus reconstruction in high-energy open tibial fractures, or 
more generally, in the return of functional mobility following minimal access or open 
surgical procedures. 
 
Clinically, the HMS appears suitable for implementation on a number of levels, each with 
their own set of challenges, and potential for impact towards optimising patient outcomes and 
cost-effectiveness.  The most readily available application is that of a clinic-based assessment 
to be undertaken before outpatient appointments by an appropriately trained technician.  This 
would allow patients to take objective, detailed mobility updates into their appointments of 
which the consulting clinician could use to base further investigations, referrals and other 
management strategies.  It is unpredictable how implementation would change the service, 
and largely dependent on how the information is utilised by clinicians.  The added benefit of 
implementation in the clinic is that within a short period a large database with detailed patient 
outcomes would be available to service managers for evaluation of management decisions 
between staff, and overall success within the department.  
 
An application of greater complexity is implementation of such systems in the community 
setting.  Restricted healthcare budgets and the changing healthcare needs of communities in 
the UK are acting as stimuli for accelerating the rationing of specialist services and shifting 
appropriate care provisions into the community.  Periodic and pro re nata assessments at the 
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patient’s home or in a community centre might offer a more cost-effective solution for 
determining the need for specialist consultations.  This is likely to improve the availability of 
clinic appointments for urgent cases at short notice, and may reduce Accident and Emergency 
attendances.  The challenge in this case is the amount of service re-structuring required, and 
the risk of vulnerable patients groups failing to seek healthcare support in the absence of 
routinely scheduled post-operative appointments.  In conjunction with community 
implementation there are options for more intensive patient monitoring and motivational 
approaches.  In theory, a patient discharged from hospital could conduct his or her own 
sensor-led assessment at frequent intervals.  Not only would this provide relatively ‘real-
time’ reports on outpatient progress to the healthcare provider, but it would also deliver 
information to the patient to act as reassurance and motivation, in the guise of a technology-
based rehabilitation platform.  Such motivational methods may trigger psychological 
responses and behaviours capable of expediting recovery.  
 
In summary, the HMS is adequately positioned for future research as a quality metric 
whenever mobility is considered as an important patient outcome.  In this arena, the HMS is 
objective, repeatable, resource sparing, and thorough, unlike other available mobility scores.  
Clinically, the HMS could provide a useful adjunct for patient assessment within multiple 
specialties, supplementing the information currently used to make patient management 
decisions.  There is also potential for considerable disruption to the current post-operative 
care paradigm through implementation of the e-AR sensor in the community setting 
throughout rehabilitation.  
 
 
Flap monitoring 
 
Considering the preclinical state of this research stream, future work must first look towards 
the technical challenges in developing the current sensor prototype into a medical grade 
device fit for every day use.  This includes sensor miniaturisation, placement, user interface 
and connectivity.  Patient and staff involvement is particularly important for these steps, as 
the uptake of new technologies can hinge on their acceptance by these groups.  Small group 
discussions or workshops where participants are encouraged to share ideas and voice 
concerns might prove valuable.   
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Following production of a medical-grade device, ‘real-life’ data are required to expose and 
characterise the challenges that were controlled in the laboratory validation study.  Motion 
artifact is likely to be one of the most significant challenges, possibly requiring the addition 
of a motion sensor to the device to help filter aberrant data.  Growing data series observed in 
the context of conventional monitoring strategies will provide opportunities to compare and 
contrast data representing uneventful recoveries to those featuring complications.  Compiling 
a library of data alongside known clinical events is an essential step to take before 
considering interventional schemes. 
 
A device such as the one described has extensive utility in both research and clinical 
applications.  Not only might it provide insight into free flap physiology, but there is also 
scope within vascular surgery and possibly the intensive care setting.  Revascularisation 
surgery in the setting of peripheral vascular disease is more prevalent than free flap 
reconstruction (particularly whilst non-free flap breast reconstruction remains common 
practice).  This device could be used to monitor distal tissue viability and hence the patency 
of the vascular graft.  Equally in intensive care, tissue oxygenation may provide a more 
sensitive metric in critically ill patients, such as those undergoing resuscitation following 
haemorrhage.  
 
Should the device prove useful in detecting tissue changes of interest in the clinical setting, 
further staff engagement is required to explore and optimise the healthcare team’s post-
operative monitoring strategy based on the new sensor, before attempting to measure the 
benefits related to cost-effectiveness resulting from wider implementation.  Patient safety is 
paramount, therefore sensor data should initially supplement rather than dictate clinical 
decision-making. 
 
The potential clinical benefit of the flap monitoring sensor is not based solely on the 
improvement in patient outcomes, but also the potential for reduced resource demand 
throughout post-operative surveillance.  In additional to saving money, the device may 
facilitate increased safe surgical output from a unit as the monitoring process is streamlined. 
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Considering BSN in general, the technology in terms of size and communications methods 
etc. appears to exist at a high enough standard to offer solutions to multiple clinical 
challenges.  In the long-term, it may be necessary to conduct a small overhaul of the structure 
and function of the NHS to accommodate the next generation of care strategies.  Whilst 
incremental changes can be implemented with less disruption, designing new medical devices 
and chronic disease schemes to fit into the current healthcare architecture and IT 
infrastructure might be too shortsighted.  Sensors record huge amounts of patient data.  
Techniques used to explore ‘big data’ would be suited to that collected by BSN to provide 
greater insight into healthcare matters of an epidemiological nature.  Sensor data can also 
provide information to the patient and their family.  This provides an opportunity to educate 
patients, and allow safe self-management of a number of conditions.  The more invisible 
BSN, such as those sensors found in smart phones, watches or clothes, can also be utilised in 
the pre-pathological setting.  Physical activity data has multiple applications in this setting, 
including acting as a previously unavailable mobility baseline for trauma patients.  There is 
also crossover from healthcare applications into entertainment and lifestyle functions for 
wearable sensors, such as using a wrist-worn sensor as an electronic key, or a heart rate 
monitor linked to the alarm clock to allow waking during light sleep phases. 
 
 
8.4.  Concluding remarks 
 
BSN have been shown on an increasing number of occasions to provide potential solutions to 
a wide range of clinical challenges.  In some scenarios, BSN are capable of facilitating 
evidence based care where it is not yet practiced.  In others, it will allow care to be provided 
outside of specialist settings, redistributing the limited resources available.  Technology is 
often associated with replacing human interaction, but the home monitoring strategies 
outlined in this thesis actively encourage patient and staff coordination, bridging the gap 
between inpatient and outpatient care.  BSN allow patients to take responsibility for suitable 
aspects of their care, and take a proactive approach to rehabilitation.  The lottery of 
subjectivity can be reduced with more robust metrics, collected in some cases continuously.  
Interventional clinical trials, with robust study designs must now start to be prepared to 
evaluate the clinical value of platforms such as the HMS and optical free flap sensor in real-
life settings.!  
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MBPHD: AN OPPORTUNITY TO LAY DOWN THE FOUNDATIONS FOR 
SPECIALIST TRAINING 
 
 
The personal specifications supplied by Modernising Medical Careers (MMC) for specialist 
surgical training, aside from basic eligibility, include proficiency in clinical skills, 
documentation of surgical exposure, understanding of basic clinical research principles, 
participation in teaching, appropriate personal skills (communication, problem solving, team 
involvement, organisation), professionalism, and commitment to specialty.  These are 
required to satisfy the hospital, the trainers, and increasingly the patients, who have very high 
expectations of standards of care.  Reduced training duration and density makes attaining the 
expected levels of the core competencies challenging, which may impact upon one’s 
likelihood of securing a specialist training post and, equally importantly, being able to 
progress satisfactorily to (and beyond) the point of completion of training.  The MBPhD, a 
‘triple therapy’ of BSc, PhD and MBBS during medical school may have originally been 
designed in the hope of developing the next generation of clinician-scientists, but this article 
explores how it may also provide an enhanced route into specialist surgical training. 
 
MBPhD is the abbreviated title to a course in which a student, whilst at medical school, is 
granted 2-3 years away from the conventional course to pursue a higher degree.  This results 
in acquiring a BSc, PhD and MBBS during an 8 or 9-year course.  It is currently offered at a 
limited number of medical schools, including the University of Cambridge, University 
College London, Imperial College London, and the University of Leicester.  In order to be 
eligible to apply, applicants are required to be registered on a medical degree course, attain at 
least an upper second class BSc, and have a ‘resit-free’ academic record.  The development 
of basic research skills and topic familiarisation during the BSc allows many elements of the 
adjoining PhD to be streamlined.  All MBPhD students are required to submit their PhD 
thesis before being re-integrated into the final stages of the MBBS programme. 
 
First and foremost, an adequately supervised PhD should assure a thorough understanding of 
research principles, and hopefully result in meaningful contribution to the scientific literature.  
With a background, and therefore insight into the clinical setting and its associated 
challenges, students are in a strong position to promote the translational aspects of their 
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research.  In addition to academia, the unique setting of the MBPhD supports a more holistic 
development. 
 
Importantly, the PhD is conducted alongside mandatory continuation of clinical placements.  
Matching the placement to the student’s interests can easily facilitate 3 extra years of flexible 
training in a chosen specialty, providing opportunities for: 
 
o Consolidation and application of preclinical knowledge 
o Developing history taking, patient examination and procedural skills 
o Observation or participation in operative cases 
o Development of interpersonal skills with both patients and colleagues 
o Experiencing life ‘on the job’ to aid career choice 
 
Students are also encouraged to take part in teaching.  A flexible schedule allows more 
formal participation in education, such as leading regular problem-based learning (PBL) 
groups or demonstrating human anatomy throughout the undergraduate course.  In the latter 
stages of the PhD, students may themselves supervise BSc or MSc projects in collaboration 
with their supervisors.  
 
Both the academic work and clinical placement allow the development of enhanced personal 
skills.  Research often involves collaborating with team members from a variety of 
backgrounds, with their own agendas, in departments where output is under close scrutiny.  
Coordinating multiple parallel projects, alongside extra departmental responsibilities such as 
public relations and contributing to grant applications, can test the management skills of the 
most organised student.  Experience in these tasks, and learning how to yield successful 
outcomes from such responsibilities, has excellent potential for translation into clinical 
scenarios.  
 
Although many students will address some of the core competencies during a standard 
medical degree and early post-graduate training, developing them to a meaningful depth is 
difficult.  To consider surgical exposure, medical student and foundation year rotations are 
brief, and ward work can produce a significant demand on time.  Reduced working hours, and 
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the understandably protective nature of current specialist trainees on their operative training 
time, results in minimal surgical opportunities for junior doctors. 
 
The MBPhD programme isn’t free from limitations.  A much more popular option is to 
undertake a PhD at some point during early post-graduate training.  A selection of 
considerations for choosing the early route are listed below: 
 
Pros Cons 
Early development of skills amplifies the potential 
gains during career (inc. job applications) 
Early establishment of career direction is preferable 
or the PhD may not complement eventual specialty 
More competent during foundation jobs Non-clinician-related constraints to research projects 
Flexible clinical commitments only Scarcity of funding 
Relative financial boost, rather than the untimely 
pay-cut often experienced by clinicians 
Principal investigators often want qualified doctors 
for clinical research positions 
Informs career choice decision Lack of universities offering MBPhD 
Opportunity to meet clinical role models/mentors Post-MBPhD routes are not yet formalised 
Not necessary to take time away from specialist 
training 
Fall behind your peer group 
Premeditated rather than dictated  
 
 
The rarity of the MBPhD, along with a lack of published data following up MBPhD 
graduates, makes it difficult to quantify its value, or describe the output.  However, data are 
available from equivalent courses in the United States, where over 100 medical schools offer 
MDPhD programmes.  The Association of American Medical Colleges (AAMC) reports that 
95% of MDPhD graduates pursue specialist clinical training, with 50% remaining involved in 
further significant research. MDPhD graduates make up just 2.5% of US medical school 
graduates, yet they account for 40% of the NIH grants awarded to physicians. 
 
Increasing numbers of medics are completing higher degrees.  The MBPhD programme is 
likely to be an attractive option to many, and should therefore be made known to UK medical 
schools in order to improve the availability of positions to appropriate students.
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APPENDIX 
 
Chapter 4 Forms 
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~ Wireless Home Monitoring Study ~ 
 
PATIENT INFORMATION SHEET & CONSENT FORM 
 
‘You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you 
wish to take part. 
 
Thank you for reading this.’ 
 
1. What is the purpose of the study? 
 
This study aims to assess the usefulness of wireless sensors to measure your vital 
signs such as heart rate, movement and efficiency of breathing when you are at 
home following your operation. At present after you are sent home, you will attend 
various outpatient appointments in the hospital and in the GP clinic. Wearing the 
body sensors will not change any of this, but will provide us with additional 
continuous measurements of your vital signs. These measurements can be sent 
wirelessly through a phone network to us, and will be stored on a secured computer 
database. Because the sensors are wireless, you will be able to wear them wherever 
you go around the house. The study will start from the time you are sent home and 
will last 2 days. 
 
2. Why have I been chosen? 
 
You have been chosen to participate in this study as you are undergoing an 
operation on your knee. We are interested in being able to monitor your wellbeing 
following this operation once you have left hospital and are in your own home. We 
plan to use wireless technology to do this in 30 patients. 
 
3. Do I have to take part? 
 
It is up to you to decide whether or not to take part.  If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason.  A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
 
4. What will happen to me if I take part? 
 
If you agree to take part we will pay you 6 home visits when we will ask you to wear 
sensors that measure you heart rate, oxygen level, and movement of your body. 
Each visit will last for 30 minutes, and a physiotherapist will be present in the first two 
visits, and will perform routine exercises with you. The 6 visits will be: 1 week before 
the operation, then 1 week, 3 weeks, 8 weeks, 16 weeks, 24 weeks after the 
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operation.  Assessment may also occur in the gait laboratory at Charing Cross 
Hospital at your convenience.  
 
5. What do I have to do? 
 
You will not be restricted from any activity that you would normally do in your home, 
but will be asked to wear the sensors at all times except when taking a bath or 
shower. Also if you recover quickly and leave the house, you will be able to take the 
sensors off and do so. The sensors will only work when you are at home. If you 
agree to take part in the study, we will ask you to fill in two short questionnaires 
before and after the study, which is not likely to take more than 10 minutes in total. 
 
6. What different types of Body Sensor do you have to wear? 
 
These consist of: 
 
1. A motion sensor for inferring gait and posture  
2. A heart rate and blood oxygen sensor 
3. A small communicator that is worn on a belt or around your neck, or can even 
sit in the same room as you. This collects the vital signs information from the 
sensors and sends it wirelessly to us. 
 
7.   What happens to the recording? 
 
Recordings of your heart rate, movement, and efficiency of breathing are taken, 
evaluated, and wirelessly sent to a secure encrypted database for us to access. We 
can compare this with other measures of the improvement of your knee. 
 
8. What are the possible disadvantages and risks of taking part? 
 
Because all the sensors we use have been tested and licensed for use in patients, 
we do not feel that there is any additional risk that you are exposed to. If the sensors 
stop working, this in no way affects your treatment, home visits, or recovery. 
 
9. What are the possible benefits of taking part? 
 
Wearing the wireless body sensors does not directly affect your treatment or 
recovery but allows us to develop a new tool for looking after patients who have 
undergone surgery, in their home environment. 
 
10. What happens when the research study stops? 
 
When the study ends, we will take the sensor equipment from you, analyse the 
results, and see how our system can be improved. 
 
11. What if something goes wrong? 
 
Imperial College London holds insurance policies which apply to this study.  If you 
experience harm or injury as a result of taking part in this study, you may be eligible 
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to claim compensation without having to prove that Imperial College is at fault.  This 
does not affect your legal rights to seek compensation. 
 
If you are harmed due to someone’s negligence, then you may have grounds for a 
legal action.  Regardless of this, if you wish to complain, or have any concerns about 
any aspect of the way you have been treated during the course of this study then 
you should immediately inform the Mr Julian Leong (contact details below).  The 
normal National Health Service complaint complaints mechanisms are also available 
to you.  If you are still not satisfied with the response, you may contact the Imperial 
College Clinical Research Office.   
 
12. Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the research will be 
kept strictly confidential.  Any information about you which leaves the hospital will 
have your name and address removed so that you cannot be recognised from it. 
 
13. What will happen to the results of the research study? 
 
The results of the research will be analysed and published in scientific journals. We 
will happily provide you with a copy of the results. 
 
14. Who is organising and funding the research? 
 
The research is being organised and funded by Imperial College London to develop 
these wireless sensors. 
 
19. Who has reviewed the study? 
 
The study has been reviewed by the regional ethics committee at St. Mary’s 
Hospital. 
 
20. Contact for Further Information 
 
If you have any questions at this point please ask the person consenting you 
for the use of these sensors. In case of further questions, please contact: 
 
Mr. Richard Kwasnicki BSc (Hons.) 
Clinical Research Fellow 
Department of Surgical Oncology & Technology, Imperial College 
10th Floor QEQM Building 
St. Mary’s Hospital 
London W2 1NY 
 
Email:  rmk107@imperial.ac.uk 
Telephone:  07851759471 
 
You will be given a copy of the information sheet and a signed consent form to 
keep  
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Centre Number:  
Study Number: 
Patient Identification Number for this trial: 
 
CONSENT FORM 
 
Title of Project: 
 
Wireless Home Monitoring of the Post-operative Surgical Patient 
 
Name of Researcher: 
 
Mr. Richard Kwasnicki BSc 
Clinical Research Fellow 
Department of Surgical Oncology & Technology, Imperial College 
10th Floor QEQM Building 
St. Mary’s Hospital 
London W2 1NY 
Email:  rmk107@imperial.ac.uk 
Telephone:  07851759471 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet dated ............................  !
 for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  !
 without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at by responsible ! 
 individuals from Imperial College or from regulatory authorities where it is relevant to my 
 taking part in research.  I give permission for these individuals to have access to my  
 records. 
4. I agree to take part in the above study.   ! 
 
________________________ ________________ ____________________ 
Name of Patient  Date Signature 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
_________________________ ________________ ____________________ 
Researcher   Date  Signature 
 
(COPIES: 1 for patient, 1 for researcher, and 1 to be kept with hospital notes)  
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Short Form Health Survey (SF-36) 
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Chapter 5 and 6 Forms 
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NIHR Portfolio adoption letter 
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Investigating Lower Limb Trauma 
 
Mr Richard Kwasnicki 
Institute of Global Health Innovation 
Bessemer Building 
South Kensington Campus 
London SW7 2AZ 
United Kingdom 
Email:   richard.kwasnicki07@ic.ac.uk 
Telephone:  +44 (0)20 7594 0806 
 
PARTICIPANT INFORMATION SHEET 
 
‘You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you 
wish to take part. 
 
Thank&you&for&reading&this.’&
 
 
1. What is the purpose of the study? 
 
We are interested in seeing how people regain the ability to perform activities of daily 
living (such as walking, standing, ascending stairs etc) after having surgery following 
an injury to one of their legs. The movements of study participants will be measured 
using a lightweight sensor (see picture).   
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This research will also be forming part of a PhD thesis at Imperial College. 
 
 
2. Why have I been chosen? 
 
You are invited to participate in this study as you have undergone surgery following 
an injury to one of your legs. 
 
 
 
3. Do I have to take part?  ! !
You decide whether or not to take part.  Please contact Richard Kwasnicki (details 
above) if you are interested in doing so.  If you decide to take part you will be asked 
to sign a consent form.  You are still free to withdraw at any time without giving a 
reason.   
 
 
4. What will happen to me if I take part? 
!Please!see!the!following!timetable:!
 
1 You have received this participant information sheet before your clinic appointment. 
2 
After your clinic appointment, you will have the opportunity to ask any questions to the 
researcher before you decide whether or not to take part.  If you are happy to participate, 
you will be asked to read and sign a consent form. 
3 
Following consent, you will be asked to complete a short health survey (SF-36), before 
being accompanied by the researcher and member of direct care team to the private, on-
site activity area (Charing Cross Hospital Rehabilitation Gymnasium).  You will be asked 
to undertake a number of short tasks (see below), such as sitting and standing, walking, 
ascending and descending stairs (a trained healthcare professional will be supervising, but 
you will only be asked to do what you feel comfortable with).  For some of these tasks, you 
will wear the miniature motion sensor shown above.  Completion of tasks and 
questionnaires will take 20-30 minutes. 
4 Any sensor/s are removed and you have completed the study. 
!Tasks!
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1. Walking up and down 12 stairs 
2. Standing up, walking 3 meters, returning to the chair, and sitting down 
3. Walking/running as far as comfortably possible in 9 minutes (if you want to 
take standing or seated rest during the 9 minutes this is quite acceptable).   
 
The data captured will only be used by the researchers in this project and will be 
completely anonymised. This data will be securely stored in a database at Imperial 
College. 
 
The study takes less than 1 hour, and therefore it is highly unlikely that you will lose 
mental capacity during the study.  However, should you do so, you will be withdrawn 
from the study.  If data has been collected before the loss of capacity, we may still 
use the data in the study to avoid introducing a scientific bias.  Participant in the 
study does NOT increase changes of losing capacity.  There are no risks associated 
with participation. 
 
 
6. What happens to the data collected? 
 
Data collected from the sensor will be stored on a secure encrypted database. The 
data will be completely anonymised and securely stored.  The data will be processed 
to give the investigators a more manageable value of physical activity for each 
participant.  Important:  None of the data collected from the study will be used 
to influence your further management.  You will receive the same care whether 
you participate or not. 
 
 
7. What are the possible disadvantages and risks of taking part? 
 
During this study, you will be asked to complete some simple activities of daily living 
(outlined above).  Trips and falls can occur during daily life outside of this study and 
are somewhat unpredictable.  We will not ask you to perform any activities that you 
are not comfortable with.  During the activities that you do, there will be an 
appropriately trained medical professional present for support.  In addition, should 
there be an accident such as a trip or fall, the rehabilitation gymnasium is within 
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hospital grounds and there are well-practised protocols for further medical support 
on site if necessary. 
 
The motion sensor is a CE approved device and is completely safe.  The sensor 
does not affect any other electrical equipment that you might carry. Apart from your 
participation today, you will not be asked to attend the clinic any more than you 
would without taking part.  We understand that one may become anxious about 
taking part in a research study, and as such we would like to invite you to call the 
support number on this information sheet should you have any concerns. 
 
Although there is no financial incentive to participate, you are entitled to reasonable 
travel expenses for any visits to the clinic over and above standard clinical care 
visits. 
 
 
8. What happens when the research study stops? 
 
After the sensor/s are removed, your participation is complete.   
 
 
9. What if something goes wrong? 
 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action.  Regardless of this, if you wish to complain, 
or have any concerns about any aspect of the way you have been treated during the 
course of this study then you should immediately inform the Investigator  (Insert 
name and contact details).  The normal National Health Service complaints 
mechanisms are also available to you.  If you are still not satisfied with the response, 
you may contact the Imperial AHSC Joint Research Office.  
 
 
10. Will my taking part in this study be kept confidential? 
 
All information collected about you during the course of the research is strictly 
confidential.  Any information about you which leaves the clinic will have your name 
and details removed. 
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11. What will happen to the results of the research study? 
 
The results of the research will be analysed and published in scientific journals. We 
will happily provide you with a copy of the results after publication. 
 
 
12. Who is organising and funding the research? 
 
The research is being organised by Imperial College who have received funding from 
the EPSRC (Engineering and Physical Sciences Research Council). 
 
 
13. Who has reviewed the study? 
 
External experts in relevant technological and medical fields have reviewed the study 
methodology.  The West of Scotland Research Ethics Committee 3 has also 
reviewed the study.  
 
 
14. Contact Richard Kwasnicki (details above) for Further Information and 
support 
 
OR  
 
for independent advice please contact: 
 
Patient Advice and Liaison Service (PALS) 
Ground floor of Queen Elizabeth the Queen Mother (QEQM) wing, St Mary's 
Hospital. Open Monday to Friday, from 10.00 to 16.00 
PALS address: PALS manager, Ground floor, Clarence wing, St Mary’s Hospital, 
London W2 1NY Telephone: 020 3312 7777, Monday to Friday from 09.00 to 
17.00 Text phone: 07962 985118 Fax: 020 3312 1753 Email: pals@imperial.nhs.uk 
 
 
 
 
Participants will be given a copy of the consent form and information sheet to keep  
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Site:  
Patient Hospital Number: 
Subject Identification Number for this trial: 
 
CONSENT FORM 
 
Title of Project: 
 
Investigating Lower Limb Trauma 
 
Name of Researcher: 
Mr Richard Kwasnicki 
Institute Global Health Innovation 
Bessemer Building 
South Kensington Campus 
London SW7 2AZ 
United Kingdom 
Email:   Richard.kwasnicki07@ic.ac.uk 
Telephone:  +44 (0)20 7594 0806 
 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet dated ............................  !
 version 1.3 for the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  !
 without giving any reason, without my medical care or legal rights being affected. 
3.   I understand that sections of any of my medical notes may be looked at by responsible               ! 
     individuals from Imperial College, the NHS Trust or from regulatory authorities where it is relevant  
to my taking part in this research. I give permission for these individuals to access my records that are   
relevant to this research. 
4.  I understand that if I was to lose capacity to consent during the study, although no further            ! 
     data would be collected, the data already collected may still be used in the study. 
5. I agree to take part in the above study.   ! 
 
 
 
________________________ ________________ ____________________ 
Name of Participant  Date Signature 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
_________________________ ________________ ____________________ 
Researcher   Date  Signature 
 
 
(COPIES: 1 for participant, 1 for researcher, 1 for medical notes)  
 !
! 287 
Investigating Lower Limb Trauma  
Imperial College Plastic and Reconstructive Surgery / Hamlyn Centre 
Mr Richard M Kwasnicki 
 
Name______________________________________ Study ID _______________Hosp 
No.________ 
DOB ___________________________ Age ___________________Sex     M / F 
Height (m) ________________Weight (Kg) _________________BMI ______________ 
 
Please Circle (or add as necessary) 
 
 
* 1 unit = small (125ml) glass of wine, half pint of beer (4%), one shot (25ml) of 40% spirit 
 
 
  
Ethnic Group White: 
British 
Irish 
Other  
_____________ 
_____________ 
_____________ 
Mixed: 
White and Black 
Caribbean 
White and Black 
African 
White and Asian 
Other 
______________
__ 
Asian: 
Indian 
Pakistani 
Bangladeshi 
Other 
__________ 
__________ 
__________ 
Black: 
Caribbean 
African 
Other 
______________ 
______________ 
______________ 
Chinese 
Other 
__________________ 
__________________ 
__________________ 
Education Secondary 
School (GCSE) 
Sixth Form 
(A-Level/IB) 
University 
Degree 
(BA/BSc, MA 
etc) 
Higher Degree 
(MD, PhD) 
 
Employment Yes No    
Marital 
Status 
Married/Civil 
partnership 
Domestic 
partnership 
Partner Single Divorced/Widowed 
Smoking Never smoked Former smoker Yes, less than 
10 per day 
Yes 10-20 per 
day 
Yes, more than 20 pd 
Alcohol* None 0-10 units pw 10-24 units pw More than 24 
units pw 
 
Exercise None 1-2 x pw 3-4 x pw More than 5 x  pw  
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Hamlyn Mobility Score 
Date ___________________ Start Time ____________ End Time _____________ Sensor _____ 
Patient Name __________________________________ Hosp Number ______________________ 
 
Timed up and down stairs (TUDS) 
 
Subject asked to walk up 10 stairs, turn around, and go back down (not required to turn around at 
bottom).  Subjects are allowed to use one handrail, and can use mobility aids (stick, crutches). 
 
‘Starting facing forward, walk up to the top of the flight of stairs, turn around quickly but 
comfortably, and return to the bottom of the stairs.  When at the base of the stairs, please stand still 
and look straight ahead, you don’t have to turn around again.  You may use the handrail, and any 
regular walking aids (stick, crutches)’ 
 
Start  Comments  
 
 
 
Timed up and go (TUG) 
 
Subject starts sitting in a stable chair with back support, but no arm rests (if chair has arm rests 
patients must not use these to stand or sit).  Chair must be 30-40cm high. Subject asked to stand and 
walk 3 meters, turn around, and walk back to the chair, and sit down.  Subjects are free to use 
mobility aids (stick, crutches).  
 
‘Starting sitting down, stand up and as soon as you are happy to do so, walk forward 3 meters (to 
marker), turn around, and without pausing, return to the chair and sit down.  When you are sat, 
please remain still and look straight ahead’ 
 
Start  Comments  
 
 
 
6 minute walk 
 
Subject asked to walk for 6 minutes on flat ground.  Walking can be round a track, or the perimeter of 
a large room, so long as a turn doesn’t occur less than every 15 meters.  Subjects are allowed to rest 
(stop or sit) at any point, for as long as they want.  Examiner must not walk alongside the patient. 
 
‘Walk as far as possible in 6 minutes between point A and point B (direct as appropriate).  You are 
free to rest, sitting or standing, at any point as many times as you like’ 
 
Start  Comments  ! !
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Participant!Feedback!Form!Investigating!Lower!Limb!Trauma!!Date!_____________/___________/___________!!!!!!!!!!!!!!!!!!Day!!!!!!!!!!!!Month!!!! !!!!!!!Year!!Participant’s!Full!Name/Id:!___________________________________________!!
 Strongly 
Disagree 
Disagree Neither 
agree/disagree 
Agree Strongly 
agree 
The sensor was easy 
to put on and take off 
     
Wearing the sensor 
did not affect your 
activities 
     
I am happy with the 
amount of feedback I 
receive on my 
progress 
     
I would be happy to 
wear the sensor at 
home for assessment 
once a day 
     
I would be happy to 
wear the sensor all the 
time 
     
I would prefer to be 
tested in the clinic 
     
I would prefer being 
assessed by a physio 
than by a sensor 
     
I would prefer being 
assessed by a doctor 
than by a sensor 
     
I saw the physio 
within 3 months of 
my operation 
     
I would like more 
physiotherapy 
     
I know which 
exercises I should be 
doing at home  
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 !
! 291 
Chapter 7 Forms 
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INFORMATION SHEET  
 
Project title: Pervasive Biological Profiling for Sports Monitoring 
   Imperial and Loughborough Pilot Studies 
 
 
You are being invited to take part in a research pilot study.  Before you decide 
it is important for you to understand why the research is being done and what 
it will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you 
wish to take part. 
 
&
What&is&the&purpose&of&the&study?&
This pilot study aims to test/evaluate and validate novel testing techniques in order to 
determine feasibility for a main study. The main study aims to monitor dynamic 
changes in a range of biomechanical, physiological and biological factors within 
athletes’ normal training and competition environments. This will therefore provide a 
far more realistic setting than existing laboratory-based ‘snapshot’ testing procedures. 
It is hoped that the performance knowledge attained will translate into novel and 
innovative training and feedback tools for smarter athletic development. !!
Why&have&I&been&chosen?&
You are invited to participate in this pilot study as a healthy adult volunteer with no 
known medical problems. 20 participants will be recruited at each of four sites 
(Imperial College London; Queen Mary, University of London; Loughborough 
University; University of Bath). After this pilot study a main study will commence 
involving up to 200 participants. !!
Do&I&have&to&take&part?&
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time without 
consequence and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect you in any way. You will be remunerated for 
travel and dietary expenses only.  !!
What&will&happen&to&me&if&I&take&part?&
Within a 2-3 month period you would wear one or more sensors and would be 
subject to one or more schedules to collect biological samples of sweat, saliva, urine 
and capillary blood. You will be asked to complete daily or minor exercise activities 
that may last 1-2hrs or cover a 24hr period.  Some participants may be monitored in 
the workplace.  
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The sensors are small, lightweight and are designed to not affect daily activity or 
movement in any way: 
 
1. The e-AR ear-worn activity recognition sensor to measure continuous body 
motion in 3 dimensions and monitor physiological parameters. 
2. Other wearable sensors that attach to different parts of your body to observe 
limb motion and posture, and other commercially available sensors for sports 
performance assessment (e.g. global positioning, electrocardiography, 
galvanic skin response, temperature, oxygenation). 
3. A small (3cm2) plastic sweat sensor held against the skin with medical tape. 
Sweat acidity level will be recorded by camera every 5-15min, whilst the 
sensor will be replaced up to 4 times a session to harvest collected sweat. 
4.  Standard health measures (e.g. stress questionairres) and, if available, 
ambient sensors will be used to monitor participants (e.g. sound, facial 
movement, temperature).    
 
For comparison and validation with conventional laboratory testing procedures, you 
would be subject to zero or more of the following procedures. The sample collection 
techniques will be taken at discrete time points and so aim to provide minimal 
discomfort or disruption to the activities: 
 
1. Saliva collection by direct expectoration, up to 6 times a session. 
2. Urine sample, either once per 24hrs or a timed sample over 1-2hrs. 
3. Capillary blood samples through pinprick, not more than 8 times per session. 
 
Your biological samples unused at the end of the project will be destroyed, unless 
additional NHS Research Ethics Committee permission has been granted for further 
testing in future related project(s). !!
What&do&I&have&to&do?&
You do not need to alter your diet or lifestyle. Whilst the sampling is designed to be 
pervasive, samples must be collected timely with the schedule that will be 
communicated to you at the start of the testing session. You will be asked not to eat, 
brush teeth or drink hot fluids for 1 hour prior to saliva collection.  !!
What&is&the&device&that&is&being&tested?&
The e-AR limb sensors are CE marked and have been tested by others previously 
but the effectiveness will be assessed. The sweat sensor is more novel and will be 
the focus of the pilot testing. Monitoring devices will not interfere in any way with 
mobile phones, portable music players, hearing aids, or other electronic devices. !!
What&are&the&possible&disadvantages&and&risks&of&taking&part?&
There are no financial costs involved with your participation, only your time. You 
should state if you are receiving similar procedures as part of another trial or other, 
as this may affect your eligibility for this study.  
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A trained first aider will be at hand at all times. In any case of mishap a medical 
doctor will be contacted immediately if on-site, otherwise participants are advised to 
immediately seek medical assistance from their local GP or hospital. !!
What&are&the&possible&benefits&of&taking&part?&
Personalised information will not be fed back to you, but anonymised results will be 
presented back to you as the study progresses. The basis of these results may be 
used to develop innovative training and feedback tools that would become available 
to athlete groups in future. We also anticipate new information on workplace stress. !!
What&happens&when&the&research&study&stops?&
When the study ends, the monitoring and sampling will cease. !!
What&if&something&goes&wrong?&
Imperial College London holds insurance policies which apply to this study.  If you 
experience serious and enduring harm or injury as a result of taking part in this 
study, you may be eligible to claim compensation without having to prove that 
Imperial College is at fault. This does not affect your legal rights to seek 
compensation. If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action.  Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been treated during the course of 
this study then you can inform the Chief Investigator at any stage during or after the 
study. He will action the standard complaints procedure and advise you on the 
process as well as give further explanation or clarification as required by you. 
Ultimately, there will be a formal written explanation and response made to you as 
well a advice on further action should you require it: 
 
Prof. Guang-Zhong Yang 
Institute of Biomedical Engineering 
Bessemer Building 
South Kensington Campus 
London SW7 2AZ 
+44 (0) 20 7594 1499   
 
If you are not satisfied with the response, you may contact the Imperial AHSC Joint 
Research Office (independent contact details given at the end of this document). Will!my!taking!part!in!this!study!be!kept!confidential?!
All information collected about you during the course of the research is strictly 
confidential.  Any data and samples will have your name and details removed so you 
cannot be recognised from them. 
 
Our procedures for handling, processing, storage and destruction of your data are 
compliant with the Data Protection Act 1998. Our procedures for handling, 
processing, storage and destruction of your biological samples are compliant with 
the Human Tissue Act 2004. !
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What&will&happen&to&the&results&of&the&research&study?&
The results of the research will be analysed and published in scientific journals. We 
will happily provide you with a copy of the results.  For some athletes historical 
performance data may be analysed to better assess health and performance 
changes.     !!
Who&is&organising&and&funding&the&research?&
The research is being conducted at the University of Bath, Loughborough University, 
Queen Mary, University of London and Imperial College London; through a research 
collaboration coordinated by Imperial College London who have received funding 
from the EPSRC (Engineering and Physical Sciences Research Council). !!
Who&has&reviewed&the&study?&
The study has been reviewed by the NHS South East London 3 Research Ethics 
Committee. 
Contact&for&Further&Information&
If you have any questions please ask the person consenting you. In case of further 
questions or concerns, please contact the individuals below: 
 
Thank&you&for&reading&this.’&
 
Research contact: 
Dr Benny Lo 
Institute of Biomedical Engineering 
Bessemer Building 
South Kensington Campus 
London SW7 2AZ 
 
Email:  benlo@doc.ic.ac.uk 
Telephone:  +44 (0)20 75818024 
 
Independent contact: 
Lucy Parker 
Joint Research Office 
G02, Sir Alexander Fleming Building 
South Kensington Campus 
Imperial College London 
 
Email:  lucy.parker@imperial.ac.uk 
Telephone: +44 (0)20 75941898 
 
You&will&be&given&a&copy&of&the&information&sheet&and&a&signed&consent&form&to&
keep.!
!
 
Centre Number:  
Study Number: 
Subject Identification Number for this trial: 
 
 
CONSENT FORM 
 
Project Title:  Pervasive Biological Profiling for Sports Monitoring 
   Imperial and Loughborough Pilot Studies 
 
Researcher: 
Dr Benny Lo 
Institute of Biomedical Engineering 
Bessemer Building 
South Kensington Campus 
London SW7 2AZ 
 
Email:  benlo@doc.ic.ac.uk 
Telephone:  +44 (0)20 75818024 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet dated .....................        !
 for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  !
 without giving any reason, without reprisal, my medical care or legal rights being affected. 
 
3. I agree to take part in the above study.            ! 
 
 
 
_________________________ ________________ ____________________ 
Name of Participant Date Signature 
 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(If different from researcher) 
 
 
_________________________ ________________ ____________________ 
Researcher Date  Signature 
 
 
(COPIES: 1 for participant and 1 for researcher) 
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